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Summary
Summary
The Myc family of proto-oncogenes encodes transcription factors that play a pivotal 
role in regulating cellular proliferation, cellular growth, differentiation and apoptosis. 
To regulate cellular grovyth, it can activate a number of RNA polymerase II- 
transcribed genes which encode ribosomal proteins, translation factors and other 
components of the biosynthetic apparatus. c-Myc can also directly activate 
transcription by RNA polymerases I and III, thereby stimulating the production of 
ribosomal (r)RNA and transfer (t)RNA. As such, c-Myc may possess the capacity to 
induce the expression of all the ribosomal components. The work in this project 
akned to investigate the mechanisms behind the c-Myc-dependent activation of RNA 
polymerase III transcription.
One mechanism by which activators of pol III transcription can stimulate the 
expression of class III genes is by promoting transcription complex formation. It had 
been previously demonstrated that c-Myc can interact with the pol Ill-specific 
transcription factor TFIIIB. Work in this thesis has further defined this interaction 
and demonstrated that activation of transcription by c-Myc can recruit this complex 
along with pol III to 5S rRNA and tRNA genes in vivo. Furthermore, the recruitment 
of TFIIIB and polymerase by c-Myc are distinct events, with a significant delay 
between TFIIIB and pol III binding, argumg against a pol III holoenzyme being 
recruited to the genes.
Most recent work on the mechanisms of transcriptional activation by c-Myc has 
focussed on its ability to influence chromatin structure. Transcriptional activation of
111
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target genes by c-Myc may involve the remodelling of nucleosomes, since c-Myc has 
been shown to bind to the Snf5 subunit of the SWI/SNF complex, as well as the 
ATPase/helicases TIF48 and TIP49. In the present study, Snf5 and Brgl, both 
components of SWI/SNF, have been found at the promoters of pol Ill-transcribed 
genes. These may have a role in the regulation of pol III transcriptional activity.
c-Myc can also recruit a variety of histone modifying enzymes to the promoters of its 
target genes. It can bind to the co-factor TRRAP, a 440 kDa protein that forms the 
scaffold of a variety of histone acetyltransferase complexes. It has been demonstrated 
that c-Myc can recruit these complexes to certain target genes, and the increase in 
histone acétylation correlates with gene expression. The TRRAP co-factor along with 
an associated HAT was found to be present in a c-Myc-sensitive manner on pol Ill- 
transcribed genes, and their presence correlated with histone acétylation and gene 
expression. In addition to these findings, depletion of endogenous TRRAP by RNAi 
in cultured cells resulted in a specific down-regulation of pol III transcription in vivo.
In summary, this thesis has identified previously undescribed mechanisms by which 
c-Myc can activate transcription by pol III, and has identified novel co-activator 
proteins involved in the regulation of class III gene expression. This work has 
important imphcations in understanding the molecular basis of how activators can 
stimulate the expression of pol Ill-transcribed genes.
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Chapter 1 1ntroduction
1.1 Eukaryotic Transcription
has recently been identified and is expressed from an alternative transcript of the 
mitochondrial RNA polymerase gene (Kravchenko et al, 2005). Pol IV is responsible
1
s
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The initial stage of gene expression is the production of RNA molecules from the
template DNA by the process of transcription. The process of transcription is
performed by the nuclear RNA polymerases, which are large, complex multi-subunit
enzymes (Wliite, 2001). Mammalian cells contain four nuclear RNA polymerases
each responsible for the transcription of a distinct set of genes, RNA polymerases I,
II, III and IV (White, 2001; Kravchenco et al, 2005), RNA polymerase I (pol I) is
responsible for the production of the 45S large ribosomal RNA (rRNA) pre-cursor,
which is subsequently processed into the 5.8S, 18S and 28S rRNAs (Grummt, 2003).
Although pol I is only responsible for the production of a single RNA species, it is 
.responsible for approximately 60-70% of all nuclear transcription (Moss and 
Stefanovsky, 2002). RNA polymerase II (pol II) is responsible for the transcription of 
a vast array of genes, it produces the bulk of messenger RNAs (mRNAs), which are 
subsequently translated into proteins, and also synthesises the majority of small 
nuclear RNAs (snRNAs) (White, 2001). RNA polymerase III (pol III) transcribes the 
genes encoding the 5S rRNA and the transfer RNAs (tRNAs) as well as the 
production of a host of other essential short untranslated RNAs (Paule and White, 
2000). Depending on cellular conditions, pol III is responsible for approximately 
10% of all nuclear transcription (Moss and Stefanovsky, 2002). RNA polymerase IV
l i
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for the synthesis of some mRNAs (Ki'avchenko et al, 2005). These RNA polymerases 
are subject to tight regulation, and this co-ordination of gene expression influences the 
fate of mammalian cells (White, 2001). The untranslated products produced by pols I 
and III are essential for sustained protein synthesis and therefore a fundamental 
determinant of the capacity of a cell to grow (White, 2005). The work performed in 
this thesis is involved in further understanding the regulation of transcription by pol 
III, and therefore fui'thering understanding of the control of cell growth.
1,1.2 Transcription and Cell Growth
The progression of the cell cycle and cellular proliferation cannot occur without cells 
first attaining a critical mass. As 80-90% of the dry mass of a cell is protein, the rate
of protein synthesis is critical to both growth and therefore proliferation (Zetterberg 
and Killander, 1965; Baxter and Stanners, 1978). In most cells the number of niRNA
molecules is greater than the number of ribosomes, therefore ribosome biogenesis is 
rate limiting for protein synthesis (Kief and Warner, 1981; Zetterberg and Killander, 
1965). Each ribosome is composed of four RNA species and over eighty proteins. 
The synthesis of the rRNA is the rate limiting step in ribosome biogenesis as almost 
all rRNA is incorporated into ribosomes (Liebhaber et al, 1978). The four rRNAs that 
are incorporated into each ribosome are the 5.8S, 18S and 28S rRNAs, produced by 
pol I and the 5S rRNA, produced by pol III (White, 2005). These RNA species are all 
essential and required in equimolar amounts, therefore the study of the co-ordination 
of both pol I and pol III transcription is required for an understanding of cell growth. 
Levels of the pol Ill-transcribed tRNAs have also been demonstrated to be critical for
the rate of protein synthesis and cell growth. Reducing levels of the initiator tRNA in
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1.1.3 Regulation of pol III transcription
yeast can influence cell growth and prolong cell doubling time (Francis and
Rajbhandary, 1990). This is supported by the fact that there is a general increase in
.tRNA synthesis in the growth response in all organisms examined (White, 2002). As 
well as the synthesis of both tRNAs and the 5SrRNA, pol III is also responsible for 
the production of a variety of other short untranslated RNAs critical to the 
biosynthetic capacity of the cell, which are discussed later in this introduction, and an 
understanding of protein synthesis and cell growth is not complete without 
considering transcription of by pol III (Wliite, 2002).
Ï;
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Due to the essential function of pol III products for protein synthesis and cell growth, 
their transcription is highly regulated. A variety of cellulai' products involved in the 
regulation of pol III transcription will be described, as well as the mechanisms behind 
their control. A recent addition to the direct regulators of pol III transcription is the 
product of the c-Myc proto-oncogene (Gomez-Roman et al, 2003). c-Myc has been 
demonstrated to potently and directly activate the transcription of genes transcribed 
by pol III (Gomez-Roman et al, 2003). The work in this thesis will attempt to 
uncover the mechanisms behind this activation, and to identify any other co-activator 
proteins involved in the process.
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1.2 Class III genes
Products of the genes transcribed by pol III are short RNAs, typically between 100 
and 300 nucleotides in length, which remain untranslated. These short RNA 
molecules are involved in vai'ious cellular processes and are listed, along with their 
function, in the table below.
Table 1.1 -  (Adapted from White, 2002)
Product Function Size
5SrRNA Ribosomal component 120 nt
tRNAs Translational Adaptors 70-90 nt
U6snRNA mRNA splicing 106 nt
7SKRNA Transcriptional elongation by pol II 330 nt
7SLRNA SRP component 300 nt
MRP RNA rRNA splicing 265 nt
HI RNA tRNA processing 369nt
Alu RNA General pol II inhibition? 300nt
B2RNA General pol II inhibition? 180nt
VARNA Translational control 160 nt
EBERRNA Translational control 165 nt
The majority of pol Ill-transcribed genes are involved primarily in protein synthesis 
from processing the mRNA, to being directly involved in the translation and
I
appropriately targeting the newly synthesised polypeptide. These functions of pol III-
1.2.2 6S rRNA genes
ribosome (White, 2001). Unlike the pol I-transcribed rRNAs, the 5S rRNA is 
transcribed in the nucleoplasm, but is transported to the nucleolus for processing and 
incorporation into the ribosome (Lafontaine and Tollervey, 2001). The human 
genome contains 300-400 5S rRNA genes and many of these genes exist in clusters or 
tandem repeats (International Human Genome Consortium, 2004).
§
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transcribed genes will be described in this introduction.
Ribosomes consist of approximately 85 proteins, as well as four species of rRNA, the 
5S, 5.8S, 18S and 28S rRNA (Doudna and Rath, 2002, Wool, 1979). The pol III 
transcribed 5S rRNA is an essential component of the ribosome, and is therefore 
essential in eukaryotic organisms for protein synthesis (Wool, 1979). The four
rRNAs are required in equal stoichiometry, each being present in one copy per
1.2.2 tRNA genes
Along with the 5S rRNA, the tRNAs are essential in the translation of mRNAs. The 
tRNA molecules serve as adaptors tliat interpret the sequence of mRNA to specify the 
order of amino acid residues in a protein. tRNA molecules, when processed, are 
between 70 to 90 nucleotides in length and adopt an L shaped secondary structure 
(Draper, 1996; White, 2002). Although the tRNAs have similar structures they can 
only recognise a specific amino acid, the amino acid is covalently linked to the 3 ’ end 
of the tRNA, and matches this to a specific codon in the message (White, 2002).
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Each eukaryotic cell contains 50 to 100 tRNA species, and because of this number 
there is a great deal o f redundancy among the tRNA genes (Sharp et al, 1984). The 
human genome contains approximately 500 tRNA genes and related pseudogenes, 
and these encode 60-90 tRNAs (International Human Genome Consortium, 2004).
The tRNA genes in man are generally scattered throughout the genome, although 
some clustering is observed (International Human Genome Consortium, 2004).
Ï
1.2.3 U6 snRNA genes
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An essential step in the production of mature mRNA molecules is the splicing of the 
pre-mRNA. Many protein-encoding genes transcribed by pol II are interrupted by 
non-coding regions called introns that must be removed by splicing to create a 
functional mRNA (Maniatis et al, 1987; Mattaj et al, 1993). Spliceosomes are small 
nuclear ribonuleoproteins (snRNPs) which are involved in pre-mRNA splicing within 
the nucleus (Maniatis and Reed, 1987; Mattaj et al, 1993). In addition to their protein 
component, spliceosomes contain five snRNAs (Maniatis and Reed, 1987; Mattaj et 
al, 1993). Four of the snRNAs are transcribed by pol II, but the U6 snRNA is 
transcribed by pol III (Kunkel et al, 1986; Reddy et al, 1987). The U6 snRNA is a 
106 nucleotide transcript, and is the most conserved amongst the splicosome snRNAs 
(Reddy et al, 1987; Brow and Guthrie, 1988), It appears that the U6 snRNA is in 
relative excess in comparison to the other snRNAs in yeast and in higher eukaryotes, 
indicating that it is not rate-limiting in spHceosome production (Kaiser et al, 1995; 
White, 2002).
: ■ if;
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1.2.4 7SL RNA gene
i l
a
The 7SL RNA is another product of pol III and this RNA forms the nucleic acid
scaffold of the signal recognition particle (SRP), along with six different polypeptides
(Walter and Blobel, 1982). The SRP is involved in protein trafficking tlirough the
insertion of nascent polypeptides into the endoplasmic reticulum (Walter and Blobel,
1982). The trafficking of proteins through this organelle is critical for post-
translational modifications, appropriate folding and delivery to their appropriate sub-
.cellular locations (Keenan et al, 2001). The 300 nucleotide 7SL is extremely
.conserved throughout evolution, with the human genome containing four copies 
(International Human Genome Consortium, 2004).
1.2.5 Other Class III Genes encoding RNP Components
The 330 nucleotide 7SK RNA is a relatively abundant RNA present in the nucleus of 
eukaryotic cells (Mattaj et al, 1993; Murphy et al, 1986). Until relatively recently the 
hinction of 7SK remained somewhat of an enigma. Several studies have now 
demonstrated that 7SK is a negative regulator of pol II elongation (Nguyen at al, 
2001; Yang et al, 2001). 7SK binds to a pol II elongation factor, PTEFb, and this 
interaction has inliibitory effects on this complex and pol III elongation (Nguyen at al, 
2001; Yang et al, 2001).
I
The HI RNA is the 369 nucleotide component of Rnase P, a complex involved in the 
5’ processing o f pre-tRNA molecules (Bartkiewicz et al, 1989). The primary 
sequence of the HI RNA is not homologous between organisms, but the tertiary
' . f
I
Chapter 1 Introduction
structure is thought to be highly conserved to retain its function (Morrissey and 
Tollervey, 1995).
1.2.6 Viral Genes transcribed by pol
The 265 nucleotide MRP RNA is a component of an endoribonuclease originally 
identified from its ability to cleave the mitochondrial transcript to generate a primer 
for mitochondrial DNA replication (Chang and Clayton, 1987; Chang and Clayton, 
1989; Topper and Clayton, 1990). Although identified in the mitochondria the RNase 
MRP is predominantly in the nucleolus where it plays an important role in pre-rRNA 
processing (Morrissey and Tollervey, 1995).
There are several viruses that encode class III genes, these viruse can use the pol III 
transcription machinery of host cells to express these genes (White, 2002). The 
adenoviral VAi and VAn genes are both transcribed by pol III in the late stages of 
adenoviral infection (Soderlund et al, 1976; Weinmann et al, 1974). The VA RNAs
act by stimulating the translation of adenoviral mRNA at late times after infection
(Thimmappaya et al, 1982). TheVAi transcript is essential for this process, but 
deletion o f the VAn transcript has no effect on the vfral life-cycle (Thimmappaya et 
al, 1982).
The Epstein-Barr virus (EBV) also contains two pol Ill-transcribed genes that are 
highly expressed in viral infections (Rosa et al, 1981). The two genes are 165 
nucleotides long and are called EBERl and EBER2 (Rosa et al, 1981). Although they 
are highly expressed in EBV infected cells, EBERl and EBER2 aie not necessary for
1.2.7 SINEs
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the normal viral repHction cycle (White, 2002). The EBER genes are able to 
substitute for the VA genes in adenoviral infection, so a similar role in stimulating 
translation is likely (White, 2002). Furthermore, EBERs aie sufficient to induce 
growth in soft agar and tumours in mice, thus providing the first example of an 
oncogenic RNA (Kitagawa et al, 2000; Komano et al, 1999; Ruf et al, 2000).
g
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A variety of short interspersed elements (SINEs) in higher organisms are pol III 
templates (White,2002). The predominant SINEs in rodents are the B1 and B2 genes. 
The B1 gene family is dervived from the 7SL gene and is homologous to the Alu 
SINEs present in primate genomes (Ullu and Tschudi, 1984). The function of the B1 
RNA remains elusive (Daniels and Deininger, 1985). The B2 family of genes are 
rodent specific SINEs and appear to have been derived fi’om a tRNA gene, and are 
essentially tRNA pseudogenes (Daniels and Deininger, 1985). A function of the B2 
SINE has recently been proposed in the heat shock response. B2 has been shown to 
bind to pol II and generally repress mRNA production in response to heat shock 
(Allen et al, 2004). The B1 and B2 genes are present in high copy numbers in the rat 
genome with 384 000 copies o f B1 and 328 000 copies of the B2 gene (Rat Genome 
Sequencing Project Consortium, 2004)
The major SINE in humans and other primates is the Alu family. The Alu family of 
genes represents approximately 10% of the human genome, with over one million 
copies (International Human Genome Consortium, 2001). Alu genes consist of two 
imperfect repeats derived fi’om the 7SL gene separated by a 18bp spacer (Ullu and
Chapter 1 Introduction
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Tschudi, 1984). The upstream repeat contains a functional promoter sequence, but
.Alu genes are generally expressed at very low levels in human cells (Liu and Schmid,
1993). Alu gene products may perform a similar role to the B2 RNA in the heat
shock response in human and primate cells. Expression of Alu transcripts is increased 
in heat shock conditions and these RNAs can bind to and inhibit pol II (Mariner et al, 
2005). The recent data proposing functions of SINEs is challenging the concept that 
these elements are merely ‘junk’ DNA.
The hmctions of genes transcribed by pol III are critical in the process of protein 
synthesis and their functions are summarised in figure 1.1.
Ï
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Figure 1.1 Pol III transcripts are involved in the protein synthetic 
pathway
Several pol III transcripts are involved in the regulation of the protein synthetic 
machinery. The newly synthesised mRNA is processed by the spliceosome, which 
includes the U6 snRNA. The MRP RNA and the HI RNA are involved in rRNA and 
tRNA processing, respectively. The tRNA and 5S rRNA genes are involved in the 
translation o f the mature mRNA molecule, with the 7SL genes involved in the 
appropriate targeting and delivery of the newly synthesised peptide to the correct 
cellular location. Boxes indicate a pol III product.
11
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1.3 Promoter Structures of Class III Genes
The promoter structures of genes transcribed by pol III are often markedly different 
from the promoters utilised by the other polymerases. The most unusual feature is 
that the vast majority requhe sequence elements downstream of the start site of 
transcription within the transcribed region, termed internal control regions (ICR). The 
structure of these promoters is discussed below and displayed in figure 1.2.
1.3.1 Type I promoter
Type I promoters are found only within the 5S rRNA genes. Much of the work done 
on the promoter structure of 5S rRNA genes has been performed using Xenopus 
laevis, as a model system. The Xenopus laevis somatic 5S gene ICR is made up fi'om 
three conserved sequence elements: the A-block located between + 50 and +64, the 
intermediate element (IE) located between +67 and +72 and the C-block at +80 to 
+97; these elements are required for efficient transcription of the gene (Figure 1.2, 
Bogenhagen et al, 1985; Pieler et al, 1985 a,b; Pieler et al, 1987). The bases between
the conserved elements appear to act merely as spacers, and mutation do not influence 
transcriptional efficiency, but short deletions or additions of bases in these regions 
reduces transcription and the stability of a transcription complex (Pieler et al, 1987), 
The 5S rRNA genes studied in other eukaryotic organisms have similar promoter 
structures and the spacing between the promoter elements is critical (White, 2002).
13
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1.3.2 Type II promoter
IThe type II promoter is the most common promoter arrangement utilised by pol Ill- 
transcribed genes. Genes with type II promoters include the tRNA genes, the major
:
SINEs and the VA genes (White, 2002). These genes are characterised by two 
conserved sequence elements, the A and B blocks, within the transcribed region 
(Figure 1.2; Galli et al, 1981). These sequence elements are about 10 base pairs in 
length, and are essential for the transcription of the gene (Galli et al, 1981). The A-
block is homologous to the A-Block contained within Type 1 promoters, and these
elements can be interchangeable, although the A- block is much closer to the start site 
of transcription in type II promoters (Ciliberto et al, 1983). The B-block is hirther
downstream of the A-block, and these blocks are generally 30-40bp apait, but this 
spacing can be increased due to short introns in the coding regions of certain genes 
(Sharp et al, 1984; Geiduschek et al, 1988). Although the A and B blocks are 
necessary and sufficient for efficient transcription, flanking sequences are likely to 
have an influence upon the transcription of most if not all tRNA genes (White, 2002).
A few class III gene promoters lack any requirement for internal promoter elements; 
these are referred to as type III promoters. Examples of genes with a type III 
promoter are the U6 snRNA, MRP and 7SK genes (White, 2002). The best- 
characterised example of a type III promoter is that of the U6 snRNA gene. The 
sequences required for expression of the human and mouse U6 snRNA gene are the 
TATA box, a proximal sequence element (FSE) and a distal sequence element (DSE);
14
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ali of which lie upstream of the transcription start site (Figure 1.2; Das et al, 1988; 
Kunkel at al, 1989; Lobo et al, 1989), As well as the upstream sequences described 
above, the yeast U6 snRNA genes have functional A and B blocks with homology to 
those utilised in type II promoters that are not present in the U6 snRNA genes of 
higher eukaryotes (White, 2002).
1
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Figure 1.2 Structure of class III genes
The three types of promoter arrangement that are utilised by pol III are displayed in 
this figure. The start site of transcription is indicated with an arrow and the 
termination signal indicated by a run of T residues.
16
Chapter 1 Introduction
T ype I e.g. 5S rRNA
---------►
A Block IE C Block TTTTTT
T ype II e.g. tRNA
---------►
A Block B Block TTTTTT
T ype III e.g. human U6 snRNA
---------►
DSE / / PSE TATA
17
Chapter 1 Introduction
1A Transcription Complex Assembly on Class III genes
transcription complexes will be discussed below.
1.4.1 Complex Assembly on a Type II promoter
affinity (Baker et al, 1986). The tolerance of variable spacing between the A and B
complex, and explained by the fact that TFIIIC can be stretched to achieve this 
remarkable flexibility (Schultz et al, 1989).
The nuclear RNA polymerases alone have little specificity for particular DNA
.sequences. In the case of pol III, recruitment to specific genes requires the prior 
assembly of pol Ill-specific general transcription factors. These factors vary 
depending on the nature of the promoter structure and the assembly of these
Î
The initial step in the formation of the transcription complex on type II promoters is 
the binding of the pol Ill-specific transcription factor TFIIIC (Paule and White, 2000; 
Schramm and Hernandez, 2002). This complex has been well defined in yeast and is 
a large and complex multi-subunit transcription factor. Yeast TFIIIC is made up of 
six subunits, which have an aggregate mass of over 500kDa (Geiduschek and 
Kassavetis, 2001; Schramm and Hernandez, 2002). The subunits of TFIIIC, 
individually, have no DNA binding activity, but the formation o f the entire complex 
creates two globulai' domains capable of binding to the A and B blocks of a type II 
promoter (Baker at al, 1986). Although TFIIIC binds to both the A and the B block of
I
a type II promoter it is the B block that appears to be the major determinant of binding 
blocks is surprising as they are bound simultaneously by a single transcription factor "'mi
S '
I 
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Figure 1.3 Transcription complex assembly on a type II promoter
The pol Ill-specific transcription factor TFIIIC binds to the A and B blocks on 
the promoters o f genes with a type II promoter. TFIIIC then recruits XFIIIB, 
which can then recruit the polymerase.
19
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Human TFIIIC appears to be more complex than its yeast homologue. The 
biochemical fraction containing TFIIIC activity can be split into two functional 
components termed TFIIIC 1 and TFIIIC2, with both required for transcription on type 
I and type II promoters, but only TFIIIC 1 being required for transcription of genes 
containing type III promoters (Yoshinaga at al, 1987; Dean and Berk, 1987; Yoon et 
al, 1995; Lagna et al, 1994; Oettel et al, 1997). The identity of TFIIIC 1 activity 
remains relatively ill defined and its polypeptide composition has not been 
unequivocally demonstrated (White, 2002). The TFIIIC 1 activity stabilises the 
interaction between TFIIIC2 and the promoters of class III genes (Wang and Roeder,
1996). Human TFIIIC2 is relatively well defined, it is composed of 5 subunits, which 
have been identified and cloned, it has a mass similar to that of yeast TFIIIC and 
performs a similar function, but the subunits have weak or no homology with subunits 
of the yeast factor (Yoshinaga at al, 1989; Sinn et al, 1995; Wang and Roeder, 1996).
The five subunits are TFIIIC 220, TFIIIC 110, TFIIIC 102, TFIIIC 90 and TFIIIC 63, 
each named after their mass in kDa (White, 2002; Schramm and Hernandez, 2002).
.The two largest subunits of TFIIIC2, 220 and 110, form the binding interface between ITFIIIC and the B-block o f type II promoters and TFIIIC 102 and 63 are associated 
with the A-block, with TFIIIC 90 bridging the two DNA binding domains (Schramm 
and Hernandez, 2002). Human TFIIIC2 plays additional roles to its yeast counterpart 
highlighted by the feet that two of its subunits TFIIIC 110 and 90 possess histone Iacetyl transferase activity (HAT) and that human TFIIIC2 can relieve chromatin-
?mediated repression of a tRNA gene (Hsieh et al, 1999; Kundu et al, 1999),
I
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The main function of TFIIIC is to recruit another complex, TFIIIB, to the promoters 
of type I and II genes (Schramm and Hernandez, 2002; White, 2002). TFIIIB is the
central class III initiation factor since it alone is sufficient to recruit the polymerase
.........................................................and specify the site at which transcription begins (Kassavetis et al, 1990). TFIIIB is
another multi-subunit pol III specific transcription factor and it is a complex of three
polypeptides in yeast and humans, one of which being the TATA-binding protein
(TBP), TBP is essential in pol III transcription and is also involved in the
transcription of genes transcribed by pol I and pol II (Burley and Roeder, 1996). Two
pol Ill-specific TBP-associated factors aie also required for TFIIIB activity. The first
of these is a factor with homology to the pol II basal transcription factor TFIIB, and
for this reason it is referred to as the TFIIB-related factor 1 (Brfl), and has a relative
molecular mass of 90kDa in humans (Roberts et al, 1996). The other human TFIIIB
associated TAF is Bdpl, with the major form being a 160 kDa polypeptide (Schramm
et al, 2000). Several alternatively spliced forms of Bdpl have been identified in
human cells (Schramm et al, 2000). The roles o f these variants remains unclear. A
250kDa variety of Bdpl may play additional roles in pol Ill-transcription with it
recently being proposed to be the unidentified TFIIIC 1 activity (Weser et al, 2004).
Type I and II promoters of pol Ill-transcribed genes have no TATA element and the 
TBP-containing TFIIIB complex does not bind to DNA dhectly and is recruited via 
interactions with TFIIIC (Bicker et al, 1985; Setzer and Brown, 1985).
All three subunits of TFIIIB are required for polymerase recruitment, but only TBP 
and Brfl have been shown to make direct interactions with the polymerase (Schramm 
and Hernandez, 2002). Of these interactions, the binding of Brfl to the yeast C34 pol
22
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III subunit (RPC39 in humans) appears to be critical (Schi'amm and Hernandez, 
2002). Additional contacts between TFIIIC and pol III may stabilise the transcription 
complex (Flores et al, 1999; Dumay et al, 1999; Hsieh et al, 1999).
1.4.2 Complex assembly on a type I promoter
The action of TFIIIC to recruit TFIIIB, and the subsequent TFIIIB-dependent 
recruitment of pol III is similar on type I and II promoters (Schramm and Hernandez, 
2002; White, 2002). The differences in these promoters is that the type I promoter of 
the 5S rRNA genes lacks a functional B block and cannot directly recruit the TFIIIC 
complex. On these promoters TFIIIC is recruited through protein-protein interactions 
with another pol Ill-specific transcription factor TFIIIA (Figure 1.4; Schramm and 
Hernandez, 2002; White, 2002). TFIIIA was the first eukaryotic transcription factor 
to be purified to homogeneity and the first eukaryotic transcription factor to have its 
gene cloned (Engelke et al, 1980; Ginsberg et al, 1984). TFIIIA is composed of a 
single polypeptide, of a relative molecular mass of 42 kDa in humans, and is the 
founding member of the C2H2 zinc finger family of DNA-binding transcription 
factors, consisting of nine tandem, zinc-dependent DNA binding motifs (Miller at al, 
1985, Moorfield and Roeder, 1994). The N-terminal three zinc fingers recognise the 
type I promoter-specific C-block in 5S rRNA promoters, and the interaction of these 
fingers contributes to 95% of total binding of TFIIIA to type I promoters (Foster et al, 
1997; Nolte et al, 1998; Clemens et al, 1992). The precise interactions of TFIIIC with 
TFIIIA still remain unclear (Schramm and Hernandez, 2002).
Ï
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Figure 1.4 Transcription complex assembly on a type I promoter
The type I promoter-specific transcription factor TFIIIA binds the internal control 
region of the gene. TFIIIC is then recruited to the promoter via protein-protein 
interactions with TFIIIA. This is then followed by the recruitment of TFIIIB and 
subsequent recruitment of the polymerase.
24
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1.4.3 Complex Assembly on Type III promoters
The type III promoters associated with vertebrate U6 snRNA, 7SK and MRP genes 
have distinct factor requirements from pol III-transcribed genes with type I and II 
promoters. The complex assembly on these genes is outlined in figure 1.5. Type III 
promoters contain a TATA box and a PSE, which are recognised by the TBP 
component of a TFIIIB complex and a multi subunit complex termed SNAPc 
respectively (Schramm and Hernandez, 2002). The TFIIIB complex utilised in the 
transcription of genes with a type III promoter differs in subunit composition to that 
used by type I and type II promoters. The TFIIIB activity is made up fiom TBP, 
Bdpl and a Brfl homologue, BrfZ (Schramm et al, 2002). Protein-protein 
interactions between SNAPc and the TBP component of TFIIIB enhance their 
interaction with the promoters of type III genes, and this may explain the strict
spacing between the PSE and the TATA box (Mittal and Hernandez, 1997; Schramm 
and Hernandez, 2002). The binding of these factors then leads to the subsequent 
recruitment of the polymerase by the TFIIIB complex (White, 2002). Although basal 
transcription only requires the presence o f the PSE and the TATA box, the binding of 
another transcription factor, Octl, to the upstream DSE element of type III gene 
promoters can enhance levels of transcription (Schramm and Hernandez, 2002).
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Figure 1.6 Transcription complex assembly on type III promoters
SNAPc and TFIIIB bind co-operatively to the PSE and TATA box of type III 
promoters. Binding of another factor, Oct-1, to the upstream DSE enhances 
transcription of genes with a type III promoter. This is through interactions between 
SNAPc and Oct-1, which enhances SNAPc/TFIIIB recruitment to the promoter. 
Polymerase is then recruited via interactions with SNAPc/TFIIIB.
27
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1.4.4 Pol III
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As previously mentioned, pol III is the largest and most complex of the nuclear RNA 
polymerases. As all three nuclear RNA polymerases perform essentially the same
task, faithhil transcription of a DNA template to produce a complementary RNA
Istrand, it is of no surprise there are common subunits between polymerases and 
significant homology between some o f the unique subunits (White, 2002). Pol III is 
well defined in budding yeast; it consists of 17 subunits, ten being unique to pol III, 
two being shared between pols I and III and five common between pols I, II and III 
(Schi’amm and Hernandez, 2002; White, 2002). Of these 17 subunits identified in 
yeast, 16 have been disrupted and demonstrated to be essential for fiinction (Chedin et 
al, 1998). Human pol III has been purified by chromatography and from cell lines 
expressing tagged pol III subunits, and orthologues of the yeast subunits have been 
identified (Wang and Roeder, 1996; Wang and Roeder, 1997; Hu et al, 2002).
The two largest subunits o f pol III are homologous to the two largest polypeptides of
pol I and pol II, as well as having homology to the p’ and p subunits of bacterial RNA 
.polymerase (White, 2001). These conserved subunits, along with subunits shared 
between the eukaryotic pols, are thought to form the RNA polymerase catalytic core, 
with the unique subunits performing other essential roles such as template selection 
and transcription factor interaction sites (White, 2001).
.1
1.4.6 Transcription termination and reinitiation
Pol III requires a variety of accessory factors for accurate initiation of transcription, 
but can terminate transcription accurately and efficiently in the absence of accessory
The termination signals on class III genes are simple clusters of four or more T 
residues that are recognised by the polymerase and are sufficient for the accurate 
cessation of transcription by pol III (Bogenhagen and Brown, 1981).
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1.4.5 Transcription Initiation and Elongation
Once the polymerase is recruited to the promoter it melts the double-helix around the 
start site of transcription. There is evidence that along with the polymerase, 
components of TFIIIB may be involved in his event (Kassevetis et al, 1998). In 
contrast to transcription by pols I and II, there are no elongation factors associated 
with the pol III transcription apparatus, this may be due to the extremely short length
of class III genes, or unique subunits of the polymerase may perform this role (White,
.2001). One of the mysteries associated with pol III transcription is how the 
polymerase transcribes through the pol III transcription apparatus, which covers the 
entire gene, without removing it or being significantly obstructed (Bogenhagen et al, 
1982; Jahn et al, 1987). It may be that protein-DNA interactions between the 
transcription complex are disrupted during elongation, but protein-protein interactions 
between transcription factors keep the complex intact (White, 2002).
7:
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factors (Cozzarelli, et al, 1983; Hammond and Holland, 1983; Watson et al, 1984.
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The formation of a transcription complex and the initiation of transcription is a 
relatively slow process (Dieci and Sentenac, 1996). This slow step is avoided because 
pol III can be recycled without being released from the template, leading to a 
subsequent round of transcription being five to ten-fold faster than that of the initial 
transcript (Dieci and Sentenac, 1996). The bends in the DNA duplex caused by the 
binding of the pol III transcription factors may facilitate the reinitiation of 
transcription by bringing the start site into close spatial orientation with the end of the 
gene, thus when transcription complexes are assembled they are capable of multiple 
rounds of transcription (White, 2002).
I;s
#
a
Chapter 1 Introduction
I
1.5 Regulation of Pol III Transcription
1.6.1 Activators of pol III transcription
It has been previously demonstrated that serum stimulation of resting culture cells can m3
.  .  #activate pol III transcription (Johnston et al, 1974; Mauck et al, 1974). Mitogenic
.stimulation of quiescent cells results in the activation of several signalling cascades 
that can directly activate pol III transcription.
One example is the protein kinase, CK2. CK2 is a highly expressed and constitutively 
active Ser/Thr protein kinase with a large number of substrates and has been
%
implicated in neoplasia and cell survival (Meggio and Pinna, 2003). The activity |
and/or levels of CK2 are elevated in response to mitogenic stimulation, and associated
-]|
with both cell growth and proliferation (Meggio and Pinna, 2003). CK2 can bind
directly to and phosphorylate the pol III transcription factor x p m g  in both yeast and 
mammalian cells (Hockman and Schultz, 1996; Johnston et al, 2002). In mammalian 
cells this is postulated to increase the affinity between TFIIIB and TFIIIC2, thus 
facilitating the formation of the transcription complex (Johnston et al, 2002).
Another cellular signalling pathway stimulated upon addition of growth factors is the 
mitogen activated protem kinase (MAPK) cascade. Induction of this pathway leads to 
activation of the extracellular signal-related kinase (ERK), through a signalling
cascade that involved a receptor tyrosine kinase, the GTPase Ras, the kinase Raf and
i:the ERK kinase MEK (Downward, 2002). This pathway can promote cell growth in g
several ways including increasing translational capacity and initiating transcription by
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pol I (Whitmarch and Davies, 2000; Stefanovsky, 2001). The MAPK kinase cascade 
can also stimulate transcription of the 5S rRNA and tRNA genes through ERK 
binding and phosphorylation of TFIIIB (Felton-Edkins et al, 2003a). Phosphorylation 
of TFIIIB enhances its ability to interact with TFIIIC and pol III, and promotes the 
formation of the transcription complex to directly stimulate pol III transcription 
(Felton-Edkins et al, 2003).
1.6.2 Repressors of pol III transcription
33
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The product of the retinoblastoma susceptibility gene is an important tumour S
suppressor protein that prevents cell proliferation and growth in the absence of 
appropriate mitogenic signals (Kaelin, 1999; Weinberg, 1995). The Rb gene encodes
a l i o  kDa phosho-protein that can regulate the activity of several key transcription
’t.Actors involved in the transcription of genes critical to cell growth and cell cycle
%progression (White, 2005). Transcription of pol Ill-transcribed genes can be
; |
efficiently repressed by addition of RB in vitro, or transfection of vectors encoding 
RB into cells (White et al, 1996; Chu et al, 1997; Hhsch et a l , 2000). Conversely, in 
a RB-knockout cell line, transcription of poll Ill-transcribed genes is markedly 
increased (White et al, 1996). In resting cells underphosphorylated RB can inhibit pol 
III transcription by binding to and sequestering TFIIIB in the nucleoplasm in the Go 
and Gi stages of the cell cycle (Scott et al, 2001). RB is inactivated by 
phosphorylation in the Gi~S transition by cyclin-dependent kinases and this 
inactivation of RB correlates well with an increase in pol III activity, suggesting an 
important role for RB in the regulation of pol III activity (Brown et al, 1998; Scott et 
al, 2 0 0 1 ).
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The tumour suppressor protein p53 is another inhibitor of pol III transcription. p53 is 
induced in response to a wide array of cellular insults, including hypoxia, 
ribonucleotide depletion and exposure to genotoxins, which leads to a complex 
program of events leading to either growth arrest or programmed cell death (Gomez- 
Lazaro et al, 2004). p53 regulates the transcription of a number of cellular targets 
including genes transcribed by pol III (Chesnokov et al, 1996; Cairns and White, 
1998). TFIIIB, the target of the RB tumour suppressor, is also bound and repressed 
by p53 (Chesnokov et al, 1996, Cairns and White, 1998; Crighton et al, 2003). The 
binding of p53 to XFIIIB inhibits the formation of the transcription complex in vivo 
by blocking the interaction between TFIIIB and TFIIIC (Crighton et al, 2003). This is 
highlighted by the increased levels of TFIIIB and pol III present on the promoters of 
pol Ill-transcribed genes, coupled with the higher levels of pol Ill-transcribed 
products, in p53 knockout cells (Crighton et al, 2003).
Another negative regulator of pol III transcription is the Mafl protein. Studies in 
yeast have identified that Mafl can interact with both TFIIIB and pol III (Pluta et al, 
2001; Upadhya et al, 2002). This protein is involved in the repression of pol III 
transcription in response to a variety of stresses including nutrient deprivation and 
DNA damage (Upadhya et al, 2002). Recent data have suggested that not only does 
Mafl repress pol III transcription in yeast, but is involved in the regulation of 5S 
rRNA and tRNA genes in mammalian cells (Graham and White, unpublished 
observations).
34
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1.6 Activation of pol III transcription by c-Myc
Pol III transcription is also directly and potently activated by the product of the c-Myc 
proto-oncogene (Gomez-Roman et al, 2003). The broad aim of this thesis is to 
develop an understanding of the mechanisms beliind this activation to further expand 
our knowledge of the control and regulation of transcription by pol III
1.6.1 The c-Myc transcription factor
The c-Myc proto-oncogene has been the subject of intense study over the past two 
decades. The interest in this gene comes from the fact that c-Myc is involved in a 
variety of essential processes and that its deregulation often leads to tumour 
formation. The most striking example of this is observed in Burkitt’s lymphoma. In 
Burkitt’s, a chromosomal translocation results in the c-Myc gene being juxtaposed 
with Ig loci, leading to constitutive activation of the c-Myc gene (Nesbit et al, 1999). 
c-Myc deregulation has been observed in many tumour cells, and is often associated 
with poorly differentiated aggressive cancers. Examples include breast, colon, 
cervical, small cell lung carcinomas, glioblastomas, melanoma, myeloid and 
lymphoblastic leukemias and lymphomas (Dang et al, 1999, Nesbit et al, 1999). The 
mechanisms behind c-Myc activation and the nature of its target genes is becoming 
clearer and will be discussed in this chapter.
35
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Myc was originally identified as the viral oncogene (v-myc) of the avian 
myelocytomatosis retrovirus, and was only the second oncogene identified (Sheiness 
et al, 1978). A cellular homologue of Myc (c-Myc) was identified in chickens 
through homology with its viral counterpart (Vennstrom et al, 1982). There is, in fact.
a family of Myc proteins which have been identified in the mammalian genome, c- 
Myc, N-Myc, L-Myc and MycS (Grandori et al, 2000).
The product of the c-Myc proto-oncogene is a transcription factor, containing a
transcription activation domain at its amino-terminus, and a carboxy-terminal region
with homology to the bHLHZ family of transcription factors (Figure 1.6; Kato et al,
1990; Murre et al, 1989). The Myc family of proteins cannot form homodimers, 
.except at high protem concentration in vitro, instead heterodimers are formed with
i
another bHLHZ protem Max (Figure 1.6; Blackwood and Eisenman, 1991; 
Prendergast et al, 1991). Myc/Max heterodimerise to form a sequence-specific DNA 
binding complex. Myc/Max heterodimers recognise the enhancer-box (E-box) 
sequence CACGTG (as well as related non-canonical sites) and activate transcription 
from synthetic reporter genes containing this element within their promoters f
(Blackwood and Eisenman, 1991; Amati et al, 1992; Krezner et al, 1992). In contrast 
to Myc, Max proteins can homodimerise and recognise E-box sequences, but 
Max dimers appear to be transcriptionally inert (Amati et al, 1992; Krezner et al, 
1992)
I
Chapter 1 Introduction
Figure 1.6 The Myc/Max/Mad network
Schematics of the Myc, Max and Mad proteins are displayed below. The known 
functional domains are indicated. bHLHZ: basic helbc-loop-helix leucine zipper 
domain; TAD: transactivation domain; MBI: Myc Box I; MBII: Myc Box II; MBIII: 
Myc Box III; NLS: nuclear localisation signal; SID: Sin3 interaction domain.
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Max is expressed in the absence of Myc; this led to the search for other Max 
interacting proteins. The Mad family of transcription factors represent four bHLHZ 
containing proteins, Mads 1-4, that can specifically bind with Max (Figure 1.6; Ayer 
et al, 1993; Zervos et al, 1993; Hurlin et al, 1995). Mad proteins are similar to the 
Myc family members as they homodimerise poorly, but form heterodimers with Max 
in vivo (Ayer et al, 1993; Zervos et al, 1993; Hurlin et al, 1995). Mad/Max dimers 
bind to the same E-box sequences that Myc/Max dimers recognise (Ayer et al, 1993; 
Zervos et al, 1993; Hurlin et al, 1995). However, in contrast to Myc, transcription 
assays demonstrate that Mad binding represses E-box dependent activation of a 
reporter gene (Ayer et al, 1993; Hurlin et al, 1995).
In general Max-interacting proteins are unstable and their expression tightly regulated 
(Grandori et al, 2000). Max itself is relatively stable and is constitutively expressed; 
control of the Myc/Max/Mad network is thought to be mediated by changes in the 
abundance of Max-interacting factors (Blackwood et al, 1992).
I
Work in this thesis will concentrate on c-Myc, the first member of the Myc family of 
transcription factors identified in cells. c-Myc has been demonstrated to alter the 
expression, both positively and negatively, of a wide variety of genes involved in 
many cellular' processes (Grandori et al, 2000). As previously mentioned, c-Myc is a 
member of the bHLHZ family of transcription factors. The bHLHZ domain is present 
at the carboxy-terminal of the c-Myc protein and is essential for c-Myc function and 
binding to Max (Grandori et al, 2000). The amino terminal 143 amino acids o f c-Myc 
can act as a transactivation domain (TAD) when fused to the DNA binding domain of
i
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;the yeast Gal4 protem (Kato et al, 1990). The amino terminus contains three highly Iconserved elements, referred to as Myc boxes (figure 1.6). Of these conserved ■Ielement Myc box I (MBI) contains phosphorylation sites involved in targeting Myc’s
€proteolytic destruction, and mutations in this region are observed in lymphomas 
(Dang et al, 1999; Bahram et al, 2000). The deletion of MBI results in reduced Itransformation activity of Myc in vivo (Pelangaris and Khan, 2003) The Myc Box II 
region (MBII) is dispensable to activate reporter genes in vitro, but it absolutely 
required for Myc-mediated transformation of cell in vivo (Stone et al, 1987), This 
activity of MBII in vivo could be attributed to the transactivation of target genes in a 
chromatin context requiring co-activator proteins that require the integrity of this 
region for binding (Eisenman, 2001). The final Myc Box, Myc Box III (MBIII), is 
also involved in the regulation of protein stability and is absolutely required for 
cellular' transformation and full activation or repression of target genes (Herbst et al,
2004; Herbst et al, 2005).
c-Myc is broadly expressed during embryogenesis and in tissue that has a high rate of 
.proliferation (Lüscher, 2001; Eisenman, 2001; Pelengaris and Khan, 2003). c-Myc 
.expression coiTelates well with a high rate of proliferation, and in cell culture c-Myc 
expression is induced in response to a wide range of mitogenic stimuli. Other 
functions of the c-Myc protein include inhibition of terminal differentiation and 7
induction of apoptosis (Lüscher, 2001 ; Eisenman, 2001 ; Pelengaris and Khan, 2003).
Targeted homozygous deletion of the c-Myc gene leads to embryonic lethality before 
10.5 days gestation in mouse models, suggesting a critical role in development (Davis 
et al, 1993). Inactivation of the c-Myc gene in rat fibroblasts causes a prolonged cell
:3:(
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et al, 1997).
1.6.4 Linking c-Myc Target Genes to c-Myc Function
The inability to find target genes that can substitute for c-Myc function, in the way 
that has been achieved for other transcription factors, has made it difficult to link c-
41
.doubling time, indication a role for c-Myc in cell growth and proliferation (Mateyak
::
Bona fide targets of the c-Myc transcription factor have been difficult to identify, due 
to relatively weak and variable transcriptional activation of synthetic targets or 
putative target genes (Grandori and Eisenman, 1997).
$
I
Much of the research in the c-Myc field has focussed on the influence of Myc proteins
on the cell cycle. The deregulated expression of Myc has been shown to allow cells
.to enter S-phase and undergo mitosis in the absence of external growth factors, which
is also a feature of transformed and tumour cell types (Eilers et al, 1991; Hamiahan
and Weinberg, 2000). Several studies have provided insights into how c-Myc
promotes cell proliferation by identifying genes either activated or repressed by c-
Myc that are involved in cell cycle progression. The Gl to S progression of the cell
cycle is controlled by the activity of the cyclin-dependent kinase (CDK) complexes
(Kohn, 1999). Components of the cyclin/CDK complexes are direct targets of the
.Myc/Max/Mad network including activation of the Cyclin D2 and CDK4 genes to 
promote cell cycle progression, as well as repression of cyclin-dependent kinase 
inhibitors and p21 (Bouchard et al, 1999; Hermeking et al, 2000; Hero Id et
al, 2002; Feng et al, 2002).
f
Chapter 1 Introduction
1.6.6 c-Myc and Cell Growth
■Myc action to specific pathways involved in cell cycle progression and transformation 
(Grandori et al, 2000; Patel et al, 2004). The difficulty in doing this may result from 
the broad range of target genes that c-Myc can affect. Indeed a large scale screen in 
Drosophilia identified that members of the Myc/Max/Mad network are associated 
with a large number of loci examined, this approximated to 15% of the class II genes 
examined (Orian et al, 2003).
Much effort has gone into defining the role of c-Myc in cellular proliferation, but it is 
becoming clear that c-Myc has a major role in cell growth. Activation of Myc drives 
a rapid increase in translation and growth, which precedes cell proliferation (Iritani 
and Eisenman, 1999; Kim et al, 2000; Schuhmacher et al, 2001). In certain conditions 
c-Myc can lead to growth in the absence of proliferation (Beier et al, 2000). As well 
as the described role in the activation of pol III transcription, c-Myc has been shown 
to control many genes which can ultimately affect cell mass. These include the gene 
products of eIF4E and eIF2a, which are rate-limiting translation initiation factors 
(Rosenwald et al, 1993; Jones et al, 1996). When examining fibroblasts in which c- 
Myc has been deleted lower rates of both protein synthesis and ribosome biogenesis 
are observed (Mateyak et al, 1997). Myc can activate genes encoding protein 
components of the ribosome, as well as directly activating the transcription of pol I 
specific transcription factors (Kim et al, 2000; Boon et al, 2001; Poortiga et al, 2004). 
There is also a direct effect on pol I transcription with Myc potently and directly 
activating the transcription of the pre-rRNA, and it is present on the rDNA in vivo 
(Grandori et al, 2005; Arabi et al, 2005) The finding that transcripts synthesised by
42
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pol III, such as the tRNA and 5S rRNA, are induced by c-Myc further indicates a 
major role for c-Myc in cell growth (Gomez-Roman et al, 2003, Felton-Edkins et al, 
2003b).
43
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1.7 Pol III trancription and cancer
1.7.1 Derepression of pol III transcription
44
Precise regulation of transcription by pol III is required for the normal growth and
proliferation of cells. Transformed and tumour cells lose this tight regulation. Early 
evidence for such deregulation came from the finding that pol III is hyperactive in 
mice with myelomas, whereas the overall activity of pol II remains normal (Schwartz 
et al, 1974). Subsequent studies have revealed that a wide variety of transformed and 
tumour cell types have elevated levels of pol III transcription (White, 2004; White,
2005). The tumour suppressors p53 and RB, and their respective pathways, are found
.to be deregulated in most, if not all human cancers (Hollstein et al, 1991; Weinberg,
1995). The deregulation of these important proteins could contribute to aberrant 
activation of pol III transcription in tumour and transformed cell lines (White, 2004;
White, 2005).
1.7.2 Activation of pol III transcription
IFor tumours to progress they need to have a raised cellular metabolism, and essential 
to this is an increase in protein biosynthesis. The oncoprotein Myc can not only drive 
proliferation by targeting pol Il-transcribed genes involved in the cell cycle, but can 
also increase the biosynthetic capacity of cells by activation of transcription by pol I 
and pol III to promote cell growth (Dang et al, 1999; White, 2005). c-Myc is
%
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of the limiting transcription factors on which it depends. Levels of all five TFIIIC2 
subunits are overexpressed at both the mRNA and protein levels in fibroblasts 
transformed by SV40 or polyomavirus (Felton-Edkins and White, 2002; Larminnie et
deregulated in a wide range o f cancers and this may contribute to the activation of pol
III transcription in transformed and tumour cell types (Felton-Edkins et al, 2003b;
.White, 2004; White, 2005). Activators of pol III transcription, such as CK2 and ERK, 
have been found to be activated in several tumour models and the activation of these 
kinases could contribute to elevated levels of pol III transcription (White, 2004).
1.7.3 Overexpression of pol III transcription factors
The most obvious way to increase pol III output is by raising the level of one or more
al, 1999). These observations proved to be of clinical significance when elevated 
TFIIIC2 activity was found in each of nine human ovarian carcinomas relative to 
healthy adjacent tissue (Winter et al, 2000). The Brfl and Bdpl subunits of TFIIIB 
are also found to be overexpressed in a subset of cervical carcinomas (Daly et al, 
2005). As these factors are dedicated exclusively to pol III transcription, these 
observation indicate a specific drive to elevate pol III transcription in cancer cells.
45
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1.8 Aims of this Thesis
The work in this thesis aims to uncover the mechanisms by which c-Myc can activate 
transcription by pol III. This will include determining the precise interactions 
between c-Myc and the pol III transcription apparatus and how this acts to promote 
the activation of pol Ill-transcribed genes. c-Myc co-activator proteins are also 
necessary for the activation of certain target genes and for the ability of Myc proteins 
to transform cells. This thesis will addiess if there is a role for any co-activator 
proteins recruited by Myc in the activation of pol III transcription.
Only with a clear understanding of what genes c-Myc can act on, and what co­
activators are involved in the process, can we start to realize and comprehend c-Myc’s 
role in cancer and perhaps work to utilise it as a therapeutic target.
I
Î
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Chapter 2 - Materials and Methods
2.1 Plasmid Preparation
2.1.1 Transformation of competent cells
2.1.2 Isolation and storage of plasmid DNA
A single colony was selected from the LB-agar plates and was used to inoculate 10 ml 
of LB-broth containing 100 pg/ml ampicillin. The culture was incubated at 37“C in 
an orbital shaker for 8  hours. The mini culture was then transferred into 500ml of 
LB-broth containing 100 pg/ml ampicillin, and incubated at 37°C in an orbital shaker
47
For plasmid propagation, E. coli XL-1 blue competent cells were transformed 
(Stratagene). Cells were stored at -80°C and were thawed on ice before 
transformation. 10-20ng of plasmid DNA was added to 50pl of thawed cells and 
mixed by gentle agitation. The cells were then incubated on ice for 20 minutes.
Following this, the cells were heat-shocked at 42“C for 30 seconds. The cells were 
then recovered by adding 500 pi of SOC medium (LB Broth, 0.05% glucose, lOmM 
MgS0 4 , lOmM MgCb), which had been pre-heated to 37°C, and then incubated at 
37°C for 30 minutes. lOOpl of the cells was then plated onto LB-agar plates (LB- 
broth, 2% agai', 100 pg/ml ampicillin) and then incubated at 37°C overnight.
1
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overnight. The following day the bacterial cells were haivested by centrifLigation at 
5100 rpm for 20 minutes at 4°C (in Sigma Laboratory Centrifuge 4K15). The plasmid 
DNA was isolated from the bacterial cells using the Qiagen Maxi-Prep Kit, according 
to the manufacturer’s instructions.
The bacterial pellet was resuspended in 10 ml of buffer PI (50 mM Tris pH 8.0, 10 
mM EDTA, 100 pg/ml RNase A) and then gently mixed with 10 ml o f buffer P2 (200 
mM NaOH, 1% SDS) to lyse the cells. This reaction was allowed to proceed for 5 
minutes at room temperature before neutralisation with 10 ml of buffer P3 (3 M 
potassium acetate, pH5.5), which results in the formation of a precipitate of potassium 
dodecyl sulphate. The bacterial proteins and chromosomal DNA were co-precipitated
with the detergent whilst the plasmid DNA remamed in solution due to a lack of close 
protein interactions. Precipitation was enhanced by a 20 minute incubation on ice,
■before being centrifuged at 20,000g for 30 minutes at 4°C (in Sigma Laboratory 
Centrifuge 4K15). The supernatant was then added to a Qiagen-tip 500, which had 
previously been equilibrated with 10 ml of buffer QBT (750 mM NaCl, 50 mM
.MOPS pH 7.0, 15% isopropanol, 0.15% Triton X-100). The Qiagen-tip 500 contains 
an anion-exchange resin to which the plasmid binds tightly, allowing the supernatant
' '
to pass thiough. The resin was then washed twice with 30 ml of buffer QC (IM 
NaCl, 50 mM MOPS pH 7.0, 15% isopropanol) and the plasmid DNA was 
subsequently eluted with 15 ml of buffer QF (1.25 M NaCl, 50 mM Tris pH 8.5, 15% 
isopropanol) and precipitated with 10.5 ml o f room temperature isopropanol. This 
was immediately centrifuged at 15,000g at 4°C for 30 minutes. The plasmid DNA 
pellet was then washed with 70% ethanol, dried at room temperature for 10 minutes 
and resuspended in an appropriate volume o f sterile dHiO.
I48
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Plasmids were stored at -20°C. The concentration of the plasmid DNA was 
determined spectrophotometrically using a quartz cuvette, using the equation 1 A260 = 
50 pg/pl dsDNA.
49
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Table 2.1 Description of plasmids
Plasmid Description Origin
pGex2T-N262 Encoding GST fiision protein containing the 
amino acids 1 -262 o f the c-Myc protein
Gift from Bob Eisenman 
(Gomez-Roman et al, 2003)
PGex2T RB (379-928) Encoding GST fusion containing the amino 
acids 379-928 of the RB protein
Gift from Dennis McCance 
(Kaelin et al, 1991)
pGex2T Encoding GST used as a control Gift from Bob Eisenman 
(Gomez-Roman et al, 2003)
pcDNA3 HA Brfl Encoding HA tagged wild-type Brfl protein Generated in house
pcDNA3 HA Brfl (S250A) Encoding HA tagged Brfl protein with a 
serine>alanine mutation at residue 250
Generated in house
pcDNA3 HA Brfl (L>A) Encoding HA tagged Brfl protein with 
leucinoalanine mutations introduced at 
positions 100 and 102
Generated in house
pcDNA3 FLAG Myc Encoding FLAG tagged wild-type c-Myc 
protein
Gift from Lars-Gunner Larsson 
(von der Lehr el al, 2003)
pcDNA3 FLAG Myc AMBI Encoding FLAG tagged c-Myc protein with 
amino acids 43-65 deleted
Gift from Lars-Gunner Larsson 
(von der Lehr et al, 2003)
pcDNA3 FLAG Myc AMBII Encoding FLAG tagged c-Myc protein with 
amino acids 128-143 deleted
Gift from Lars-Gunner Larsson 
(von der Lehr et al, 2003)
p Super TRRAP si Encoding sliRNAs against the TRRAP 
transcript
CRUK shRNA library
pSuper MyoD si Encoding sliRNAs against the MyoD 
transcript
CRUK shRNA library
50
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The remaining culture was harvested by centrifugation, 5100rpm for lOminutes at
51
2.2 GST pull-down assays
■
2.2.1 Preparation of recombinant GST fusion proteins
■I
For plasmid propagation, E. coil BL21 Rosetta competent cells were transformed
■
(Invitrogen). Cells were stored at -80°C and were thawed on ice before 
transformation. 10-20ng of plasmid DNA was added to 50pi of thawed cells and 
mixed by gentle agitation. The cells were then incubated on ice for 20 minutes.
Following this the cells were heat-shocked at 42°C for 30 seconds. The cells were 
then recovered by adding 500 pi of SOC medium (LB Broth, 0.05% glucose, lOmM
MgS0 4 , lOmM MgCb), which had been pre-heated to 37“C, and then incubated at
37°C for 30 minutes. lOOpl of the cells was then plated onto LB-agar plates (LB-
broth, 2% agar, 100 pg/ml ampicillin) and then incubated at 37°C overnight. A single
colony of transformed bacteria was grown overnight in 10ml of LB broth with 
.100pg/ml at 37*^ 0 in an orbital shaker. The 10ml of saturated culture was used to 
inoculate 500ml of LB Amp, and this culture was grown at 37”C in an orbital shaker 
until the culture reached an O D 5 9 5  of 0.6-1.0. 1ml of sample was then removed, 
pelleted by centrifugation, for 30s at 13,000g, and resuspended in 50pl 2x SDS 
sample buffer (150 mM Tris-HCl pH 6 .8 , 1% SDS, 10% P-mercaptoethanol, 20% 
glycerol, 0.5% bromophenol blue), as an uninduced control. The large culture was 
then induced with 0.1 mM final concentration of IPTG and grown for 4 hours at 3TC 
in an orbital shaker. A 0.5ml sample of the induced culture was removed, pelleted by 
centrifugation for 30s at 13,000g, and resuspended in 50pl 2x SDS sample buffer.
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4^C, and snap frozen on dry ice, the pellet was then stored at ~80^C. The uninduced 
and the induced sample were resolved by SDS-PAGE, and the gel stamed with 
coomassie brilliant blue stain, to check for induction of the protein. Once induction 
was confirmed, the cells were resuspended in 2 0 ml of lysis buffer, and sonicated 2 x 
for 30 seconds on ice. The crude lysate was then centrifuged at 10,000g for lOmin at 
4°C. The clarified extract was then aliquoted and snap frozen in a dry ice methanol 
bath.
2.2.2 In vitro transcription and translation of proteins in 
reticulocyte lysate
In vitro transcription and translation of proteins was performed using the Novagen 
single tube protein in vitro transcription and translation kit. Reactions were carried
Î
out usmg 1 pg of plasmid DNA or 2 pi of PCR product. PCR reactions were carried 
out using reagents described in section 2.7.3, without radio-labelled dCTP, using 0.25 
pg of plasmid template (pcDNA3-HA-Brfl) in a total reaction volume o f 50 pi (PCR 
conditions: denaturing - 95°C 5 min; cycling [x35] - 95°C Imin, 55°C Imin, 72°C 2 
mhi; final extension 72°C 5 min). The template DNA was made up to 2 pi and added 
to 8  pi of transcription mixture and incubated at 30°C for 30 minutes. To the 
transcription mixture, 30 pi of translation mixture, 40 pCi Methionine and 6  pi 
dHiO, was added. The mixture was then incubated at 30°C for 1 hom\
I
■■■■;.
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Table 2.2 Primers used to produce templates for in vitro 
transcription and translation of fragments of Brf1
Region of 
Brfl
Forward Primer Reverse Primer
1-280 5’ TAATACGACTCACTATA 
GGGAGAGCCACCATG 3’
5’- GCTCGTCTCGAGCTAGAA 
CTCATC AATGGTC AAC-3 ’
281-677 5’ TAATACGACTCACTATA 
GGGAGAGCCACCATGAAG 
ATCGACGTGGAG 3’
5’-TTGCAACTCGAGTCAGTAG
CCGTCGTCCTCATC-3’
1-94 5’ TAATACGACTCACTATA 
GGGAGAGCCACCATG 3’
3’-CGTCGTCTCGAGCTAGAACT
CATCAATGGTCAAC-5’
94-280 5’ TAATACGACTCACTATA 
GGGAGAGCCACCATGCAC 
CACCTGGGGAACCAG 3’
5’- GCTCGTCTCGAGCTAGAACT 
CATC AATGGTCAAC-3 ’
94-200 5’ TAATACGACTCACTATA 
GGGAGAGCCACCATGCAC 
CACCTGGGGAACCAG 3’
5’-TCTCCCTCGAGTCACAGGCAC
GGGTCTATGGC-3’
200-281 5’ TAATACGACTCACTATA 
GGGAGAGCCACCATGGCC 
ATAGACCCGTG3’
5’- GCTCGTCTCGAGCTAGAACT 
CATC AATGGTC AAC-3 ’
(T7 promoter underlined)
53
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2.2.3 GST pull down assay i
GST or GST fusion proteins were coupled to glutathione agarose beads (Sigma). 20
pi of packed volume of glutathione agarose beads were incubated with the GST or
.GST fusion protein containing clarified extracts for 1 hour at 4®C on a rotating wheel.
.During this incubation period, lOpl of reticulocyte lysate containing the in vitro 
translated protein was incubated with 2 0  pi packed volume of pre-washed glutathione 
agarose beads in a total volume of 600 pi made up with 1 x TBS, to pre-dear the in 
vitro translated protein. The beads bound to the recombinant GST proteins were 
washed three times to remove non-specific binding of bacterial proteins and to these 
beads 250 pi of pre-cleared reticulocyte lysate was added to each condition. The
i:
Î
binding reaction was allowed to proceed for 30 minutes at 4®C on a rotating wheel. 
The beads were then washed three times with 500 pi of 1 x TBS to remove non- 
specific binding to the immobilised recombinant proteins before the bound material 
was released by the addition o f an equal volume of 2  x protem sample buffer. 
Samples were then resolved by SDS-PAGE and the recombinant proteins were then 
visualised by coomassie staimng (0.5% coomassie brilliant blue, 30% methanol, 10% 
acetic acid) and subsequent destaining (30% methanol, 10% acetic acid) to ensure
equal loading of samples. The gels were then incubated with autofluor (National 
,Diagnostics), to enhance the radio-labelled signal. The gels were then dried under a 
vacuum and exposed to autoradiographic film overnight at -80“C. Binding was 
quantified using the Image! programme (National Institute for Health, USA).
I
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2.3 Ceil Culture
Cell cultme was performed in a class II hood using standard aseptic technique and 
sterile reagents and conditions.
2.3.1 HeLa cells and HEK 293 cells
HeLa and HEK 293 cells were maintained in DMEM (Cambrex) supplemented with 
10% foetal bovine serum (Sigma), 2mM L-Glutamine (Sigma), 50 units/ml penicillin 
(Sigma) and 50pg/ml streptomycin (Sigma). Cells were passaged when 80-90%
■-Î,
confluent (3-4 days between passages) using buffered trypsin (Sigma).
2.3.2 MycER and pBabe cells
MycER and pBabe cells were maintained in DMEM supplemented with 10% foetal 
bovine serum, 2mM L- Gluatmme, 50 units/ml penicillin, 50pg/ml streptomycin and 
5pg/ml puromycin (Sigma). Cells were passaged when 80-90% confluent using 
buffered trypsin. To activate the MycER protein, MycER cells were grown to 
confluency, then serum starved (0.25% Serum) for 48 houi’s to lower levels o f 
endogenous c-Myc, before addition o f the oestrogen homologue, 4-hydroxytamoxifen 
(4-OHT). As a control for the addition of 4-OHT, pBabe cells were treated in exactly 
the same way.
2.3.3 Rat 1A wildtype and Rat 1A c-myc null cells
Rat 1A cells were maintained in DMEM supplemented with 10% foetal bovine serum,
2mM L-Glutamine, 50 units/ml penicillin and 50pg/ml streptomycin. Rat 1A c-Myc‘^“ I
cells were maintained in DMEM supplemented with 10% foetal bovine serum, 2mM
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L-Glutamine, 50 units/ml penicillin, 50pg/ml streptomycin and 300 pg/ml G418 
(Promega) (Matek et al, 1997). •S’
2.3.4 Mouse erythroleukaemia (MEL) 585 cells
MEL 585 cells were maintained in RPMI 1640 (Cambrex) supplemented with 15 % 
foetal bovine serum, 2mM L-Glutamine, 50 units/ml penicillin and 50pg/ml |
streptomycin. To differentiate MEL cells N,N’-Hexamethylene-bisacetamide 
(HMBA) (Sigma) was added to the media to a final concentration of 5mM.
2.3.5 Cryo-storage of cells
Live cells were subjected to long-term storage by resuspending near subconfluent #
75cm^ flasks in 2ml of maintenance media containing 10% DMSO. This suspension 
was aliquoted into cryotubes and placed at -80®C overnight to ensure slow freezing, 
before being transferred to hquid nitrogen for long-term storage.
-I;i
'
ÎCells were recovered by rapid thawing at 37°C and were then added to 9 ml of pre- 
warmed media. The resultant mixture was then centriftiged at 298g for 5 minutes at 
room temperatui-e. After centrifugation, the supernatant was removed and the cells 
resuspended in 12 ml of fresh media before being transferred to a 75 cm  ^flask.
Î
■f
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2A Preparation of Extracts
2.4.2 Preparation of nuclear-enriched extracts
Two 10cm dishes of cultured cells were placed on ice and the maintenance media
57
2.4.1 Preparation of extracts for western blots and co- 
immunopreclpitations
Cultured cells were placed on ice and the maintenance media asphated. The cells %
were then washed twice in PBS. Cells were then scraped into PBS (2ml per 10cm 
dish: 0.5ml per 2cm well) and transferred to 50ml Falcon tubes. Cells were 
centrifuged at 500g for 5min at 4°C, and the PBS discarded. Cells were resuspended 
in approx 1ml o f PBS and transferred to a microfuge tube. The tube was then 
centrifuged at 13,000g for 30 sec, and the PBS discarded. The cell pellet was then
■■■resuspended in freshly made micro extraction buffer (450 mM NaCl, 50mM NaF, 20
ÏmM HEPES pH 7.8, 25% glycerol, 1 mM DTT, 0.5mM phenylmethylsulphonyl 
fluoride (PMSF), 0.2 mM EDTA, 40pg/ml bestatin), the volume used being 
equivalent to the volume of the pellet. The resuspended sample was then snap frozen 
on dry ice, and immediately thawed in a 30° C water bath. This freeze thaw cycle was
,repeated thiee times to lyse the cells. Following the final thaw the tubes were then
centrifuged at 13,000g at 4°C for 10 min to separate the cell debris. The supernatant 
was quickly removed and snap frozen on dry ice. Microextracts were stored at -  
80°C.
■f
asphated. The cells were then washed twice in PBS. Cells were then scraped into
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.PBS (2ml per 10cm dish) and transferred to 15ml Falcon tubes. Cells were 
centrifuged at 500g for 5min at 4°C, and the PBS discarded. The pellet was
resuspended in 2ml of PBS and split into 2 1.5ml microfuge tubes. The tubes were 
centrifuged for 5 sec, 13,000g at 4°C. The supernatant was removed and the cells in
I
I
each tube were resuspended in 1ml of Buffer A (lOmM HEPES pH 7.9, 1.5mM 
MgCb, lOmM KCl, 0.5mM DTT, 0.2mM PMSF). The tubes were centriftiged for 5 
sec, 13,000rg at 4°C. The supernatant was removed and the cells in each tube were 
resuspended in 1ml of Buffer A. The cells were placed on ice for 15 minutes to swell 
and lyse the cells. The tubes were vortexed for 30 seconds and then centrifuged for 5 
sec, 13,000g at 4°C. The supernatant was then discarded and each cell pellet was 
resuspended in an equal volume of buffer C (lOmM HEPES pH 7.9, 25% (v/v) 
glycerol, 0.45M NaCl, 1.5mM MgCfr, 0.125mM EDTA, 0.5mM DTT, 0.2mM 
PMSF). The cells were incubated on ice for 15 minutes. The tubes were centrifuged 
for 5 minutes, 13,000g at 4°C. The supernatant was removed, aliquoted and snap 
frozen on dry ice. The nuclear-enriched extracts were stored at -80°C.
2.4.3 Determination of protein concentrations
Protein concentrations were determined using Bradford’s reagent (BioRad) diluted 1 
in 5 with distilled H2 O. The colour change produced in this reagent m response to 
being mixed with protein can be quantified by absorbance at 595 mn, and these values
.are directly proportional to the concentration of protein in the sample. For each 
experiment, a standard curve was constructed by measuring absorbance of 
0,2,4,6,8,10 and 12 pg of BSA in 1ml of Bradford’s reagent. Ipl of each microextract 
was added to 1ml of reagent. Absorbance readings at 595nm were performed in
i."I;.;S
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duplicate, and the protein concentration of each sample was determined from the 
standard cui’ve.
■I:
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2.6 Separation of proteins by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and western blotting
2.5.1 SDS-PAGE
Protein extracts, as prepared in section 2.4, were resolved by denaturing SDS-PAGE 
on 10% (unless otherwise indicated) polyacrylamide gels (375mM Tris pH 8.8, 0.1% 
SDS), with 4% polyacrylamide stacking gels (125mM Tris pH 6.8, 0.1% SDS). Prior 
to loading, samples were boiled for 2 minutes in Ix protein sample buffer (62.5 mM 
Tris pH 6.8, 0.5% SDS, 5% (3-mercaptoethanoi, 10% glycerol, 0.125% bromophenol 
blue). Electrophoresis was performed in SDS running buffer (0.1% SDS, 76.8 mM 
glycine, lOmM Tris pH 8.3) at 200V. Electrophoresis was continued for 
approximately 60 minutes, until the bromophenol dye had moved to the bottom of the 
gel.
2.5.2 Western Blot Analysis
Followed SDS-PAGE, proteins were transferred to a nitrocellulose membrane 
(BioRad) using the BioRad Mini Trans-Blot Electrophoretic Transfer Cell system. 
Transfer was canied out in 1 X transfer buffer (76.8 mM glycme, lOmM Tris pFI 8.3, 
20% methanol) at 50V, overnight at 4°C. Membranes were then stained using 1 x 
Ponceau S to ensure efficient transfer of the protein to the membrane, and 
subsequently washed with PBS. Membranes were then blocked in milk buffer (32.5 
mM Tris, 150 mM NaCl, 0.2% Tween-20, 5% skimmed milk powder (Marvel)) for 2 
hours at room temperature. The membranes were then incubated in the presence of
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the appropriate primary antibody diluted in milk buffer for 2 hours at room 
temperature. Primary antibodies and their appropriate concentrations are listed in 
table 2.3. Membranes were washed three times in milk buffer to remove excess 
primary antibody. Membranes were then incubated in the presence of the appropriate 
secondary antibody (Dako) at a dilution of 1:1000 in milk buffer. Subsequently, 
membranes were washed five times with western wash buffer (32.5 mM Tris, 150 
mM NaCl, 0.2% Tween-20), to remove excess secondary antibody. The bound 
antibodies were then detected using enhanced chemiluminescence (ECL), as directed 
by the manufacturer (Amersham).
; î
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Table 2.3 Antibodies used in western blot analysis
Protein Antibody Type Dilution Source
Brfl 128 Serum 1:1000 In house
Bdpl 2663 Serum 1:1000 In house
TBP SI-1 Polyclonal 1:1000 Santa Cruz
T F i i ic  n o 4286 Serum 1:1000 In house
TFIIIC 220 Ab7 Serum 1:1000 In house
RPC 155 1900 Serum 1:1000 In house
c-Myc N-262 Polyclonal 1:500 Santa Cruz
Max C-17 Polyclonal 1:1000 Santa Cruz
TRRAP H-300 Polyclonal 1:500 Santa Cruz
FIA F-7 Monoclonal 1:2500 Santa Cruz
FLAG M2 Monoclonal 1:2500 Sigma
Actin C-11 Polyclonal 1:5000 Santa Cruz
SP-1 1C6 Monoclonal 1:1000 Santa Cruz
fi
:
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2.6 Co-immunoprecipitation
2.6.1 Transfection of HEK293 cells using Lipofectamine
HEK 293 cells were plated into 10 cm dishes and were transfected at a confluency of 
approximately 70-80%. One 10 cm dish was transfected per condition with a total of 
4 pg of plasmid DNA per dish; this was comprised of Ipg of pcDNA3-Brfl and 3 pg 
of a Myc expression vector (described in table 2.1). The appropriate mix of plasmid 
DNA for each condition was mixed with 0.5 ml of OptiMEM media (Gibco). In a 
separate tube, 20pi of Lipofectamine (Invitrogen) was mixed with 0.5ml of 
OptiMEM. This Lipofectamine mix was added to the tube containing the plasmid 
DNA and mixed by pipetting. The DNA/Lipofectamine complexes were allowed to 
form by mcubation at room temperature for 45 minutes m the dark. During this 
incubation, the cells were washed with 5 ml of OptiMEM, and then 4 ml of OptiMEM 
added per plate. The plates were then incubated at 37°C for the remainder of the 
incubation time (approximately 30 minutes). After the incubation, 1ml of the 
Lipofectamine-DNA-OptiMEM mix was added to each dish and the plates left to 
incubate for 5 hours at 37°C hr the incubator. After the incubation period, the 
Lipofectamine-DNA-OptiMEM mix was removed and replaced with 10 ml of fiesh 
maintenance media. Cells were incubated for a further 48 hours to allow expression 
of the transfected DNA. Cells were harvested and protein extracts were prepared as 
described in section 2.4.2.
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2.6.2 Co-immunoprecipitation
Aiiti-FLAG (Sigma) antibody was coupled to protein-G sepharose beads. 25 pi of 
packed beads was used per immunoprécipitation (IP); these beads were washed twice 
with 200 pi 1 X TBS, prior to incubation with 5 pi anti-FLAG antibody, made up to a 
total volume of 50 pi with TBS on a shaker for 1 hour at 4°C. Following antibody 
binding, beads were washed twice with 1 x TBS to remove excess antibody. For co- 
immunoprecipitation reactions, 250 pg of protein extract was added to the beads and 
incubated end over end for 2 hours at 4°C. The beads were then washed five times 
with 1 X TBS (25 mM Tris pH 7.6, 150mM NaCl) before the bound material was 
released by the addition of an equal volume of 2 x protein sample buffer. Samples 
were then analysed by SDS-PAGE and subsequent western blot analysis.
2.6.3 Co-immunoprecipitation using ^®S-labelled proteins
25 pi of packed beads was used per immunoprécipitation (IP); these beads were 
washed twice with 200 pi 1 x TBS, prior to incubation with 1 pg of anti-TRRAP or 
anti-TFIIA antibody, made up to a total volume of 50 pi with TBS on a shaker for 1 
hour at 4°C. Following antibody binding, beads were washed twice with 1 x TBS to 
remove excess antibody. For co-immunoprecipitation reactions, 150 pg of HeLa 
nuclear extract as well as 5 pi o f in vitro transcribed and translated protein was added 
to the beads and incubated end over end for 2 hours at 4°C. The beads were then 
washed five times with 1 x TBS before the bound material was released by the 
addition of an equal volume of 2 x protein sample buffer. Samples were then 
analysed by SDS-PAGE and subsequent western blot analysis.
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2.7 Reverse-Transcriptase Polymerase Chain Reaction (RT- 
PCR)
65
2.7.1 RNA Extraction
Total cellulai’ RNA was extracted from tissue culture cells grown in 10cm dishes 
using TRI reagent (Sigma). Culture media was removed from the cells and the cells 
were scraped into 1ml of TRI and transferred into sterile microfuge tubes. The tubes 
were incubated for 1 min at room temperature before 200pl o f chloroform was added 
to each sample, which was subsequently mixed by vortexing for 15 seconds. Samples 
were incubated for a further 5min at room temperature before being centriftiged at 
13,000g for 15 minutes. The centrifiigation step separated the samples into 3 phases : 
the lower red organic phase containing the proteins, the intermediate phase which
contained the DNA, and the upper clear aqueous phase containing the RNA. The 
RNA-containing aqueous phase was carefully removed and transferred to a clean 
microfuge tube, 0.5 ml of isopropanol was added to the sample to precipitate the 
RNA, the tubes were then mixed by vortexing, incubated for lOmin at room 
temperature and centrifuged for lOmin at 13,000rpm at 4°C. The pellet was washed
with 75% ethanol, centrifuged agam for lOmin at 13,000 at 4°C. The wash was 
removed and the pellet dried at room temperature for approx lOmin. The RNA was 
redissolved in approximately 20pl DEPC H2O and samples were heated to 50°C to 
facilitate resuspension. All RNA samples were stored at -80°C. The concentration of 
the RNA was determined spectrophotometrically using a quartz cuvette using the 
equation 1 A260 = 40 pg/pl RNA.
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2.7.2 cDNA production
3pg of RNA, prepared as outlined in section above, was added to 200ng of 
hexanucleotide primers (Roche) made up to a final volume of 24pl. Tubes were 
incubated at 80°C for 10 minutes for primer annealing. Tubes were transferred to ice 
then 8pl of 5 X Fhst Strand Buffer (Invitrogen Life Technologies), 4pl of O.IM 
dithiolthreitol (DTT) (Invitrogen Life Technologies), 2pl of a dNTP mix containing 
all four dNTPs at a concentration of 1 OmM each (Promega) and 1 pi of Superscript II 
reverse transcriptase (Invitrogen Life Technologies). Reverse transcription reaction 
was incubated at 42°C for 1 hour. Reaction was terminated by incubating tubes at 
70°C for 15 min to destroy the enzyme.
in 1 X TBE prior to loading 2 pi o f samples. Before loading, samples were heated at
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2.7.3 Polymerase Chain Reaction (PCR)
Each PCR was performed using 2pl of cDNA (As described in 2.7.2) or 2pi of ChIP 
DNA (as described in section 2.8). Each PCR reaction had a total volume of 20pl 
containing Ix Mg^^ free taq DNA polymerase buffer (Promega), 1.5mM MgCL, 
0.2mM of each of dATP, dCTP, dGTP and dTTP, and l.SpCi of [a-^^P] dCTP
(Amersham). Primer sequences and cyclmg parameters are described m table 2.4. 
.Reaction products were diluted 1:1 with formamide loading buffer (98% formamide, 
0.01% bromophenol blue, 0.01% xylene cyanol, 5mM EDTA), and resolved on 7% 
polyacrylamide sequencing gels containing 7% urea and Ix TBE (45 mM Tris, 45 
mM boric acid, 0.625 mM EDTA pH 8.0). Gels were pre-run at 40W for 30 minutes i
*v:;:îI:ï
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95°C for 2 minutes. Electrophoresis was carried out for 1 hour at 40W, and then gels 
were vacuum dried for 1 hour at 80“C. PCR products were visualised by 
autoradiography.
Ï%IÎa-là,J
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Table 2.4 Primers for RT-PCR
Transcript Primer Cycle
Number
Product
Length
PCR Conditions 
(denaturing; 
cycling; final 
elongation)
5S rRNA 5’ GGCCATACCACCCTGAACGC 3’ 
5’ CAGCACCCGGTATTCCCAGG 3’
18-20 107 bp 95“C for 3 min; 95®C 
for 30 s, 58“C for 30 
s, 72“C for 1 min; 
72®C for 5min
ARPPPO 5’ GCACTGGAAGTCCAACTACTTC 3’ 
5’ TGAGGTCCTCCTTGGTGAACAC 3’
18-20 266 bp 95“C for 2 min; 95”C 
for 1 mill, 58®C for 
30 s, 72“C for 1 min; 
11°C for 5 min
tRNA"^ '" 5’ GAGGACAACGGGGACAGTAA 3’ 
5’ TCCACCAGAAAAACTCCAGC 3’
25-27 8 8  bp 95"C for 3 min; 95°C 
for 30 s, 68”C for 30 
s, IT C  for 30 s; 
72”C for 5 min
tRNA 5’ AGGACTTGGCTTCCTCCATT3’ 
5’ GACCTAAGGATGTCCGCAAA 3’
25-27 84 bp 95"C for 3 min; 95'’C 
for 1 min, 65®C for 
30 s, irc for 15 s; 
72®C for Imin
TRRAP 5’ CAGGAAGTGAAACGCTTAGG 3’
5’ GTCTTCAGAAGGTTCTGAAGAC 3’
26-28 252 bp 95“C for 3 min; 95°C 
for 1 min, 58°C for 
30 s, 72"C for 1 min; 
72°C for 5 mill
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2.8 Chromatin immunoprécipitation (ChIP) assay
needle three times. Low salt buffer was then added to the suspension to a final 
volume of 2.7ml. 300pl of 20% sarcosyl was then added to the cell suspension to lyse
'S
Cells were grown in 10cm tissue culture dishes until approaching confluency for ChIP 
assays. One 10cm dish of cells was used per IP. Formaldehyde was added to the 
culture medium to a final concentration of 1% to cross-link the protein DNA 
complexes. Crosslinking was allowed to proceed for 10 minutes at 37°C. Excess 
glycine was then added at a final concentration of 0.125M, to stop the crosslinking, 
and the plates transferred to ice for harvesting. The cells were harvested in the plating 
media/formaldehyde/glycine mix and transferred to 50ml Falcon tubes. The pellets
were then harvested by centrifugation at 500g for 5 minutes at 4°C. The cell pellets 
were washed in ice cold PBS, followed by centrifugation at 500g for 5min at 4°C 
(The pellets could then be snap frozen at this stage on dry ice, and stored at -80°C, for 
analysis at a later date).
The cell pellets were washed with ice cold PBS/0.5% NP-40, then centrifuged at 500g 
for 5 minutes at 4°C. Following removal of the supernatant fr om this wash, cells 
were then resuspended in 40ml of high salt buffer (0.5% NP-40, PBS, IM NaCl), and 
incubated on ice for 30 minutes. Following the mcubation the cells were centrifuged 
at 1500rpm for 5 minutes at 4°C and washed with 40ml PBS/1% NP-40. The cell 
pellets were then resuspended in 40ml of low salt buffer (0.5% NP-40, lOmM Tris
HCl, pH 8.0, 1 mM EDTA, 0.1 M NaCl) and incubated on ice for 30 minutes.
Following the incubation, the tubes were centrifuged at 500g for 5 minutes at 4°C. 
Pellets were then resuspended m 1ml of low salt buffer and passed tlii'ough a 26g
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the nuclei. The lysed nuclei were then transferred to a sucrose cushion and 
centrifuged at 4000g for 10 minutes at 4°C. The supernatant was discarded and the 
pellet resuspended in 3ml TE. The suspension was then transferred to a second 
sucrose cushion, and centrifuged at 4000g for 10 minutes at 4°C. The final pellet 
containing the genomic DNA and cross-linked proteins was resuspended in 2ml TE 
(10 mM Tris pH 8.0, ImM EDTA), and the DNA then sheared into smaller fragments 
by sonication (Branson sonifier 250, 10 x 10 s, duty cycle 30%). 0.2 ml of l lx  NET 
Buffer (1.56 M NaCl, 5.5 mM EDTA, 5.5% NP-40, 550 mM TrisCl, pH 7.4) was 
added to the 2ml sample, which was then transferred to microfuge tubes and 
centrifuged at 13,000g for 5 minutes. The supernatant was then aliquoted evenly in 
microfuge tubes. The indicated amount of antibody was added per aliquot (Table 
2.6), and these were incubated, end over end, overnight at 4°C.
The following day, 50pi of protein G sepharose beads was added to each tube, and 
these were left to incubate for a fiirther 2 horns. The beads were then recovered on 
polypropylene columns (Pierce), and washed twice with 10ml RIPA (50 mM TrisHCl, 
pH 8.0, 150mM NaCl, 0.1% SDS, 0.5% deoxycholate, 1% NP-40) buffer, twice with 
10ml LiCl (10 mM Tris HCl, 250 mM LiCl, 0.5% NP-40, 0.5% deoxycholate, 1 mM 
EDTA, pH 8,0) and finally twice with TE. The beads were then transferred to 
microfuge tubes and the protem DNA complexes eluted with 200pl TE/1%SDS by 
incubating end over end for 10 minutes at room temperature. This elution was 
repeated and the supernatants pooled. The pooled supernatants along with the inputs 
were incubated overnight at 42°C in the presence of proteinase K to degrade the 
antibodies and protems. The DNA was then extracted twice using 400pl phenol/ 
chloroform/ isoamylalchohol (25:24:1) and once using chloroform alone. 1 ml of
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ethanol (2.5x volume) and 40pl of 3M sodium acetate was added and the tubes were
.thoroughly mixed by inversion. The DNA was precipitated at -20°C overnight.
Samples were centrifuged at 13,000g for 20 minutes to pellet the precipitated DNA. 
The supernatant was removed and the pellets were washed with 150pl 70% ethanol
and re-centrifuged at 13,000g for 5 minutes. The supernatant was removed and the 
pellets were air dried before adding 50pl of TE to resuspend the DNA. The samples 
were then analysed by PCR, primer sequences and conditions are displayed in the 
table below (Table 2.5)
;
j
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Table 2.5 Primers used In PCR analysis of ChIP samples
Transcript Primers Cycle
Nunber
Product
Size
PCR Conditions 
(denaturing; 
cycling; final 
elongation)
5S rRNA 5’ GGCCATACCACCCTGAACGC 3’ 
5’ CAGCACCCGGTATTCCCAGG 3’
20-25 107 bp 95"C for 3 min; 95'*C 
for 30 s, 58“C for 30 
s, IT C  for I min; 
IT C  for 5rain
ARPPPO 5’ GCACTGGAAGTCCAACTACTTC 3’ 
5’ TGAGGTCCTCCTTGGTGAACAC 3’
20-25 266 bp 95“C for 2 min; 95T  
for 1 min, 58”C for 
30 s, IT C  for 1 min; 
IT C  for 5 min
Cyclin D2 
Promoter
5’ GGCATAACCTTTATCCCTGGTT 3’
5’ AACCCCATGG ATTCCTATTGATT 3’
25-30 252 bp 95“C for 3 min; 95"C 
for 1 min, 60“C for 
30 s, 12°C for I min; 
12°C for 5 min
p21 Coding 
Region
5’ CTCTGGGAAGCCAGAAGTTGTT 3’ 
5’ GGTCCAGTCCCTGCArCl’AAGT 3’
25-30 257bp 95T  for 3 min; 95T  
for 1 min, 55“C for 
30 s, 72"C for 1 min; 
72°C for 5 min
tRNA"^ '" 5’ GAGGACAACGGGGACAGTAA 3’ 
5’ TCCACCAGAAAAACTCCAGC 3’
25-30 88 bp 95°C for 3 min; 95°C 
for 30 s, 68“C for 30 
s, 72°C for 30 s; 
72"C for 5 min
tRNA^ ')" 5’ AGGACTTGGCTTCCTCCATT 3’ 
5’ GACCTAAGGATGTCCGCAAA 3’
25-30 84 bp 95“C for 3 min; 95“C 
for 1 min, 65“C for 
30 s, 72"C for 15 s; 
72°C for 1 min
Ïs
*
■
I
72 I
Chapter 2 Materials and Methods
Table 2.6 Antibodies for ChIP analysis
Protem Antibody Type Source Quantity used per IP
Brfl 128 Serum In house 20 pi
Bdpl 2663 Serum In house 20 pi
TBP mTBP-6 Monoclonal In house 200 pi
TFIIIC 110 4286 Serum In house 20 pi
TFIIIC 220 Ab7 Serum In house 20 pi
RPC 155 1900 Serum In house 20 pi
c-Myc N-262 Polyclonal Santa Cruz 4 pg
Max C-17 Polyclonal Santa Cruz 4 pg
TRRAP H-300 Polyclonal Santa Cruz 4 p g
Acetyl Histone H4 06-866 Polyclonal Upstate 4pg
Acetyl Histone H3 06-599 Polyclonal Upstate 4pg
Gcn5 H-75 Polyclonal Santa Cruz 4pg
Tip60 H-93 Polyclonal Santa Cruz 4 pg
TAFi48 M19 Polyclonal Santa Cruz 4 pg
TFIIA FL-109 Polyclonal Santa Cruz 4 pg
TFIIB C18 Polyclonal Santa Cmz 4 pg
I
■ , ; K i
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2.9 Transient transfection of shRNA s to knockdown 
endogenous protein levels
Hela cells were plated into 6 well dishes at a confluency of 4 xlO^ cells per well. The 
cells were left to grow overnight, resulting in a confluency of approximately 80-90% 
of cells per well. For each well to be treated, 2pg of the pSuper RNAi plasmid was 
added to 250 pi of OptiMEM and mixed. In a separate tube, 7.5pl of Lipofectamine 
2000 (Invitrogen Life Technologies) was mixed with 250 pi of OptiMEM and 
incubated at room temperature for 5 minutes. This Lipofectamine 2000 mix was 
added to the tube containing the plasmid DNA and mixed by pipetting. The 
DNA/Lipofectamine 2000 complexes were allowed to form by incubation at room 
temperature for 20 minutes in the dark. Dur ing this incubation the cells were washed 
with 3 ml of DMEM, and then 2 ml of DMEM added per well. The plates were then 
incubated at 37°C for the remahider of the incubation time (approximately 15 
minutes). After the incubation, 0.5 ml o f the Lipofectamine 2000-DNA-OptiMEM 
mix was added to each dish and the plates left to incubate for 5 hours at 37°C in the 
incubator. After the incubation period, 2.5 ml o f DMEM containing 20% FBS was 
added to the cells. Cells were incubated for a further 48 hours to allow expression of
the transfected DNA. Cells were harvested and protem extracts and RNA were 
prepared as described previously.
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Chapter 3: Investigating the interaction between 
TFIIIB and c-Myc
3.1 Introduction
c-Myc has been demonstrated to activate genes transcribed by pols I, II and III 
(Chapter 1; Oskarsson and Trumpp, 2005). Unlike the promoters of pol I and pol II- 
transcribed genes activated by c-Myc, pol Ill-transcribed genes do not contain good 
matches to the E-Box DNA sequence that is recognised by c-Myc/Max heterodimers 
(E-boxes). Instead the interaction between c-Myc and class III genes appears to be 
through protem-protein interactions with the pol Ill-specific transcription factor 
TFIIIB (Gomez-Roman et al, 2003; Felton-Edkins et al, 2003b). It is believed that it 
is TFIIIB, rather than DNA sequence, that is responsible for the presence of c-Myc on 
pol Ill-transcribed genes (Gomez-Roman et al, 2003; Felton-Edkins et al, 2003b).
i
3.1.1 Regulation of pol III transcription by altering levels and 
activity of TFIIIB
TFIIIB is a complex composed of three subunits TBP, Brfl and Bdpl (Geiduschek 
and Kassavetis, 2001; Schramm and Hernandez, 2002). As discussed in chapter 1, the 
function of TFIIIB is to bind to class III genes, in a TFIIIC-dependent manner, and 
subsequently recruit pol III to the start site of transcription, where it also plays a role 
in promoter opening (Geiduschek and Kassavetis, 2001; Schramm and Hernandez,
2002). The interaction between TFIIIB and promoter-bound TFIIIC is, at least in
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yeast, the rate-limiting step in the formation of an active transcription complex (Moir 
et al, 1997; Rameau et al, 1994). Given the pivotal role of TFIIIB in the formation of 
the transcription complex, it is of no surprise that pol III transcription can be regulated 
through modulation of its activity.
In both yeast and mammalian cells the levels of pol III transcription can be controlled 
by altering the levels of subunits of TFIIIB. In S. cerevisiae pol III transcription 
declines during the transition from logarithmic to stationary phase growth (Sethy at al, 
1995), This is attributed to lower levels of the Brfl protein (Sethy et al, 1995). In 
mammalian cells, the differentiation of F9 embryonal carcinoma cells into parietal 
endoderm is accompanied by a decrease in the rate of pol III transcription (White et 
al, 1989). This decrease is due to specific down-regulation of TFIIIB, specifically of 
Brfl and Bdpl (White et al, 1989; Alzuherri and White, 1998; Athineos and Wliite, 
unpublished observations).
Levels of pol III transcription fluctuate during the cell cycle. Pol III transcription 
increases dui'ing late G1 and declines during mitosis (White et al, 1995). Add-back 
experiments demonstrated that TFIIIB activity is limiting during early G1 (Wliite et 
al, 1995). The levels of TFIIIB subunits do not appear to change during the cell 
cycle, but their action is controlled by regulation of their activity (Scott et al, 2001; 
Fairley et al, 2003). The tumour suppressor proteins p53 and RB can inhibit pol III 
transcription through interactions with TFIIIB (Chu et al, 1997; Larminie et al, 1997). 
In resting cells, TFIIIB is inactivated through an interaction with RB, which prevents 
its interaction with both TFIIIC and pol III, therefore preventing transcription 
complex formation on pol Ill-transcribed genes (Sutcliffe at al, 2000). The binding of
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TFIIIB is also regulated by phosphorylation of its Brfl subunit (Johnston et al, 2002;
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RB to the TFIIIB is proposed to be dependent on the TFIIIB specific TAFs, as
addition of TBP cannot rescue RB mediated inhibition of pol III transcription in vitro
(Larminie et al, 1997). Inactivation of RB through phosphorylation results in the
.release of TFIIIB and subsequent activation of pol III transcription (Scott et al, 2001).
.I
Another repressor of pol III transcription that acts on TFIIIB is the p53 tumour
suppressor protein (Cairns and White, 1998). The expression of p53 is induced in 
response to a variety of cellular insults, and its induction leads to an inhibition of pol 
III transcription (Gomez-Lazoro et al, 2004; Hofseth at al, 2004). This inhibition is 
through diiect binding to TFIIIB, through the TBP subunit (Chesnokov et al, 1996;
Cairns and White, 1998; Crighton et al, 2003). Once bound by p53, TFIIIB loses its 
ability to interact with TFIIIC and this results in a marked decrease of TFIIIB and pol 
III occupancy on pol Ill-transcribed genes (Crighton et al, 2003)
:î
Felton-Edkins et al, 2003a; Fairley et al, 2003). The oncogenic kinase CK2 can bind 
to TFIIIB and phosphoiylate Brfl (Johnston et al, 2002). The phosphorylation of 
TFIIIB by CK2 facilitates its recruitment to TFIIIC (Johnston et al, 2002). TFIIIB is 
also phosphorylated by the MAP kinase Erk (Felton-Edkins et al, 2003a). Erk binds 
to and phosphorylates Brfl, and this leads to an increase in the interaction between 
TFIIIB and TFIIIC and consequent increase in pol III transcription (Felton-Edkins et 
al, 2003). Brfl is also phosphorylated during mitosis, but this phosphorylation event 
is involved in the repression, rather than the activation of pol III transcription (Fairley 
et al, 2003).
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3.1.2 c-Wlyc interacting proteins involved in transcriptional 
activation
Like TFIIIB, c-Myc can interact with a variety of proteins to both positively and 
negatively alter its activity, c-Myc can interact with proteins that can influence its 
action in a number of ways: recruitment of chromatin remodelling activities 
(SWI/SNF and relatives) (Cheng et al, 1999; Wood et al, 2000), recruitment of 
modifying complexes (CBP, TRRAP and associated complexes) (McMahon et al, 
1998; Bouchard et al, 2001; Frank et al, 2001; Vervoorts et al, 2003), interaction with 
ubiquitin ligases (Fbw7 and Skp2) (Welcker et al, 2004, Yada et al, 2004; Kim et al, 
2003; von der Lehi* et al, 2003) and a host of other factors (Reviewed in Sakamuro 
and Prendergast 1999) (Figure 3.1),
As well as these co-activator proteins c-Myc has also been shown to bind to the 
general transcription factors required for transcription by pol I and pol II. It has been 
demonstrated that c-Myc can bind to the TFIID complex via interactions with TBP 
and to the RAP74 subunit of TFIIF (Maheswaran et al, 1994; McEwan et al, 1996). 
TFIIF and TFIID are associated with the c-Myc TAD and it is proposed that these 
interactions are associated with c-Myc transcriptional activation (Maheswaran et al, 
1994; McEwan et al, 1996). c-Myc can also prevent the formation of the pol II 
transcription complex through association with the pol Il-specific transcription factor
proposed to prevent the interaction between TFIID, TFH-I and the promoter (Roy et
'Ki
TFII-I, to repress target genes (Roy et al, 1993) The interaction with TFII-I is
al, 1993).
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Figure 3.1 Schematic of c-Myc protein indicating interaction 
domains for a variety of co-activator protein
Schematic of c-Myc indicating the conserved regions indicating the points of 
interaction with co-activator proteins, Snf5, TRRAP, TIP48/49, Skp2, Fbw7, P-TEfb, 
TBP, TFIIIB and Max. The regions of the c-Myc protein are described in figure 1.5.
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It was recently demonstrated that c-Myc can also directly activate pol I transcription 
(Grandori et al, 2005; Arabi et al, 2005). c-Myc is present on the rDNA repeats and 
its occupancy correlates with the occupancy of the pol I-specific transcription factor 
SLl (Grandori et al, 2005). SLl is an essential complex composed of TBP and three
-
pol I-specific TAFs; TAFil 10, TAFi63 and TAFi48 (Grummt, 2003), The SLl-c-Myc 
interaction is tlirough two conserved regions of the c-Myc protein; the bHLHZ and 
the MBII domains (Grandori et al, 2005) (Figure 3.1).
%
Promoters of the c-Myc target genes transcribed by pol I and pol II contain the E-box 
sites necessary for c-Myc/Max binding, and c-Myc may use these to recruit general 
transcription factors to the promoters of these genes (Grandori et al, 2000; Grandori et 
al, 2005). As previously discussed, it is tlirough TFIIIB rather than DNA binding that 
c-Myc interacts with pol Ill-transcribed genes, therefore this simple model of c-Myc 
binding to DNA and recruiting the general transcription factors, is unlikely to be the 
case.
In this chapter the interaction between TFIIIB and c-Myc will be examined. As 
TFIIIB is subject to regulation by multiple factors, the interplay between these 
regulators needs to be studied fully to understand how they exert their influence on 
pol III transcription in vivo. To do this, the interactions between subunits of TFIIIB 
and c-Myc will be determined and further defined. These interactions will be 
compared to how other regulators of pol III transcription bind to this complex and to 
determine if they shai'e any common binding domains. Also in this chapter, the 
TFIIIB interaction domain of c-Myc will be further defined and mutant c-Myc
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proteins will be tested for their ability to bind to XFIIIB and to stimulate pol III 
transcription.
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3,2 Results
3.2.1 Mapping the TFIIIB interaction with c-Myc
As summarised in the introduction to this chapter, c-Myc can bind to the pol III-
83
specific transcription factor TFIIIB (Gomez-Roman et al, 2003). The interaction
.between c-Myc and TFIIIB was confirmed by co-immunoprecipitation and co- 
fractionation experiments (Gomez-Roman et al, 2003), but the subunit(s) of TFIIIB 
that c-Myc interacts with are unknown. It was also demonstrated by pull-down 
experiments that TFIIIB interacts with the N-terminal 262 amino acids of c-Myc, 
which includes part of the central domain of c-Myc and the minimal TAD, but does 
not include the C-terminal basic helix loop helix zipper domain (Gomez Roman et al,
2003). The binding of c-Myc to TBP has been previously reported and this 
interaction is dependent on amino acids 1-143 of c-Myc, which is the minimal TAD 
(McEwan et al, 1996). To investigate whether c-Myc could bind to any of the other 
components of TFIIIB individually, pull-down assays were performed using GST 
fused to the N-terminal 262 amino acids of c-Myc and GST alone. Recombinant 
proteins were expressed in bacteria and immobilised on glutathione agarose beads. 
The proteins were then resolved by SDS-PAGE and the gels stained to check for 
equivalent protein levels (Figure 3.2a). In vitro transcribed and translated Brfl, Bdpl 
and TBP, radio-labelled using ^^ S methionine, were then incubated with the 
immobilised proteins to test for binding. The TBP component of TFIIIB binds 
specifically to GST-Myc N262 (Figure 3.2b). This interaction between TBP and c- 
Myc has been previously reported by several groups (Maheswaran et al, 1994; 
McEwan et al, 1996). Also seen in this experiment is a strong interaction between
:
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Figure 3.2 c-Myc interacts with the TBP and Brf1 components of 
TFIIIB
GST-Pull down analysis of c-Myc binding to subunits of TFIIIB. A. Coomassie 
staining of SDS-PAGE gel to demonstrate levels of GST and GST-Myc N262 used in 
the pull-down. B. ^^S-labelled in vitro transcribed and translated Brfl, Bdpl and 
TBP were tested for their ability to interact with immobilised GST or GST-Myc 
N262.
84
Chapter 3 Investigating the interaction between TFIIIB and c-Myc
GST-M yc N 262
85
" i
organisms, but has no obvious similarity to other known proteins (Mital et al, 1996). 
To investigate the interaction between Brfl and c-Myc, smaller regions of the Brfl 
coding sequence were amplified by PCR to be used as templates to produce the 
smaller peptides (figuie 3.4a). To do this, the forward primers contained a T7
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GST-Myc N262 and Brfl (Figure 3.2b). The binding of c-Myc to TBP and Brfl is 
specific, as the other pol Ill-specific TAF Bdpl, does not bind to the c-Myc fusion 
protein (Figure 3,2b).
The Brfl protein is critical in the control of pol III transcription through interaction 
with both activators and repressors. To further investigate the Brfl-c-Myc 
interaction, we tested the ability of Brfl fragments to bind to the recombinant c-Myc 
protein, to further define the c-Myc binding domain of Brfl.
The structure of the Brfl protein can be split into two domains, the N-terminal TFIIB- 
related domain and a C-terminal domain, which is unique to Brfl (Figure 3.3; Mital et 
al, 1996). The N-terminal 280 amino acids of hBrfl are 24 % identical to hTFIIB, 
sharing similar domains including a Zn ribbon domain and two imperfect direct 
repeats (Mital et al, 1996). The direct repeats of hBrfl are homologous to those found 
in cyclins and to the pocket domain of RB and its relatives (Figure 3.3; Mital et al, 
1996; Hisatake et al, 1993). It is through this N-terminal domain that Brfl can 
interact with some of the activators and repressors of pol III transcription. The C- 
terminal domain of hBrfl, which shares no homology with TFIIB, contains the high 
affinity TBP binding site and is critical for the formation and function of the TFIIIB 
complex (Figure 3.3; Buratowski and Zhou, 1992; Colbert and Hahn, 1992; Khoo et 
al, 1994). The C-terminal region of Brfl is homologous with Brf proteins from other
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Figure 3.3 Schematic of hBrfl
Schematic diagram of Brfl indicating the conserved domains; Zn ribbon, direct 
repeats and the Brfl homology regions, HI H2 and H3, and their relative positions in 
the polypeptide. Also indicated is the region of Brfl that is homologous with TFIIB.
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Figure 3.4 c-Myc interacts with the direct repeats of Brf1
A. Immobilised GST and GST-Myc N262 were used to pull down a range of ^^ S 
labelled in vitro transcribed and translated fragments of Brfl (indicated in figure) to 
test for specific binding to c-Myc (Fragments under 30 kDa were run on 15% SDS- 
PAGE gels). B. Graphs quantifying the binding of these fragments to GST and GST- 
Myc N262 as a percentage of the input (Quantification done using ImageJ).
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promoter, and the PCR products were in vitro transcribed and translated in the 
presence of ^^S-labelled methionine. The in vitro transcribed and translated Brfl 
fragments were used in GST pull-down assays to test for an interaction with the N- 
terminal 262 amino acids of c-Myc (Figure 3.4a). The C-terminal region of Brfl, 
encoded by amino acids 281-677, which is conserved within Brfl homologues, but 
has no similarity to TFIIB, does not interact with the c-Myc fusion protein (Figure 
3.4a), There is an interaction observed between the N-terminal region (amino acids 1- 
280) and GST-Myc N262 (Figure 3.4a). When smaller fragments of the N-terminal 
region were assayed it was observed that the Zn-finger region (amino acids 1-93) does 
not interact with GST-Myc N262. When the direct repeats of Brfl (amino acids 94- 
280) were tested, it was found that they can bind to the c-Myc fusion protein (Figure 
3.4a). The interaction between c-Myc and the direct repeats is dependent on the
f::?
; Ïf
integrity of both repeats, as neither can bind when tested individually (amino acids
j':,;94-200 and 200 to 280) (Figure 3.4a). Quantification of several of these experiments 
indicates that the dfrect repeats alone do not bind as efficiently to c-Myc as the entire 
TFIIB-related region, indicating some function of the Zn ribbon domain in the 
interaction (Figure 3.4b).
The tumour suppressor RB has been demonstrated to interact with the Brfl subunit of 
TFIIIB, and it is through an interaction with TFIIIB that RB functions to repress pol 
III transcription (Suttcliffe and White, mipublished observations; Larminie et al, 1997; 
Chu et al, 1997). To compare what regions of Brfl are required for RB bmding to 
those required for c-Myc binding a similar pull-down approach was performed with in 
vitro transcribed and translated fragments of the Brfl protein and testing their ability 
to interact with immobilised recombinant RB. The GST-RB frrsion protein used
92
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contains residues 379-928 of RB; this region is sufficient to inhibit pol III 
transcription and also to bind TFIIIB (Larminie et al, 1997). This fragment of RB 
includes the pocket domain and is the minimal region necessary to regulate cell 
growth and proliferation (Weinberg, 1995; Whyte, 1995). Recombinant GST and 
GST-RB (379-928) proteins were expressed in bacteria and immobilised on 
glutathione agarose beads and proteins were resolved by SDS-PAGE and the gels 
stained to check for input protein levels (figure 3.5a). When the smaller fragments of 
Brfl were tested for an interaction with GST-RB (379-928) the N-terminal region of 
Brfl (amino acids 1-280) bound efficiently to the RB protein (figure 3,5b). When the 
C-terminal region of Brfl (amino acids 281-677) was tested for binding to RB no 
interaction was observed (figure 3.5b). Smaller fragments of the N-terminal region of
:Brfl were tested for an interaction with GST-RB (379-928), GST-RB (379-928) can
.interact specifically with a fragment of Brfl containing the Zn ribbon motif and the 1® 
direct repeat (amino acids 1-200) and an interaction is also observed between the 2”‘* 
repeat of Brfl in isolation (amino acid 200-280) (Figure 3,5b). This indicates that two 
separate regions of Brfl are involved in the interaction with RB (Figure 3.5b). It is 
also interesting to note that the RB interaction with Brfl is different to the c-Myc 1interaction with Brfl.
The dfrect repeats of Brfl are involved in the interaction between TFIIIB and another
activator of pol III transcription, the MAP kinase Erk (Felton-Edkins et al, 2003a). A
mutation of Brfl in the ERK docking domain can prevent pol III activation by 
.mitogenic stimuli. It had previously been found that members of the MAP kinase
,family interact with their substrates via specific docking sites, known as D-domains
ir
(Sharrocks et al, 2000). Mutation in such a domain of Brfl, through substitution of
.a
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Figure 3.5 The RB Interaction with Brfl is distinct from the c-Myc 
interaction
A. Coomassie stained gel, demonstrating levels of GST and GST -RB typically used 
in these experiments, B. Immobilised GST and GST-RB (379-928) were used to pull 
down a range of ^^S-labelled in vitro transcribed and translated fragments of Brfl 
(indicated in figure) to test for specific binding to RB (Fragments under 30 kDa were 
run on 15% SDS-PAGE gels). B. Graphs quantifying the binding of these fragments 
to GST and GST-RB (379-928) as a percentage of the input (Quantification done 
using I mage J).
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leucine residues at position 100 and 102 in the Brfl sequence to alanines (Brfl L>A), 
results in a reduced interaction between Brfl and ERK (Felton-Edkins et al, 2003a). 
To examine any possible effects on c-Myc binding to this mutated form of the protein, 
its interaction was examined in a pull-down assay using recombinant GST-MycN262 
(Figure 3.6). The results of this experiment indicate that mutation of the D-domain of 
Brfl did not have any effect on the ability of the protein to bind to c-Myc (Figure
3.6).
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Figure 3.6 A mutation in Brf1 that disrupts ERK binding has no 
effect on the c-Myc interaction
Immobilised GST and GST-Myc N262 were used to pull down either wildtype ^^ S 
labelled in vitro transcribed and translated Brfl or Brfl (L>A) to test for any 
difference in binding to c-Myc.
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3.2.2 Conserved regions of c-Myc are not required for binding to 
TFIIIB
these regions of c-Myc and play critical roles in Myc biology.
A host of studies have been performed to identify regions of c-Myc that ar e involved
in protein/protein interactions and the biological activity of the protein. Several
studies have identified two regions of the c-Myc protein that aie highly conserved
between members of the c-Myc family, and are critical for the biological activity of c-
Myc, termed Myc Box 1 (MBl) and Myc Box 11 (MBll) (Grandori et al, 2000; Patel et
al, 2004). MBl and MBII are located between amino acids 45-63 and 128-143 in the
c-Myc protein respectively (Grandori et al, 2000). Deletion or mutation of these
.conserved elements has profound effects on the biological activities of c-Myc (Stone 
et al, 1987; Sarid et al, 1987; Freytag et al, 1990; Goruppi et al, 1994). As discussed 
in the introduction to this chapter, several proteins have been shown to interact with
To examine the potential roles of these conserved regions of c-Myc in the interaction 
with TFIIIB, co-immunoprecipitation experiments were performed. Vectors encoding 
FLAG-tagged c-Myc proteins were transfected into HEK 293 cells coding for the 
wild-type protein, a mutant lacking MBl (amino acids 45-63 deleted), a mutant 
lacking MBII (amino acids 128-143 deleted) and an empty vector. Co-transfected
with the Myc constructs was a vector encoding HA-tagged Brfl. Co- 
immunoprecipitations were performed by immunoprecipitating the extracts using an 
anti-FLAG antibody followed by western blotting with an anti-HA antibody (Figure
3.7). As expected, the wildtype c-Myc protein interacts specifically with TFIIIB
I
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Figure 3.7 Deletion of MB! or MBIl of the c-Myc protein does not 
effect binding to TFIliB
HEK 293 cells were transiently transfected with a vector encoding HA-Brfl along 
with vectors encoding FLAG tagged wildtype c-Myc, c-Myc AMBI, c-Myc AMBII 
and empty vector. Extracts from these cells were immunoprecipitated using an anti- 
FLAG antibody, and the resolved by SDS-PAGE and then analysed by western 
blotting with anti-FLAG and anti-HA antibodies.
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(Figure 3.7; Gomez-Roman et al, 2003). Deletion of the conserved Myc boxes does 
not interfere with the interaction between c-Myc and TFIIIB, with equivalent amounts 
of Brfl co-immunoprecipitating with the mutant Myc proteins (Figure 3.7).
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3,3 Discussion
As previously discussed, c-Myc binds to TFIIIB and it is this interaction which is 
thought to be responsible for the recruitment of c-Myc to the promoters of pol Ill- 
transcribed genes. It has been reported previously that c-Myc can bind to TBP, but I 
have observed a novel interaction with another TFIIIB subunit, Brfl (Figure 3.2). To 
further investigate this interaction, fragments of Brfl were tested for their ability to 
bind to c-Myc. The c-Myc binding site on Brfl was a region spanning amino acids 
94-281 (Figure 3.4a and 3.4b). This region contains the two imperfect direct repeats 
of Brfl and the presence of both of these repeats appears to be necessary for c-Myc 
binding, perhaps involving regions not together in the sequence, but in close 
proximity within the tertiary structure of the protein. The zinc ribbon domain of Brfl, 
although not sufficient for binding to c-Myc, appears to be necessary for the full 
interaction, as deletion of this region results in lower affinity binding (Figure 3.4b).
TFIIIB and its Brfl subunit are involved in multiple interactions with regulators of
pol III transcription. The RB tumour suppressor binds to TFIIIB to inhibit pol III
transcription complex formation (Larminie et al, 1997; Sutcliffe et al, 2000). RB also 
.binds to Brfl, and this interaction is also in the direct repeats of Brfl (Figure 3.5b and 
3.5c). Unlike the binding of c-Myc, RB can bind to both of the direct repeats
individually, suggesting a different binding motif in Brfl (3.5b and 3.5c).
i
.
Although the binding of c-Myc and RB to Brfl is clearly through different 
mechanisms, it would be interesting to know if these proteins can bind to TFIIIB 
simultaneously, as they have opposite roles in regulating pol III transcription (White,
104 I
I
Chapter 3 Investigating the interaction between TFIIIB and c~Myc
2004; White 2005). It may be that these proteins can compete with each other in vivo 
to convert TFIIIB into active and inactive states. Although this interplay between the 
two regulators may happen, the role o f c-Myc in activating pol III transcription is
clearly more than a de-repressor of RB inhibition as it can activate pol III 
transcription in murine fibroblasts that are deficient for RB and the related pocket 
proteins (Gomez- Roman et al, 2003). I
■I
#
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Another regulator of pol III transcription is the MAPK ERK. ERK can bind to and 
phosphorylate the Brfl subunit of TFIIIB. This phosphorylation event can promote 
the formation of the pre-initiation complex on pol Ill-transcribed genes. A mutant 
form of Brfl, which has less affinity for ERK, can bind to c-Myc as efficiently as wild 
type Brfl (Figure 3.6). As both ERK and c-Myc will be activated and will both exert 
their effect on pol III transcription in response to similar mitogenic stimuli, the use of 
this mutant will be help to elucidate how these separate proteins activate pol III 
transcription.
Further experiments need to be performed to further define the interaction between c-
Myc and B rfl. If we can identify the interaction domain of Brfl that can bind to c-
Myc, we will be able to further understand the role of this activator in pol III
transcription. A mutant Brfl deficient in c-Myc binding, but capable of interaction
with the pol III transcription apparatus and other regulators of transcription may help 
.us answer the question of how important c-Myc is in the activation of pol III 
transcription. Also, perhaps more interestingly, a mutant form of Brfl, which cannot 
interact with c-Myc, may also let us investigate how important the activation of pol III 
transcription is for c-Myc-dependent transformation of cells.
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To identify residues within the direct repeats of Brfl that are involved in c-Myc
106
binding, we can compare residues between yeast Brf (yBrQ and human Brfl. When 
used in pull down assays, yBrfl binds to the recombinant c-Myc protein used in these
,:|:i
assays (data not shown). If the sequences of yBrf and hBrfl are compared and only 
regions that share high homology are targeted, it may be possible to develop a 
strategy to identify potential binding domains. It would be useful to also use the 
TFIIB sequence in this comparison, but as there are studies suggesting c-Myc and 
TFIIB cannot interact (McEwan et al, 1996), as well as studies suggesting that they do 
(Shrivasta et al, 1996; Stefan Roberts, personal communication), this controversy 
would have to be resolved before TFIIB could be used in the comparison.
As mentioned in the introduction, c-Myc contains two regions within the TAD that 
are extremely well conserved throughout the Myc family of proteins, MBI and MBIT 
These regions are critical to the ability of c-Myc to transform cells and are also 
important for interactions with co-activator proteins.
i
f
Î
.1Co-immunoprecipitation assays demonstrate that mutant c-Myc proteins lacking these 
regions can bind to TFIIIB as efficiently as the wildtype protein (Figure 3.8). The
region of c-Myc binding to TFIIIB is still unclear and needs to be investigated, but is
.narrowed down to the N-terminal 262 amino acids of c-Myc, not dependant on the
.conserved MBI and MBII regions (Figure 3.7). Further experiments need to be 
performed to naiTow down this interaction domain, to define regions of c-Myc critical 
for TFIIIB binding.
Î
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In experiments later in tins thesis, co-activator proteins that can bind to c-Myc will be 
investigated in their ability to contribute in the c-Myc dependent activation of pol III 
transcription.
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Experiments have been performed to assess the ability of c-Myc proteins missing
iMBI or MBII to stimulate pol III transcription. Preliminary results suggest that both 
MBI and MBII are critical for c-Myc dependent activation of pol III transcription
:(data not shown). The lack of activation when using mutant c-Myc proteins, even 
though they are wildtype for TFIIIB binding, may suggest that co-activator proteins 
that bind to these regions of c-Myc, may be involved in the c-Myc dependent 
activation of pol III transcription.
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4,1 Introduction
The data presented in Chapter 3 demonstrates that the product of the c-Myc oncogene 
binds to two subunits of the pol Ill-specific transcription factor TFIIIB. The 
functional consequences of this interaction are investigated in the remainder of this 
thesis. This chapter focuses on the potential ability of c-Myc to recruit pol III specific 
transcription factors to form an active transcription complex on the promoters of 
target genes. Determining the mechanisms behind the c-Myc-dependent activation of 
pol III transcription is crucial when attempting to understand c-Myc’s contribution to 
tumourigenesis.
Transcription can be divided into three stages: initiation, elongation and termination.
As discussed in Chapter 1 due to the short length of the transcripts and the ability of 
pol III to recognise a termination signal without the need of accessory factors,
elongation and termination are not thought to be the main stages that pol III
:transcription is regulated (Wliite, 2002). Therefore, the primary mechanism by which 
a pol Ill-transcribed gene is regulated is at the level of transcriptional initiation. To
'I108
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initiate transcription of class III genes, the basal transcription factors and the
polymerase need to be recruited to the promoter of the target gene. Activation of the
vast majority of pol Ill-transcribed genes requires the recruitment of a multi-subunit,
. .pol Ill-specific transcription factor, TFIIIC. This complex recognises and binds to the 
promoter in a sequence-specific mamier. This is followed by the recruitment of 
another pol Ill-specific complex, TFIIIB, that is recruited by protein:protein 
interactions with TFIIIC (Schramm and Hernandez, 2002; White 2002; Chapter 1). 
The polymerase, which cannot recognise the start sites of transcription alone, is then 
recruited to the start sit of transcription mainly through protein:protein interactions 
with TFIIIB (Schramm and Hernandez, 2002; White 2002; Chapter 1). In studies 
completed to date the polymerase recruiting factor, TFIIIB, is targeted by activators 
and repressors of pol III transcription to either prevent or promote the formation of the 
pol III pre-initiation complex (White, 1998, White, 2004).
4.1.2 Regulators of Pol III transcriptional Initiation
TFIIIB is a multi-subunit complex containing the TATA-binding protein, TBP, and 
two pol III specific TAFs, Brfl and Bdpl (Chapter I; Schramm and Hernandez,
2002), As previously discussed, both activators and repressors of pol III transcription 
have been shown to target TFIIIB to exert their action on pol III transcription (White,
1998, White, 2004). The oncogenic kinase CK2 has been demonstrated to be ;
involved in the activation of pol III transcription in yeast and mammals (Hockman 
and Schultz, 1996, Johnston et al, 2002), CK2 can bind to and phosphorylate TFIIIB 
to activate transcription. The target subunit differs in higher eukaryotes, compared to 
lower eukaryotes, with the pol III specific TAF, Brfl, being the target in mammals,
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and TBP being the target m yeast (Johnston et al, 2002; Ghavidel and Schultz, 1997).
This binding results in the assembly o f an initiation complex through a greater affinity
of TFIIIB for TFIIIC ( Johnston et al. 2002). Another activator of pol III transcription
is the MAP kinase ERK. The ERK MAP kinase cascade has been demonstrated to
promote cell growth by activating transcription by pol I, by directly phosphorylating
and activating the pol I-specific transcription factor UBF (Stefanovsky et al, 2001).
ERK induces Pol III transcription by binding to and phosphorylating Brfl (Felton-
Edkins et al, 2003a). This phosphorylation event leads to the formation of the basal
transcription complex, by increasing the affinity of TFIIIB for both TFIIIC and pol III
.(Felton-Edkins et al, 2003a). It has been demonstrated using synthetic inhibitors of 
the MAP kinase pathway, that promoter occupancy of both TFIIIB and pol III is 
lower when Erk in inactive (Felton-Edkins et al, 2003a).
Pol III transcription can also be repressed by tumour suppressor proteins that exert 
their effect on TFIIIB. When in its active, hypo-phosphoiylated form, the tumour
suppressor Rb can inhibit pol III transcription by binding to TFIIIB (White et al, 
1996; Larminie et al, 1997; Chu et al, 1997; SutcUffe et al, 2000). This binding of Rb 
to TFIIIB inhibits the interaction between TFIIIB and TFIIIC, and the interaction of 
TFIIIB and the polymerase (Sutcliffe et al, 2000). The tumour suppressor p53 can 
also inhibit pol III transcription by targeting TFIIIB (Chesnokov et al, 1996; Cairns 
and White, 1998). p53 can bind to the TBP subunit of TFIIIB and this binding of p53 
to TFIIIB compromises its ability to interact with TFIIIC (Cairns and White, 1998).
ÎI
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Induction of p53 in cultured cells leads to TFIIIB occupancy on pol Ill-transcribed 
genes being reduced, while TFIIIC occupancy remains constant (Crighton et al,
2003). The sequestration of TFIIIB by tumour suppressors represents a mechanism 
by which normal cells can prevent inappropriate expression of pol III products, to
110
Specific subunits of the polymerase recruitment factor, TFIIIB, have also been found
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regulate the biosynthetic capacity of the cell. Experiments in this chapter will 
investigate whether c-myc can activate transcription by pol III by targeting pol Ill- 
specific transcription factors.
4.1.3 Activation of Transcription through increases in 
transcription factor expression
Another mechanism to regulate pol III output is by raising the levels of one or more of
.the limiting transcription factors on which it depends. Changes in pol III gene 
expression have been shown to coincide with changes in the expression of pol III 
specific transcription factors. The activity of the pol III promoter recognition 
complex, TFIIIC, is raised in response to adenoviral infection or SV40 transformation 
(Hoeffler and Boeder, 1985; White et al, 1990). Levels of all five subunits of TFIIIC 
are upregulated in fibroblasts transformed with SV40 or polyoma virus and, more 
clinically relevant, all five subunits are elevated at the protein and mRNA level in 
each of a panel of ovarian carcinoma biopsies as compared to normal tissue 
(Larminie et al, 1999; Felton-Edkins and White, 2002; Winter et al, 2000) S',
to be elevated in tumour cell lines to contribute to an increase in pol Ill-transcription.
TBP is overexpressed as a consequence of activation of the Ras pathway in virus
:
transformed cell culture lines, and this leads to an increase in pol Ill-transcription 
(Wang et al, 1997). Overexpression of TBP has also been found in a panel of colon 
carcinomas compared to normal tissue, and overexpression of TBP has been found to 
cause tumours in nude mice (Johnston et al, 2003). Levels of the pol Ill-specific
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TAFs, Brfl and Bdpl, have been demonstrated to be elevated in some transformed 
and tumour cell lines (Daly at al, 2005; Felton-Edkins et al, 2002).
Although c-Myc can directly activate pol III transcription independently of de novo 
protein synthesis (Gomez-Roman et al, 2003), c-Myc may play an additional role in 
regulating expression of pol Ill-specific transcription factors.
4.1.4 Activation of transcription by c-Myc through interactions 
with basal transcription factors
112
Not only are subunits of the pol HI transcription apparatus unregulated in response to 
transformation, elevating the protein levels of the pol Ill-specific TAF, Brfl, using an 
inducible cell line, is sufficient to activate pol III transcription and drive cellular 
growth and proliferation (Marshall and White, unpublished observations).
The c-myc transcription factor can interact with components of the pol II basal 
transcription machinery. It has been shown that c-Myc is associated with TBP and 
TFIIF in vivo (Maheswaran et al, 1994; McEwan et al, 1996), The interaction 
between c-Myc and components of the basal transcription machinery may represent a 
mechanism through which c-Myc can contribute to the recruitment of the pol II pre- 
initiation complex to the promoters of target genes (Maheswaran et al, 1994). It has 
been demonstrated that the recruitment of TBP to the promoters of certain target 
genes efficiently activates transcription, suggesting recruitment of TBP can be rate- 
limiting in the activation o f transcription of protein-encoding genes (Chetteijee and 
Struhl, 1995; Klages and Strubin, 1995). c-Myc may work as an activator in this way
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by recruiting the TBP-containing TFIID complex to the promoters of target genes, c- 
myc has been shown to interact with the pol Ill-specific TBP containing TFIIIB 
complex. As genes transcribed by pol III do not contain well defined E-box 
sequences in their promoter regions, it is thought that the interaction with TFIIIB is 
responsible for the presence of c-myc at the promoters of pol Ill-transcribed genes 
(Gomez-Roman et al, 2003; Felton-Edkins et al, 2003b, Chapter 3), As pol Ill- 
transcribed genes do not contain E-box sequences, the simplistic model through which 
c-myc-max heterodimers bind to the promoters of target genes and contribute to the 
binding of a TBP-containing factor to the promoter, cannot be the case in transcription 
of pol Ill-transcribed genes. c-Myc may still contribute to the formation of a pol III 
pre-initiation complex by acting in concert with TFIIIB Experiments in this chapter 
focus on the formation of the pol III pre-initiation complex in response to activation 
of c-Myc.
113
Chapter 4 Activation o f pol III transcription by c-Myc results in recruitment o f
transcription factors
4,2 Results
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4.2.1 c-Myc is recruited to class III genes in vivo
As summarised in the introduction to this chapter, c-Myc is a potent and direct 
activator of pol III transcription (Gomez-Roman et al, 2003). To attempt to uncover 
the mechanisms by which c-Myc can achieve this, a c-Myc-inducible cell line was 
used. The cell lines were derived from A31 murine fibroblasts stably transfected with 
a vector encoding a c-Myc fusion protein (MycER) or vector alone (pBabe). The 
MycER vector encodes full length c-myc fused to a modified oestrogen receptor 
binding domain at its C-terminal bHLHZ DNA binding domain (Littlewood et al, 
1 9 9 5 ) Yhe modified oestrogen receptor ligand-binding domain can no longer bind to 
oestrogen, but retains affinity for the synthetic ligand, 4-hydroxytamoxifen (4-OHT) 
(Littlewood et al, 1995, Danielian et al, 1993). In the absence of ligand the MycER 
fusion protein remains cytoplasmic, unable to enter the nucleus (Figure 4.1). Upon 
addition of the ligand, 4-OHT, the MycER protein can refold and translocate to the 
nucleus to interact with its co-activator protein Max, to then transactivate c-Myc 
target genes (Figure 4.1; Bouchard et al, 2001).
%
To determine that the cells were behaving as predicted, the cells were serum starved 
for 48 hours, to lower levels of endogenous c-Myc, and then treated with 4-OHT to 
activate the MycER protein. Nuclear enriched extracts were made from pBabe and
MycER cells and nuclear levels of MycER were determined by western blot after the
indicated time points (Figure 4.2). The MycER protein is translocated to the nucleus 
of MycER cells 2 hours after addition of 4-OHT, and remains high at the 4 hour time
1
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Figure 4.1 Schematic of c-myc activation in the MycER cell line
A. MycER cells are serum starved to lower levels of endogenous c-myc. In the 
absence of ligand the MycER protein is excluded from the nucleus and remains 
cytoplasmic, unable to act on its target genes. B. Upon addition of 4-OHT the ligand 
binds to the hormone-binding domain of the oestrogen receptor protein, and this 
results in a conformational change of the fusion protein. C. This conformational 
change leads to nuclear translocation of the MycER protein, which allows it to 
dimerise occupancy with Max transactivate its target genes.
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point (Figure 4.2). A signal is detected for nuclear MycER at the 0 hr time pomt, 
which is prior to activation by the ligand (Figure 4.2). This is due to “leakiness” in
the system, with a small pool of the MycER protein being present in the nucleus in the
;
absence of ligand. As expected no signal was obtained from the nuclear extracts from 
the pBabe cells (Figure 4.2).
In order to assess c-Myc binding to class III genes in these cell lines, ChIP assays
were performed. The protein-DNA complexes were immunoprecipitated using a c-
Myc-specific polyclonal antibody. Recovered DNA was analysed by PCR using
specific primers. In response to MycER activation, the chimeric protein is recruited
to the promoter of the Cyclin D2 gene after 2hours and remains associated at 4hours
(Figure 4.3a; Bouchard et al, 2001; Frank et al, 2001). In addition, the MycER
protein is recruited to the pol Ill-transcribed 5S and tRNA^^" genes in response to
addition of 4-OHT (Figure 4.3a). The recruitment of MycER to the promoters of
class III genes and the cyclin D2 positive control is specific, as no recruitment is
.observed at the p21 promoter (Figure 4.3a). ChIP assays were performed to ensure 
the material immunoprecipitated using the anti c-Myc antibody was due to the 
activated MycER protein, and not due to an artefact caused by addition of 4-OHT. I
pBabe cells were treated with 4-OHT and cells harvested at the indicated time points. 
.No increase in DNA corresponding to the tRNA and the 5S rRNA gene was 
immunoprecipitated using a c-Myc antibody after 4-OHT treatment, as determined by 
PCR, indicating the effect was specific to the MycER cell line (Figure 4.3b).
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Figure 4.2 MycER protein translocates to the nucleus in response 
to activation by 4-OHT
Nuclear enriched extracts were prepared form cells containing pBabe or MycER 
vectors, treated with 200nM 4-OHT to activate the MycER protein for the indicated 
times. Samples were resolved by SDS-PAGE and western blotting was performed 
using anti-c-Myc and anti-TAFi48 antibodies.
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Figure 4.3 MycER Is recruited to pol Ill-transcribed genes
A. MycER was induced in fibroblasts by addition of 200nM 4-OHT. ChIP assays 
were performed at the indicated time points after MycER activation using antibodies 
against c-myc and TAFi48 (control). The samples were normalised by comparing the 
genomic DNA inputs. The samples were then analysed by PCR, alongside input 
genomic DNA (10% and 1%), using primers specific to the promoters of 5S, tRNA^®“, 
Cyclin D2 and p21 genes, as indicated. B. ChlPs were performed as above using the 
pBabe control cell line. The samples were then analysed by PCR, alongside input 
genomic DNA (10% and 1%), using primers specific to the promoters of 5S and 
tRNA^^" genes.
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RT-PCR analysis of RNA harvested from Rat derived MycER cells activated with 4- 
OHT revealed a specific increase in the levels of pol III transcripts (Gomez-Roman et 
al, 2003). To determine the timing of the induction of pol III transcription in murine 
MycER cells, RT-PCR analysis of pol III transcripts was performed using RNA 
hai'vested from pBabe and MycER cells treated with 4-OHT. The levels of pol III 
transcripts were normalised to the pol Il-transcribed ARPP PO transcript. The levels 
of the pol III transcript pre-tRN A is not affected by the addition of 4-OHT in the 
pBabe cell line (Figure 4.4). In contrast, the addition of 4-OHT to the MycER cells 
caused an induction of the pol III-transcribed tRNA^®“ and 5S rRNA genes 3 hours 
after addition of the hormone to the cells (Figure 4.4). The timing of the induction pol
III transcription in A31 derived MycER cells is similar to that observed in Rat derived 
MycER cells (Figure 4.4; Gomez-Roman et al, 2003). There was a higher level of 
transcription of the tRNA^™ gene in the MycER cells compared to the pBabe cells 
before treatment with 4-OHT (Figure 4.4). The higher level of transcription of the 
tRNA gene in the MycER cells compared to the pBabe cells is likely to be due to the 
small amount of the MycER protein present in the nucleus of MycER in the absence 
of 4-OHT (Figure 4.2).
4.2.2 Activation of c-Myc results in a sequential recruitment of the 
Pol III transcription apparatus to class III genes
As outlined in the introduction to this chapter, and in chapter 1, activators of Pol III 
transcription can act by increasing levels o f pol III transcription factors or can act at 
the level of transcriptional initiation to promote the formation of the pol III 
transcription complex. Using the MycER cell line the relative promoter occupancies
Î
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Figure 4.4 Pol III transcriptional activation by MycER activation
Cultured pBabe and MycER cells were treated with 200nM 4-OHT for the indicated 
time points and the cells were harvested for total RNA. RNA was analysed by RT- 
PCR for expression of 5S, pre-tRNA and ARPP PO (control) using gene-specific 
primers.
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of the pol III transcription apparatus was measured in response to MycER activation, 
to assay any role of c-Myc in formation of this complex.
It has been previously determined that pol III transcription can be activated by c-Myc 
independently of any secondary events due to c-Myc mediated regulation of protein 
encoding genes (Gomez-Roman et al, 2003). To confirm pol III transcription factors 
were not being induced in these assays, western blots were performed on nuclear 
enriched extracts from pBabe and.MycER cells treated with 4-OHT. Western blotting 
revealed that there was no induction of the protein levels o f Brfl, Bdpl, TFIIIC 110, 
TFIIIC 220 or the large pol III sub-unit RPC 155 in response to c-Myc activation 
(Figure 4.5). This result confirmed that c-Myc is activating pol III transcription, in 
these experimental conditions, by a mechanism other than the expression of pol III 
specific transcription factors.
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When activating pol I transcription c-Myc can stimulate recruitment of the pol I-
Sspecific transcription Actors UBF and SLl, as well as the polymerase (Grandori et al, |
2005; Arabi et al, 2005). To determhie if there are any changes in the promoter 
occupancy of the pol III transcription apparatus in response to the activation of c-myc,
V
Chip assays were performed using the MycER cell line. ChIP assays were performed 
using antibodies against the TFIIIB subunits Brfl and Bdpl; the TFIIIC subunits 
TFIIIC 110 and TFIIIC 220; the largest subunit of the polymerase RPC 155 and the 
pol I TAF, TAFi48, as a negative control. The TFIIIC subunits TFIIIC 110 and 
TFIIIC 220 are bound to the tRNA and 5S rRNA genes prior to the activation of I
the MycER protein. The activation of MycER does not result in further binding of 
either TFIIIC subunit to the tRNA^®“ or 5S rRNA genes (Figure 4.6a). The TFIIIB
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Figure 4.5 Analysis of expression of pol ill basal transcription 
factors in response to MycER
Nuclear enriched extracts were prepared from cells containing pBabe (control) or 
MycER vectors, treated with 4-OHT for the indicated times. Extracts were resolved 
by SDS-PAGE and blotted using antibodies against Brfl, Bdpl, TFIIIC 110, TFIIIC 
220 and RPC 155.
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subunits Brfl and Bdpl are bound at low levels to tRNA^^“ and 5S rRNA genes prior 
to MycER activation. The activation of MycER results in an enrichment of both Brfl 
and Bdpl levels on the tRNA^®“ and 5S rRNA genes 2 hours after MycER activation
were due to the activated MycER protein, and not due to the 4-OHT. pBabe cells
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(Figure 4.6a). The polymerase subunit RPC 155 is bound to the tRNA^^“ and 5S 
rRNA genes at low levels prior to MycER activation, remains at a low level after 
2hours of 4-OHT treatment, but its occupancy on tRNA^®“ and 5S rRNA is enriched 
4 hours after MycER activation (Figure 4.6a). The immunprecipitations of the pol III 
transcription apparatus in this experiment are specific as no products were detected 
using specific primers against the promoter of the pol Il-transcribed p21 gene (Figure 
4.6a).
Chip assays were performed to ensure the differences in promoter occupancies of the 
pol III specific transcription factors binding to the tRNA^®“ and the 5S rRNA gene
were treated with 4-OHT and cells harvested at the indicated time points. No 
.differences in the occupancies of the pol III transcription apparatus were observed on 
the tRNA^^“ and the 5S rRNA gene after 4-OHT treatment, as determined by PCR, 
indicating the effects were specific to the MycER cell line (Figure 4.6b).
4.2.3 TFIIIB and Pol III promoter occupancy is reduced on class III 
genes in c-myc null fibroblasts
Levels of the pol Ill-specific transcription factor TFIIIB and the polymerase are 
enriched on the tRNA^®  ^and 5S rRNA genes in response to c-Myc activation (Figure 
4.6a). To establish the effects of c-Myc deficiency on the promoter occupancy of the
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Figure 4.6 MycER activation leads to sequential recruitment of 
general transcription factors to promoters of pol Ill-transcribed 
genes
A. c-myc was induced in MycER fibroblasts by addition of 200nM 4-OHT. ChIP 
assays were performed at the indicated time points after MycER activation using 
antibodies against Brfl, Bdpl, TFIIIC 110, TFIIIC 220, RPC 155 and TAFi48 
(control). The samples were normalised by comparing the genomic DNA inputs. The 
samples were then analysed by PCR, alongside input genomic DNA (10% and 1%), 
using primers specific to the promoters of 5S, tRNA^®“ and p21 genes as indicated. B. 
ChlPs were performed as above using the pBabe control cell line. The samples were 
then analysed by PCR, alongside input genomic DNA (10% and 1%), using primers 
specific to the promoter of the tRNA^™ gene.
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pol III transcription apparatus, c-Myc null fibroblasts were compared to matched c- 
Myc wildtype cells (Mateyak et al, 1997).
The cells containing wildtype c-Myc display higher expression of pol Ill-transcribed 
genes, as compared to the c-Myc deficient cells determined by northern blot (Gomez- 
Roman et al, 2003). To confirm that the levels of pol III transcription in c-Myc 
wildtype fibroblasts was higher than the level of that in the c-Myc deficient 
fibroblasts, RT-PCR analysis of Pol III transcripts was performed using RNA 
harvested from the cells. The levels of transcription of pre-tRNA^^“ and pre-tRNA^^*  ^
were reduced in the c-Myc deficient fibroblasts compared to the wildtype; this effect 
was specific as no effect was seen on the pol II transcribed ARPPPO control transcript 
(Figure 4.7).
I
To examine what effects c-myc deficiency has on the promoter occupancy of the pol 
Ill transcription apparatus, ChIP assays were performed using antibodies against the
:large Pol III subunit, TFIIIB subunit Brfl, TFIIIC subunit TFIIIC 110 and TFIIB as a 
negative control. The promoter occupancy of TFIIIC is comparable between the wild 
type and null cell lines. In contrast the levels of both the polymerase and TFIIIB are 
enhanced on the tRNA^^" and tRNA^ *^^  genes in the wildtype cell line compared to 
that of the null cell line (Figure 4.8).
The abundance of pol III transcription factors was analysed in these matched cell 
lines. Western blots were performed using antibodies against TBP, Brfl, TFIIC 110, 
RPC 155 and actin (control). The levels of TBP, TFIIIC and the pol III subunit are 
comparable between c-Myc null and c-Myc wildtype cell lines (Figuie 4.9). The
131
Chapter 4 Activation o f pol III transcription by c-Myc results in recruitment o f
transcription factors
Figure 4.7 Pol III transcription is compromised in c-Myc deficient 
fibroblasts
RNA was harvested from c-myc null or wild-type rat fibroblasts. RNA was analysed 
by RT-PCR for expression of pre-tRNA^®“, pre-tRNA^^*  ^and ARPP PO (control) using 
gene-specific primers.
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Figure 4.8 Pol III and TFIIIB are enriched on the promoters of Poi 
Ill-transcribed genes in vivo in a c-Myc-sensitive manner
The promoter occupancy of TFIIIB and pol III was measured in matched c-myc'^" and 
c-myc '^^  ^rat fibroblasts. ChlPs were performed using antibodies against Brfl, TFIIIC 
110, RPC 155, and TFIIB. The samples were normalised by comparing the genomic 
DNA inputs and adjusting the samples accordingly. The samples were then analysed 
by PCR, alongside input genomic DNA (10% and 1%), using tRNA^™, tRNA^^, and 
ARPP PO primers as indicated.
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Figure 4.9 The ievels of the Brf1 sub-unit of TFIIIB are lower in c- 
Myc null fibroblasts
Whole cell extracts were harvested from c-myc null and wild type fibroblasts. Protein 
extracts were resolved by SDS-PAGE, and western blotting was performed with 
antibodies against Brfl, TBP, RPC 155, TFIIIC 110 and actin.
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levels of the TFIIIB subunit Brfl are elevated in c-Myc wildtype cells, compared to c- 
Myc null cells (Figure 4.9).
4.2.4 Levels of Polymerase on promoters of pol Ill-transcribed 
genes is reduced in response to terminal differentiation of MEL 
cells
To investigate how physiological changes in c-Myc levels correlate with expression 
of pol III transcribed genes and transcription factor occupancy, experiments were 
performed using murine erythrleukemia (MEL) cells. . These cells derive from 
proerythroblasts that were immortalized with the Friend vfral complex (Friend, 1978). 
When MEL cells are treated with 5mM HMBA they are able to re-enter their original 
differentiation program. The exact nature of how this compound can cause cells to re­
enter the differentiation programme is unclear. Within 24 to 48 hours this process 
leads MEL cells to develop the erythroid phenotype. During this differentiation levels 
of c-myc protein and mRNA rapidly fall in the early stages of addition of the 
chemical (1-2 hours), followed by re-expression of the c-Myc gene and re­
accumulation of the protein at later time points (Lachman and Skoultchi, 1984). The 
action of c-Myc in MEL cells is critical to the differentiation program, as dismpting 
its expression by introducing exogenous c-Myc into the cells inhibits differentiation 
(Dmitrovsky, 1986; Prochownik and Kukowska, 1986). Western blot analysis 
revealed that the MEL cells were behaving as previously described, c-Myc levels 
falling rapidly at the onset of differentiation, and recovering at the later time point 
(Figure 4.10 ).
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Figure 4.10: c-Myc levels are sensitive to HMBA-induced
differentiation of MEL cells
Whole cell extracts were made from MEL cells differentiated by treatment with 
HMBA after the indicated times. Samples were resolved by SDS-PAGE and western 
blotting was performed using anti-c-Myc, anti-Brfl, anti-RPC155 and anti-actin 
antibodies.
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To address the effects of depleted c-Myc levels in response to HMBA-induced 
differentiation, we analysed the effects of differentiation and c-Myc down-regulation
on levels of pol III transcription in MEL cells 5 hours after treatment with HMBA. 
RNA was harvested from undifferentiated and HMBA treated cells and levels of poi 
III transcripts analysed by RT-PCR. This showed that levels of tRNA^™ and tRNA^ "^^  
expression are down regulated during HMBA-induced differentiation of MEL cells 
(Figure 4.11).
To address if the falling levels of c-myc in differentiating MEL has correlates with a 
change in the promoter occupancies of pol III transcription factors, ChIP assays were 
performed using undifferentiated MEL cells and MEL cells treated with HMBA for 5 
hours. Initially the level of c-Myc associated with class III genes was looked at. 
Chip assays were performed using anti-c-Myc and anti-TFIIB antibodies. The levels
of c-Myc associated with the 5S rRNA genes was determined by PCR, and this
revealed that the lower levels of the c-Myc protein in the differentiated cells (Figure
4.10) correlates with lower levels of c-Myc associated with a class III gene (Figure 
4.12a). ChlPs were then performed using anti-Brfl, anti-Pol III and anti-TFIIB
antibodies, and the relative promoter occupancies were compared. The levels of pol 
III associated with the 5S rRNA and tRNA^^" are lower in the differentiating MEL 
cells compared to the undifferentiated cells (Figure 4.12b). In contrast, the levels of 
Brfl occupancy are comparable in the differentiated and undifferentiated cell lines, 
indicating that there is no loss of TFIIIB binding in response to lowering of c-Myc 
levels (Figure 4.12). The levels of expression of Brfl and the polymerase subunit 
RPC 155 are unchanged during this stage of differentiation indicating that the
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differences in promoter occupancy are due recruitment rather than their levels (Figure
4.10).
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Figure 4.11: Pol III transcription is reduced in response to MEL 
cell differentiation
RNA was harvested from undifferentiated MEL cells and MEL cells treated with 5 
mM HMBA for 5 hours. RNA was analysed by RT-PCR for expression of pre- 
tRNA '^^^ pre-tRNA^^*  ^and ARPP PO (control) using gene-specific primers.
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Figure 4.12: Levels of pol III occupancy are reduced on the
promoters of pol Ill-transcribed genes in differentiated MEL cells
The promoter occupancy of c-Myc, TFIIIB and pol III was measured in 
undifferentiated compared to differentiated MEL cells. A. ChlPs were performed 
using antibodies against c-Myc and TFIIB (negative control). The samples were 
normalised by comparing the genomic DNA inputs and adjusting the samples 
accordingly. The samples were then analysed by PCR, alongside input genomic DNA 
(10% and 1%), using 5S rRNA and tRNA^®“ gene-specific primers. B. As in a, but 
using antibodies against Brfl (128), RPC 155 (1900), and TFIIB.
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4.3 Discussion
To investigate the effects of c-Myc on pol III transcriptional activation a MycER 
inducible cell line was used. The MycER protein is rapidly translocated to the 
nucleus in response to activation of the protein usmg 4-OHT (Figures 4.1 and 4.2). 
The nuclear translocation of the c-Myc fusion protein coincides with a recruitment of 
MycER to the cyclin D2 promoter (Bouchard et al, 2001). The activation of MycER 
also results in a specific recruitment of the chimeric c-Myc protein to the pol Ill- 
transcribed tRNA and 5S rRNA genes (Figure 4.3).
The activation of MycER in rat fibroblasts results in a specific activation of pol III 
transcription as determined by RT-PCR (Gomez-Roman et al, 2003). I found that 
activation of c-Myc in A31-derived MycER mouse fibroblasts also results in a 
specific induction of pol Ill-transcribed genes 3 hours after MycER activation (Figure 
4.4). There is a significant delay between MycER binding to the promoters of pol Ill- 
transcribed genes and an activation of transcription. This delay is puzzling and may 
indicate further unidentified events that occur between c-Myc recruitment to a pol Ill- 
transcribed target gene and the subsequent activation of transcription.
In vitro experiments examining pol Ill-transcribed genes have suggested a step-wise 
assembly of basal transcription factors and polymerase onto the promoters of target 
genes to form a pre-initiation complex, followed by transcriptional activation 
(Geiduschek and Kassavetis, 2001). This is in contrast to mechanisms proposed for 
transcription complex assembly in vivo. Studies investigating transcription by pol II 
have suggested that the polymerase can associate stably with components of the basal
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transcription machinery in the absence of DNA, and that the assembly of this complex 
occurs in the nucleoplasm. This is postulated to result in the formation of a 
holoenzyme, this large complex being recruited to the DNA in a single step 
(Reviewed in Koleske and Young, 1995). Indeed it has been reported that pol III, 
TFIIIB and TFIIIC, factors necessary for the transcription of the vast majority of pol 
Ill-transcribed genes, form a pol III holoenzyme (Wang et al, 1997).
The data presented in this chapter would suggest that, in the model systems used, c- 
myc activation of pol III transcription, results in a stepwise recruitment of 
transcription factors rather than the recruitment of a pre-formed pol III holoenzyme 
(Figure 4.6a). The promoter occupancy of TFIIIC appears to be independent of levels 
of the activated, exogenous MycER protein. The activation of the MycER protein and 
its recruitment to the promoters of the tRNA^®“ and 5S rRNA genes coincides with the 
recruitment of two subunits of the pol Ill-specific transcription factor TFIIIB after 2 
hours, followed by delayed recruitment of pol III at 4 hours after 4-OHT treatment 
(figure 4.6a). An interaction between TFIIIB and c-Myc has been observed both in 
vivo and in vitro and the formation of this complex could result in an activation of 
TFIIIB, leading to enhanced occupation of a c-Myc/TFIIIB complex on the promoters 
of target genes. The recruitment of the polymerase occurs after c-Myc/TFIIIB 
binding to the 5S rRNA and tRNA^®“ genes, coinciding with the activation of pol III 
transcription (Figures 4.4 and 4.6a). This lag in polymerase binding suggests that 
TFIIIB is not associated with pol III prior to TFIIIB binding to the promoters of class 
III genes, further discounting recruitment of a pol III holoenzyme in this system. The 
delay in polymerase binding suggests that further events, such as chromatin 
remodelling, post-translational modification of transcription factors or recruitment of
148
1
Chapter 4 Activation o f pol III transcription by c~Myc results in recruitment o f
transcription factors
unidentified co-activator proteins, may be required at the promoters of pol Ill- 
transcribed genes after recruitment of c-Myc and TFIIIB. Changes in pol III 
transcription factor occupancy have been observed in mitosis, ERK inhibition and p53 
induction, but this has not previously been reported in the activation of pol III 
transcription (Fairly et al, 2003; Felton-Edkins et al, 2003a; Crighton et al, 2003). 
The step-^vise recruitment of pol III transcription factors in response to a stimulus has 
also never previously been documented in vivo.
The promoter occupancies of the pol III transcription factors were measured in c-Myc 
deficient cells compared to wild type. Similar to the MycER cells, levels of 
endogenous c-Myc do not appear to alter the promoter occupancy of the TFIIIC 
complex (Figure 4.8). These results may suggest that TFIIIC is stably associated with 
class III genes, regardless of whether the gene is being transcribed, suggesting that 
TFIIIC binding to the promoter is not a step involved in c-Myc activation of a pol III 
transcribed gene. This is consistent with previous observations o f TFIIIC occupancy 
in mitosis and in response to ERK inhibition (Fairly et al, 2003, Felton-Edkins et al, 
2003a).
In c-Myc wildtype cells the gene occupancy by TFIIIB and pol III is elevated 
compared to in the c-Myc deficient cells (Figure 4.8). This agrees with the 
differences in the levels o f pol III transcription, as measured by RT-PCR (Figuie 4.7). 
The increased promoter occupancy o f TFIIIB in cells with higher levels of c-myc is 
similar to the observations using the MycER cells. However the c-Myc deficient cells 
have lower levels of Brfl than the c-Myc wildtype cells (Figure 4.9). The lower 
levels of Brfl may contribute to the lower levels of pol III transcription in these cells.
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A  di'amatic decrease in pol III transcription is observed when F9 embryonal 
carcinoma cells are differentiated, and this can be partly attributed to lower level of
Brfl (White et al, 1989; Alzuherri and White, 1998). When activating MycER there 
was no induction of Brfl in the short time course looked at, so the differences in
tvexpression of Brfl are likely to be due to long term effects of c-Myc deficiency on the
.expression of Brfl. It has stül to be determined if the gene encoding Brfl is a direct 
or indirect tar get of c-Myc, but sequence analysis of the Brfl gene promoter reveals
several E-box sequences (Figure 4.13). It may be that m tumour formation c-myc 
.could activate pol III transcription not only by directly activating transcription by
■ ■
recruiting the pol III transcriptional apparatus, but also by increasing the levels of pol 
III transcription factors. Further experiments need to be done to determine c-myc 
involvement in the expression of Brfl.
To address how down regulation of c-Myc effects pol III transcription in a
physiological context, MEL cells were used as a model of differentiation. The level
of c-Myc protein falls rapidly in response to chemically-induced differentiation of
MEL cells, and this is accompanied by a fall in pol III transcription. Unlike
differentiation of the F9 embryonal carcinoma model levels of pol III transcription
factors are not sensitive to the differentiation in the time course examined, but levels
of c-Myc and pol III associated with the promoters is reduced, consistent with the 
.reduction in protein levels and reduction of transcription, respectively. It is 
interesting to observe that levels of TFIIIB associated with the promoters of pol Ill- 
transcribed genes appear to be unaffected by the loss of c-Myc and polymerase. My 
experiments in fibroblasts show that c-Myc is involved in recruiting both TFIIIB and 
pol III to the promoters of target genes, but is only the occupancy of the polymerase
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Figure 4.13: The Brfi promoter contains several high affinity c- 
Myc/Max binding sites
5 kb of human and rat genomic DNA, spanning the upstream end of the Brfl gene, 
was analysed using the transcription factor binding site programme CONSITE 
(available at www.phlofoot.org). Potential c-Myc/Max binding sites (E-boxes) 
identified in both species, and their approximate locations, are represented in the 
diagram.
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appears to be sensitive to a dramatic fall in c-Myc levels during the early stages of 
MEL cell differentiation (Figure 4.12b). The difference in might simply reflect the 
stability of binding of c-Myc, pol III and TFIIIB to the complex. Pol III can 
dissociate from the transcription complex relatively easily (White, 2002). TFIIIB 
may be more stably retained due to interactions with TFIIIC and DNA (White, 2002). 
It may be that it takes more than 5 hours for TFIIIB to dissociate from the class III 
genes. Further experiments need to be performed looking at the occupancy of TFIIIB 
after longer time points.
In the model systems used c-Myc is involved in the recruitment of TFIIIB, followed 
by recruitment of polymerase to the promoters of genes that TFIIIIC is stably 
associated with. The polymerase is sensitive to c-Myc levels, and c-Myc appears to 
be required for the maintenance of polymerase association with pol III transcribed 
genes, but high levels of c-Myc can recruit TFIIIB to the promoters of pol III 
transcribed genes, but do not appear necessary for maintaining promoter occupancy.
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Chapter 5 Myc co-activator proteins associated with 
class III Genes
5.1 Introduction
The data presented in chapter 4 demonstrate that c-Myc is involved in the recruitment 
of the pol III transcription apparatus to the promoters of target genes, to promote the 
formation of the pol III transcription initiation complex. Much of the recent work on 
the mechanisms by which c-Myc can activate target genes has focused on c-Myc 
recruiting co-activator proteins to their promoters. Many of the co-activator proteins 
identified have been implicated in altering the localised structure of the chromatin that 
packages the DNA into the nucleus. Experiments in this chapter will focus on the 
involvement of c-Myc associated co-activator proteins and then role in the activation 
of pol III transcription.
6.1.1: Chromatin Organisation
A mammalian cell packages away around 2m of DNA into the chromatin structui'e 
that is contained m a nucleus less than 10pm in diameter. In eukaiyotic cells, DNA is 
associated with a family of small basic histone proteins which form a higher order 
condensed protein:DNA complex termed chromatin. The fundamental base of
Ichromatin is the nucleosome, which consists of 146bp of DNA wrapped twice round 
an octamer formed from the globular domains of two molecules of each of histones 
H2A, H2B, H3 and H4 (Luger et al, 1997). The globular domains of the histones
&
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form the core of the nucleosome, and the basic flexible tail regions of the histones 
protrude from the octamer, and are thought to be associated with the negatively 
charged DNA wiapped around the outside (Luger and Richmond, 1998). Each 
nucleosome is connected with 10-80bp of linker DNA associated with a linker 
histone, such as histone HI or H5, and the structure is progressively folded into higher 
order more condensed structures, which remain ill-defined (Felsenfeld and Groudine, 
2003).
The structure of higher order packed chromatin is generally repressive for 
transcription, due to the inaccessibility of the DNA (Felsenfeld and Groudine, 2003).
Appropriate gene expression therefore requires interplay with complexes that when
recruited by transcriptional activators, or repressors, can adjust the chromatin
Structure to alter its accessibility (Jenuwein and Allis’ 2001; Gamble and Freedman,
2002). There are two main classes of enzyme that perform this task and they are 
broadly described as cliromatin remodelling enzymes. The first class is the ATP- 
dependent chromatin-remodelling enzymes. These me multi-subunit complexes that 
utilise energy from ATP to alter the contacts between the histones and the DNA, thus 
facilitating disruption of the nucleosome structure (Owen-Hughes, 2003; Mohrmann 
and Verrijzer, 2004). The second class is the enzymes, which can covalently modify 
the histones. These modifications generally occur on the more flexible and charged 
histone tails that protrude from the nucleosome, altering the biochemical properties of 
this region (Luger and Richmond, 1998; Wu and Grunstein, 2000). Within this group 
there are factors that can acetylate, phosphorylate, methylate, and ubiquitinate the 
histones (Wu and Grunstein, 2000; Figure 5.1). The many different covalent 
modifications that can label the histone tails of the nucleosomes are postulated to
I
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create a “histone code” of modifications, that predicts multiple histone modifications 
acting together or in a sequential manner to specify unique downstream functions 
(Reviewed in Stralil and Allis, 2000; Turner, 2000).
This chapter will be focussing on the covalent modification of histone proteins by 
histone acetyl transferases and the ATP-dependent chromatin remodelling enzymes. 
Enzymes from both categories have been shown to interact with the c-Myc protein to
alter transcription of target genes.
5.1,2 ATP-dependent chromatin remodelling enzymes and c-Myc
I
The prototype ATP-dependent cliromatin remodelling complex, SWI/SNF, was 
identified in yeast genetic screens investigating mutants in mating type switching 
(SWI) and sucrose fermentation (sucrose non fermenting, SNF) (Winston and Carlton,
1992; Peterson and Herskowitz, 1992). Mutants identified in these screens not only 
showed defects in these functions, but altered expression of a wide range of target 
genes; indeed later studies revealed that mutants in the SWI/SNF complex altered 
expression of 6% of yeast genes (Winston and Carlton, 1992; Peterson and 
Herskowitz, 1992; Holstege et al, 1998; Sudarsanam et al, 2000).
The yeast SWI/SNF complex was found to contain 11 subunits, with one of the 
subunits, Snf2, having motifs that shared homology with DNA and RNA helicases
I
(Gorbalenya et al, 1993; Smith et al, 2003). Consistent with this SnG, was found to
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Figure 5.1 : Post translational modifications of the histone tails
The known post-translational covalent modifications of histones (H2A, H2B H3 and 
H4). Lysine (K) méthylation (Me) is represented in red. Acétylation (Ac), 
phosphorylation (P) and ubiquitination (Ub) are indicated in green, blue and orange, 
respectively. Arginine (R) méthylation is represented in black (figure from Sims et al,
2003).
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be able to hyrolyse ATP in the presence of DNA, but was found to have no helicase 
activity in strand displacement assays (Côté et al, 1994). Subsequent assays 
demonstrated that the assembly of histones on the DNA further stimulated this 
ATPase activity, and the complex was shown to stimulate transcription factor binding 
to DNA and to alter the positions of the nucleosomes on the template (Reviewed in 
Owen-Hughes, 2003, Li et al, 2004). The ability of these complexes to mobilise 
nucleosomes on a DNA template can lead to either a decrease or an increase in the 
accessibility of the associated DNA sequence (Owen-Hughes, 2003). Consistent with 
this, ATP-dependent chi'omatm remodelling enzymes have been shown to both 
activate and repress transcription of target genes (Holstege et al, 1998; Sudarsanam et 
al, 2000).
159
Through homology with the Snf2 protein in yeast, a host of chromatin remodelling 
complexes have been identified in eukaryotes. In humans the Snf2-related proteins 
Brgl and BrmI have been shown to exist in multiple hSWI/SNF complexes. Other 
classes of ATP-dependent chromatin remodelling enzymes have been identified, all
existing in multi-subunit complexes with a core ATPase necessary for their fonction 
(reviewed in Varga-Weisz, 2001 ).
As described above, the ATP-dependent chromatin remodelling enzymes have been 
shown to regulate the transcription of certain target genes. It has been demonstrated 
that SWI/SNF complex can be recruited to promoters thiough interactions with 
transcriptional activators (reviewed in Owen-Hughes, 2003, Li et al, 2004). In 
mammals, SWI/SNF complexes have been shown to play a role in the transcriptional
I
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.activation of an assortment of genes, including (3-interferon, hsp70, p-catenin and
retinoblastoma (Owen-Hughes, 2003). One of the best characterised examples of 
SWI/SNF involved in the activation of a target is a Brgl-containing human SWI/SNF 
complex mobilising a nucleosome to reveal the TATA box of the p-interferon gene 
promoter to allow recruitment of the pol II transcription apparatus (Agaloti et al, 
2000).
Components of the hSWI/SNF complex have been implicated in cancer development.
Snf5, a conserved subunit of hSWI/SNF, and the ATPase subunit, Brgl, are mutated
in several different tumours and tumoui* cell lines (Versteege et al, 1998; Sevenet et
al, 1999; Decristofaro et al, 2001; Wong et al, 2000). Homozygous inactivation of
. . . . .Snf5 is embryonically lethal in mice, and a conditional inactivation of Snf5 in mature 
mice leads to higlily penetrant tumours, indicating that Snf5 is a tumoui" suppressor 
(Roberts et al, 2003, Roberts and Orkin, 2004). The Brgl ATPase is a candidate 
tumour suppressor, as its homozygous deletion also leads to embryonic lethality in 
mice, and haploid insufficiency has been demonstiated to predispose mice to tumours 
(Roberts and Orkin, 2004).
The hSWI/SNF complex contains eleven polypeptides mcluding invariant core and 
.also variant subunits. Snf5 is a core sub-unit of the SWI/SNF complex. A search for 
Snf5-interacting proteins using a two-hybrid screen revealed an interaction between 
the bHLHz domain o f c-Myc and Snf5 (Cheng et al, 1999; Figure 5.2). This
-interaction was confirmed in vivo, and transient transfection of dominant interfering Iforms of Snf5 or Brgl block c-Myc-dependent transactivation as determined by
■
r
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Figure 5.2: Schematic indicating chromatin remodelling factors 
binding to c-Myc
Schematic indicating the regions of c-Myc that interact directly with the co-activators 
TRRAP, Snf5, TIP48, TIP49 and CBP. The conserved Myc Box 1 (MBI) and Myc 
Box 2 (MBII), as well as the basic helix-loop-helix zipper domain (bHLHz) are 
indicated on c-Myc as well as its binding partner Max. Also indicated are Gcn5 and 
TIP60 protein that bind to c-myc indirectly through an interaction with TRRAP.
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reporter assays, demonstrating a functional interaction between c-Myc and the 
SWI/SNF complex (Cheng et al, 1999).
In a study to find novel proteins interacting with the transactivation domain of c-Myc 
two related ATPase/helicases, TIP48 and TIP49, were identified. Both TIP48 and 
TIP 49 form complexes with c-Myc in vivo, and mutations in TIP49 have been shown 
to inhibit c-Myc oncogenic activity (Wood et al, 2000). Both TIP48 and TIP49 have 
been demonstrated to bind to the c-Myc target gene nucleolin in a c-Myc-dependent 
manner (Figure 5.2; Frank et al, 2003). In yeast, both TIP48 an TIP49 are in 
complexes with the ISWI-related ATPase Ino80, perhaps representing another 
fimctional interaction between c-Myc and a chi'omatin remodelling machine (Jonsson 
et al, 2004). They have also been identified as part of a histone acetyl transferase 
complex, along with another c-Myc interacting protein, TRRAP, which will be 
addressed later in this chapter (Ikura et al, 2000).
5.1.3: Histone Acetyl Transferases (HATs)
163
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As previously discussed, nucleosomal DNA is generally repressive to transcription.
A mechanism for altering the accessibility of the DNA is covalent modification of the 
histones, especially on the histone tails (Wu and Giimstein, 2000). One of the best- 
characterised histone modifications is reversible acétylation of lysines residues 
contained within the tail regions. Histone acétylation and deacetylation are mediated 
by opposing enzyme families: the HATs and the histone deacetylases (HDACs),
arespectively. HATs function enzymatically by transferring an acetyl group from 
acetyl Co-enzyme A (acetyl Co A) to a side chain of a lysine residue of a histone tail 
(Marmorstein and Roth, 2000; Roth et al, 2001). A separate group of enzymes.
Chapter 5 Myc co-activator proteins associated with class III genes
HDACs, can remove the acetyl group from the lysine, to reverse this modification 
(Kuo and Allis, 1998).
In a large scale screen of the histone modification patterns of a genome of 
Drosophilia, it was observed that areas of the genome containing active genes 
(euchromatin) were associated with areas of chromatin hyperacetylated on histone H3 
and histone H4 tails, and areas containing inactive genes (heterochromatin) were 
shown to be associated with deacetylated histones (Schubeler et al, 2004).
The neutralisation of the lysine residues in the histone tails is postulated to weaken the 
nucleosome:DNA and nucleosomemucleosome interactions to increase the 
accessibility of the DNA (Hong et al, 1993; Lee et al, 1993, Luger and Richmond, 
1998). The increase in the acétylation state of chromatin affects the higher order 
structme of the chromatin and leads to a more open and permissive chromatin 
environment for transcription (Kuo and Allis, 1998; Li et al, 2004).
As well as global increases in histone acétylation being associated with 
transcriptionally active areas of the genome, more subtle localised changes in 
nucleosome acétylation surrounding the promoter of genes by recruitment of HAT 
complexes correlate well with the activation of certain target genes (Kuo et al, 1998, 
Fernandez et al, 2003). Most of the data showing that increases in localised histone 
acétylation leads to gene activation is correlative, but in a recent study using a 
reconstituted system it was demonstrated that HATs could activate transcription by 
acetylating histones, and that the histone acétylation was necessary for activation of 
the reporter gene (An et al, 2004).
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5.1.4 The Myc/Max/Mad Network and Acétylation
Recent work has shown that not only are histones HAT substrates, but transcription
?
factors such as p53, c-Myb, E2F1 and c-Myc can be aceteylated to have positive 
effects on transcription by increasing DNA binding activity and/ or protein stability 
and half life (Gu and Roeder, 1997; Tomita et al, 1999; Martinez-Balbas et ai, 2000;
Vervoorts et al, 2003).
The Mad proteins, which are antagonists of c-Myc function, have been demonstrated 
to compete with c-Myc to form heterodimers with Max to bind to the same E-Box 
sequences to repress transcription of target genes (reviewed in Grandori at al, 2000; 
Chaper 1). All Mad proteins interact with the mammalian Sin3 proteins through an 
N-terminal Sin3-interaction domain (SID), and the integrity of this domain is required 
for Mad-mediated transcriptional repression. Sin3 proteins have been demonstrated 
to interact with HDACs to form co-repressor complexes, and repression of genes by 
the Mad proteins is sensitive to chemicals that can inhibit HD AC activity (Alland et 
al, 1997; Hassig et al, 1997; Laherty et al, 1997). Mad-HDAC complexes can bind to 
the promoters of target genes in an E-box dependent manner to repress transcription, 
and this repression is attenuated when cells are treated with HCAC inhibitors 
(Reviewed in Grandori et al, 2000)
With the discovery that Mad proteins could repress transcription through interactions 
with HD AC complexes, it was postulated that the c-Myc protein may interact with 
HATs. TRRAP was identified in a screen for novel proteins which interact with the
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N-terminal transactivation domain o f c-Myc (Figure 5.2; McMahon et al, 1998). 
TRRAP is a 440kDa polypeptide whose C-terminal domain displays homology to the 
Ataxia-telangietasia mutated (ATM)/ PI-3 kinase super-family, although mutations in 
the amino acid sequence suggest that TRRAP cannot fonction as a protein kinase 
(McMahon et al, 1998; Vassilev et al, 1998). TRRAP has no apparent DNA binding 
motif, but can be recruited to the DNA tlirough interactions with transcription factors, 
for example c-Myc or E2F1 or nuclear receptors, which mediate the targeting of 
TRRAP to the promoters of target genes (McMahon et al, 1998; Lang et al, 2001; 
Yanagisawa et al, 2002). The interaction between c-Myc and TRRAP is dependent 
on the integrity o f the essential MBII region and an area in the extreme amino 
terminal of c-Myc (McMahon et al, 1998, Figure 5.2). By knocking down
endogenous TRRAP levels using an antisense approach, McMahon and colleagues 
showed that the recruitment of TRRAP is essential for transformation of mammalian 
cells by c-Myc (McMahon et al, 1998). The gene encoding TRRAP is essential, as 
demonstrated by mouse knock out studies (Herceg et al, 2001). Trrap'^' mice die 
during embryonic development; cells with the Trrap'^' genotype can be recovered at 
the blastocyst stage, and when compared to Trrap or Trrap they display severe 
growth retardation (Herceg el al, 2001). Genome wide analysis of TRRAP knockout 
cells compared to wildtype, using micro arrays, revealed that there can be an increase 
as well as a decrease in gene expression o f target genes, revealing that TRRAP, 
directly or indirectly, is involved in the activation as well as the repression of 
transcription (Herceg et al, 2003).
TRRAP and its yeast homologue Tralp have been demonstrated to be an essential 
component of several complexes with HAT activity. These include SAGA, PCAF,
166
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c-Myc can also interact with the HAT CBP, but this interaction is independent of 
MBII and independent of TRRAP (Vervoorts et al, 2003). CBP can acetylate histones 
surrounding the promoters of c-Myc target genes (Vervoorts et al, 2003). CBP was
increase in its half-life (Vervoorts et al, 2003).
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ITIP60, NuA4, TFTC and STAGA complexes (Grant et al, 1998; Vassilev et al, 1998, 
Ikura et al, 2000; Allard et al, 1999; Brand et al, 1999; Martinez at al, 2001). The 
TRRAP/Tralp-containing HAT complexes can be broadly divided into two 
categories. The PCAF, SAGA, TFTC and STAGA complexes, that contain the PCAF 
and Gcn5 HATs, preferentially acetylate histone H3, whereas the NuA4 and Tip60
preferred histone substrate is histone FI4 (Sterner and Berger, 2000; Roth et al, 2001). I
As discussed earlier in this chapter, TRRAP can interact with the transcription factor 
c-Myc and, through these interactions, TRRAP has been shown to recruit HAT 
activity to the promoters of c-Myc target genes (Frank et al, 2001, Bouchard et al,
2001, Fernandez et al, 2003). Further work has demonstrated that c-Myc can bind to 
both Gcn5 and Tip60 containing HAT complexes, and that these interactions are 
dependent on TRRAP (McMahon et al, 2000; Frank et al, 2003; Figure 5.2).
It has been shown that both the integrity of TRRAP and the HAT activity of Gcn5 are
required for c-Myc mediated transcriptional activation (Liu et al, 2003). A dominant-
negative form of Tip60 can delay c-Myc-mediated acétylation of histone H4 (Frank et
al, 2003). The evidence suggests that not only can TRRAP act as the adaptor to 
.recruit HAT activity to a gene promoter; it may specify the HAT activity it recruits.
I-IIi':
•:
also shown to acetylate the c-Myc protein leading to increased c-Myc stability and an
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Experiments in this chapter focus on ATP-dependent chromatin-remodelling enzymes 
and HAT complexes that interact with c-Myc, and are potentially involved in the 
activation of pol III transcription.
s
I
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5.2 Results
5.2.1 Swi/Snf and TRRAP are present on pol Ill-transcribed genes 
in vivo
to the association of the Pol III transcription apparatus, TRRAP and two components 
of the hSWI/SNF chromatin-remodelling complex, Snf5 and Brgl, are associated with 
pol Ill-transcribed genes in HeLa cells (figure 5.3). The association of these proteins 
with pol Ill-transcribed genes appears to be specific as they are not associated with 
the pol Il-transcribed ARPP PO gene (Figure 5.3).
I:As summarised in the introduction to this chapter, there are many co-activator 
proteins that have been demonstrated to be involved in the transcription of c-Myc 
target genes. To determine whether any of these factors were involved in pol III 
transcription, ChIP assays were performed to test for promoter occupancy on pol Ill- 
transcribed genes. ChIP assays were performed on asynchronously growing HeLa 
cells using anti-c-Myc, anti-TRRAP, anti-SnfS and anti-Brgl antibodies (Figure 5.3). 
As positive controls antibodies against the TFIIIB components Brfl and TBP, along 
with an antibody against the RPC 155 subunit of the polymerase were used, and a 
TAFi48 antibody and beads were used as negative controls. As expected, the TFIIIB 
subunits Brfl and TBP and the polymerase subunit RPC 155 are associated with the 
promoters of pol Ill-transcribed genes m HeLa cells, shown by their association with 
the 5S and tRNA ® genes, but neither the pol Ill-specific TAP, Brfl, or pol III is
associated with the pol Il-tianscribed ARPP PO control gene (Figure 5.3). In addition
169
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Figure 5.3: c-Myc, TRRAP and components of the hSWi/SNF
complex bind to class III genes in vivo
Chip assays were performed on cultured HeLa cells using antibodies against Brfl, 
TBP, RPC155, c-Myc, TRRAP, Snf5, Brgl, TAFi48 or with beads alone. As 
expected, binding of the positive controls, Brfl, RPC 155, TBP and c-Myc, was 
detected at the 5S and tRNA"^® genes, as determined by PCR using gene-specific 
primers. The c-Myc cofactor TRRAP and two components of the hSWI/SNF 
complex, Brgl and Snf5, were found to be specifically associated with the 5S and 
tRNA^® genes. The interactions of TRRAP and hSWI/SNF with Pol III promoters is 
specific as no signal was obtained by PCR using primers specific to the pol II- 
transcribed ARPP PO gene.
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In order to determine whether the components of the hSWI/SNF chromatin- 
remodelling complex were present in a c-Myc-dependent manner, a c-Myc-inducible 
cell line was used. The cell line used is the A31 cell line stably transfected with a 
vector encoding an oestrogen-responsive Myc fusion protein (MycER) that was used 
and described in chapter 4 (Figure 4.1). The cells were quiesced by serum starvation 
for 48 hour prior to treatment with 4-OHT, to lower levels of endogenous c-Myc. 
Chip assays were performed on these cells after the indicated time points after 
MycER activation using an antibody against the Snf5 subunit of the hSWI/SNF 
complex. No binding of the components of Snf5 was observed on the promoter of the 
tRNA^®“ gene (Figure 5.4). This may indicate that Snf5 is not present at the 
promoters of pol Ill-transcribed genes in a c-myc dependent manner, or that an 
insufficient amount of the protein was immunoprecipitated.
To test whether the apparent lack of promoter association of Snf5 is specific to class 
III gene promoters, the binding of Snf5 to another c-Myc target gene was tested. In 
contrast to class III genes the cyclin D2 promoter has a consensus E-box sequence 
required for c-Myc binding (Bouchard et al, 2001). No binding of Snf5 to the 
promoter of the cyclin D2 promoter was observed, consistent with a failure in the 
immunoprécipitation (Figure 5.4). Similar results were obtained from ChIP assays in 
MycER cells looking for promoter occupancy of the Brgl ATPase subunit of 
SWI/SNF (data not shown).
To determine whether the interaction of TRRAP with pol Ill-transcribed genes occurs 
in other cell lines, ChIP assays were performed using another human derived cell line. 
Chip assays were performed using asynchronously growing HEK293 cells, using an
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Figure 5.4: Analysis of hSWI/SNF binding to the promoters of 
class III genes in response to c-myc activation
A. c-Myc was induced in MycER fibroblasts by addition of 200nM 4-OHT. ChIP 
assays were performed at the indicated time points after MycER activation using 
antibodies against Snf5 and TAFi48. The samples were normalised by comparing the 
genomic DNA inputs. The samples were then analysed by PCR, alongside input 
genomic DNA (10% and 1%), using primers specific to the promoters of the tRNA^®“ 
and cyclin D2 genes, as indicated.
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anti-TRRAP antibody. As a positive control an antibody against Brfl was used, and 
as negative controls an anti-TFIIB antibody and beads alone. As expected, Brfl is 
present on pol Ill-transcribed genes in these cells, as shown by the association with 
the 5S, tRNA^^“ and tRNA^® genes, but not the pol Il-transcribed ARPP PO gene 
(Figui'e 5.5). In addition to the association of Brfl with pol III-transcribed genes,
transcribed AlRPP PO gene (Figure 5.5).
I
TRRAP is also present at the 5S, tRNA^®” and tRNA^^ genes, but not the pol II-
5.2.2 TRRAP binding to pol ill-transcribed genes is enriched in the 
presence of c-myc
I
■
The binding of the TRRAP protein to the promoter of the myc target gene nucleolin is 
enhanced in c-Myc wildtype compared to myc null rat fibroblasts, as determined by
CMP assays (Frank et al, 2001). To establish whether the binding of TRRAP to pol
Ill-transcribed genes is c-Myc dependent, the binding of TRRAP to class III genes 
was compared in matched c-Myc wildtype and c-myc null rat fibroblasts (described in
Mateyak et al, 1997). It has previously been established that c-Myc-deficient
fibroblasts display lower levels of pol III transcription compared with matched c-Myc 
.wildtype (Gomez-Roman et al, 2003; Figure 4.7). CMPs were performed using anti- 
.pol III RPC155, anti-TRRAP and anti-TFIIB antibodies. In the wildtype cell line the 
promoter occupancy of the pol III subunit is enriched compared to that of the c-Myc- 
deficient cell line on the tRNA^^" and tRNA^ *^^  genes, consistent with the results 
presented in chapter 4 (Figure 5.6a; Figure 4.7). In the c-Myc wildtype cell line there 
is also an enrichment of the TRRAP protein on the promoters of the tRNA^®“ and
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Figure 5.5: TRRAP is present on the promoters of class 111 genes 
in HEK 293 cells
Chip assays using HEK 293 cells were performed to test for association of TRRAP 
with pol Ill-transcribed genes. The ChIP assays were performed using anti bodies 
against Brfl, TRRAP, TFIIB and beads alone. The samples were then analysed by 
PGR, alongside input genomic DNA (10% and 1%), using 5S, tRNA^®“, tRNA^®, and 
ARPP PC primers as indicated. The association of both the positive control, Brfl, and 
TRRAP with pol Ill-transcribed genes is specific, as no signal is detected by FOR 
using primers specific to the pol Il-transcribed ARPP PC gene.
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Figure 5.6: TRRAP is enriched at the promoters of pol Ill-
transcribed genes in vivo in a c-Myc-sensltive manner A. The promoter 
occupancy of TRRAP was measured in matched c-Myc'^' and c-Myc^^  ^rat fibroblasts. 
ChlPs were performed using antibodies against the large pol III subunit, RPC 155, 
TRRAP and TFIIB (negative control). The samples were normalised by comparing 
the genomic DNA inputs and adjusting the samples accordingly. The samples were 
then analysed by PCR, alongside input genomic DNA (10% and 1%), using tRNA^ ®'^ , 
tRNA^^, and ARPP PO primers, as indicated. B. Whole cell extracts were made from 
c-Myc wildtype and c-Myc null cells. The protein extracts were resolved by SDS- 
PAGE and blotted using antibodies against TRRAP and actin.
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tRNA^^  ^ genes, compared with the occupancy on the same genes in the c-Myc 
deficient cell line (Figure 5.6a). This increase is not due to higher levels of TRRAP in 
the wildtype cell line, as shown by western blotting (Figure 5.6b). This is consistent 
with c-Myc being involved in the enrichment of TRRAP on pol Ill-transcribed genes.
5.2.3 Binding of c-myc to pol Ill-transcribed genes results in 
recruitment of TRRAP and increased histone acétylation
180
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Bouchard and colleagues exammed the levels of TRRAP and localised histone
acétylation on the cyclin D2 gene promoter using a cell line with a 4-OHT inducible
MycER construct (Bouchard et al, 2001). To address whether TRRAP could be
recruited to pol Ill-transcribed genes in a c-Myc-dependent manner, ChIP assays were 
.performed using the MycER and pBabe (control) cell lines. MycER and pBabe cells
■■were serum starved for 48hrs prior to treatment with 4-OHT, to down regulate the 
endogenous c-Myc protein. The cells were treated with 4-OHT and harvested at the 
indicated time points and ChIP assays were performed using anti-TRRAP and anti- 
TAFi48 antibodies. Activation of MycER resulted in a recruitment of TRRAP to the 
promoters of the 5S rRNA and tRNA^®“ genes after 2hrs (Figure 5.7a). The effect is 
not due to 4-OHT, as ChlPs using the pBabe control cell line do not show any 
recruitment of TRRAP to the 5S rRNA or tRNA^®“ genes in response to treatment 
with the synthetic hormone (Figure 5.7b). The timing of the recruitment of TRRAP is 
consistent with the protein being recruited with c-Myc, as they are both recruited to 
pol III-transcribed genes within 2his in response to MycER activation (Figure 4.3a 
and Figure 5.7a).
I
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Figure 5.7: TRRAP Is recruited to pol Ill-transcribed genes in a c- 
Myc dependent manner in vivo
A. c-Myc was induced in MycER fibroblasts by addition of 200nM 4-OHT. ChIP 
assays were performed at the indicated time points after MycER activation using 
antibodies against TRRAP and TFIIB. The samples were normalised by comparing 
the genomic DNA inputs. The samples were then analysed by PCR, alongside input 
genomic DNA (10% and 1%), using 5S and tRNA^®“ primers as indicated. B. As 
above, but using the pBabe transfected control cell line.
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5.2.4 Promoter occupancy of c-myc, TRRAP, and acetylated 
histone H3 are lowered in response to MEL cell differentiation
183
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Transcriptional activation of several target genes by c-myc has been shown to alter
levels of localised acétylation of the histone tails of nucleosomes surrounding their
promoter regions (Bouchard et al, 2001; Frank et al, 2001; Fernandez et al, 2003). To
examine whether this was the case in pol Ill-transcribed genes, CMP assays were
performed using the MycER and pBabe cell lines. The cells were serum starved and
myc was induced with 4-OHT, as previously described, and cells were harvested at
.the indicated time points. Activation of MycER resulted in a localised increase in 
histone H3 acétylation surrounding the promoters of the 5S rRNA and tRNA^®“ genes 
but not an increase in the levels of acetylated Mstone H4 (Figure 5.8a). TMs 
contrast to the results observed on the promoter of the cyclin D2 gene, where 
increase in the levels of localised acétylation of both histones H3 and H4 is observed 
in response to activation of MycER, suggesting a different method of activation, when 
comparing the pol Il-transcribed cyclin D2 gene and the pol Ill-transcribed genes 
(Figure 5.8a; Bouchard et al, 2001). The effect on histone acétylation was not an 
indirect effect of 4-OHT addition, as no changes in histone acétylation on 5S rRNA 
and tRNA^®“ genes were observed in the pBabe cell line (Figure 5,8b).
I
To further investigate how TRRAP and histone acétylation can contribute to the c~ 
Myc activation of pol Ill-transcribed genes under physiological conditions I used a 
mouse erythroleukaemia (MEL) cell line. As described in chapter 4, the MEL cell 
line can be differentiated using the chemical HMBA; tMs differentiation results in an
I
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Figure 5.8: Activation of MycER induces localised histone H3
acétylation surrounding the promoters of class III genes
A. c-Myc was induced in MycER fibroblasts by addition of 200nM 4-OHT, ChIP 
assays were performed at the indicated time points after MycER activation using 
antibodies against acetylated lysines of histone H3 and histone H4, using an antibody 
against TAFi48 as a negative control The samples were normalised by comparing the 
genomic DNA inputs. The samples were then analysed by PCR, alongside input 
genomic DNA (10% and 1%), using 5S, tRNA^®“, cyclin D2 and p21 primers as 
indicated. B. As above, but ChIP was performed using the pBabe-transfected control 
cell line. Samples were analysed by PCR, alongside input genomic DNA (10% and 
1%), using 58 and tRNA^^*^-specific primers.
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5.2.6 TRRAP interacts with TFIIIB in a c-Myc-dependent manner
The c-Myc protein interacts specifically with the pol III specific transcription factor 
TFIIIB (Gomez-Roman et al; Chapter 3). To determine if TRRAP associates with
186
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immediate, dramatic fall in c-Myc levels and can be used as a model system for loss 
of c-Myc (Figure 4.10).
To investigate any difference in the levels of TRRAP, Max and localised histone H3
acétylation associated with pol Ill-transcribed genes ChIP assays were performed on
.undifferentiated and differentiated MEL cells. Levels of c-Myc associated with pol 
Ill-transcribed genes are reduced in the differentiated cells compared to the 
undifferentiated MEL cells (Figure 4.12a). The levels of TRRAP associated with the 
promoters of the 5S rRNA and tRNA^^" genes were also clearly reduced in response 
to differentiation (Figure 5.9a). Unlike c-Myc levels, the levels of the TRRAP protein 
do not change over the time course, so changes in the promoter occupancy were not 
simply due to TRRAP levels becoming limiting in the cell (Figure 5.9b). The levels 
of Max associated with pol Ill-transcribed genes stayed constant, indicating that the 
presence of Max on a pol Ill-transcribed gene is not dependent on the presence of c- 
Myc (Figure 5.9a).
,To test if the reduced levels of TRRAP associated with the promoters of pol III
transcribed genes correlates with a reduced level o f localised histone acétylation ChIP
.assays were performed on undifferentiated and differentiated MEL cells using an anti­
acetyl H3 antibody. In differentiated MEL cells there was a reduced level of 
acetylated histone H3 associated with tRNA^^^ and 5S rRNA genes (Figure 5.9c).
i
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Figure 5.9: Promoter occupancy of TRRAP is reduced in response 
to chemically induced differentiation of MEL cells
Differentiation of murine erthroleukemia (MEL) cells was induced by treatment with 
5mM HMBA for 5hours. ChIP assays were performed on undifferentiated and 
differentiated MEL cells, using antibodies against Max, TRRAP and TFIIB (negative 
control). The samples were normalised by comparing the genomic DNA inputs. The 
samples were then analysed by PCR, alongside input genomic DNA (10% and 1%), 
using tRNA^^“ and 5S rRNA primers as indicated. B. Whole cell extracts were made 
from MEL cells treated with 5 mM HMBA for the indicated times. The protein 
extracts were resolved by SDS-PAGE and blotted using antibodies against TRRAP, 
Max and actin. C. ChIP assays were performed as in A, but using antibodies against 
acetylated histone H3 and TFIIB (control).
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that this interaction is sensitive to the presence of c-Myc (Figure 5.10b).
6.2.6 Knocking down TRRAP levels using RNAi results in lowering 
levels of Pol III transcription
TFIIIB, CO-immunoprécipitation assays were performed. HeLa nuclear extracts were
mixed with reticulocyte lysate containing ^^S-labelled in vitro transcribed and
.translated Brfl, these extracts were immunoprepitated with anti-TRRAP antibody or 
anti TFIIA antibody as a negative control. The recovered protein complexes were 
resolved by SDS-PAGE and subject to auto-radiography to test for co- 
immunoprecipitation of the Brfl component of TFIIIB. The binding of TFIIIB to 
TRRAP was confirmed by the co-immunoprécipitation of Brfl and TRRAP, this 
interaction is specific, as a TFIIA antibody does not immunoprecipitated Brfl (Figure 
5.10a).
To determine if the interaction between TFIIIB and TRRAP is c-Myc dependent, co- Iimmunoprécipitation experiments were performed comparing the interaction between
:
TRRAP and ^^S-labelled Brfl in extracts made from c-Myc null and c-Myc wildtype 
fibroblasts. In the extracts from c-Myc wildtype fibroblasts the specific interaction 
between TFIIIB and TRRAP is observed, but this interaction is not observed when the
same experiment was performed in extracts from c-Myc null fibroblasts, indicating
RNA interference was used to test whether or not transcription of tRNA genes was 
sensitive to the level of endogenous TRRAP. A pool of vectors encoding short- 
hairpin RNAs against the TRRAP transcript were transiently transfected into HeLa 
cells (Brummelkamp et al, 2002; Berns et al, 2004). To confirm knockdown of the
190
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Figure 5.10 : TRRAP interacts with TFIIIB in a c-Myc-dependent 
manner
A, Reticulocyte lysate (5pi) containing in vitro-translated Brfl was added to 300pg 
HeLa cell nuclear extract and then immunoprecipitated using anti-TRRAP or anti- 
TFIIA antibodies. Proteins retained after wash steps were resolved by SDS-PAGE 
and then visualised by autoradiography. 5% of the extraet was run as an input B. 
Reticulocyte lysate (5pi) containing in vitro-translated Brfl was added to 250pg of 
whole cell extracts prepared fi'om either c-myc'^' or c-myc^^ ,^ then 
immunoprecipitated using anti-TRRAP or anti-TFIIA antibodies. Proteins retained 
after wash steps were resolved by SDS-PAGE and then visualised by 
autoradiography. 5% of each of the original extracts were run as inputs.
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Figure 5.11: Depletion of endogenous TRRAP levels in HeLa cells 
by RNA interference selectively reduces class III gene expression 
in HeLa cells
Growing HeLa cells were transfected with pSuper vectors encoding short hairpin 
RNAs (shRNAs) against TRRAP or MyoD (control). A. Whole cell extracts were 
harvested from transfected cells 48 hours after transfection and analysed by western 
blot, using antibodies against TRRAP or Spl (control). B. RNA was harvested from 
transfected cells 48 hours after transfection and analysed by RT-PCR for the 
expression of TRRAP, tRNA^®“, tRNA^^  ^ and ARPP PO (control).genes are lower in 
cells with less TRRAP as shown by RT-PCR (Figure 5.11b). This effect of the 
TRRAP shRNA was specific, as confirmed by the levels of the control transcript 
ARPP PO remaining constant (Figure 5.11b).
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TRRAP protein levels, western blots were performed using extracts from TRRAP 
shRNA-transfected cells, and cells transfected with shRNA vectors against MyoD, a 
muscle specific transcription factor, as a control. The levels of the TRRAP protein 
are partially, but clearly knocked down in TRRAP shRNA-transfected cells compared 
to the control (Figure 5.11a). The levels of transcription of the 5S, tRNA^®“ and 
tRNA^ *^^  genes are reduced in the cells with lower levels of the TRRAP protein 
(5.11b). This effect is specific as levels of the pol Il-transcribed ARPP PO transcript 
do not change in these cells (5.11b).
5.2.7 The HAT Gcn5 is recruited to pol Ill-transcribed genes in a c- 
Myc dependent manner
TRRAP is a common component of several different HAT complexes associated with
195
c-Myc that have been implicated in the transactivation of c-Myc target genes. Myc
■
has been shown to be in complex with Gcn5 and Tip60, through an interaction with
the TRRAP protein (McMahon et al, 2000; Frank et al, 2003). To test if these HATs
are present at the promoters of pol Ill-transcribed genes, CMPs were performed using
matched c-Myc wildtype and c-Myc null fibroblasts. ChIP assays were performed
using anti-Gcn5, anti-Tip60 and anti-TFIIB antibodies. The level of Gcn5 associated
with the tRNA gene is enriched in the c-Myc wildtype fibroblasts compared to the
c-Myc deficient fibroblasts (Figure 5.12a). The levels of Tip60 are marginally above 
.the control IP; thus it may be associated with class III genes, but its binding to pol Ill- 
transcribed gene promoters is not enriched in the presence of c-Myc (Figure 5.11a).
I
Chapter 5 Myc co-activator proteins associated with class III genes
The association of Gcn5 with the pol Ill-transcribed gene is specific, as no binding 
was observed on ARPP PO gene (Figure 5.12a).
Figure 5.12: Gcn5 is associated with the promoters of class III 
genes in a c-Myc-sensitive manner
A. The promoter occupancy of Gcn5 was measured in matched c-Myc'^" and c-Myc"^ "^^  
rat fibroblasts. ChlPs were performed using antibodies against Gcn5, T1P60 and 
TFIIB (negative control). The samples were normalised by comparing the genomic 
DNA inputs and adjusting the samples accordingly. The samples were then analysed 
by PCR, alongside input genomic DNA (10% and 1%), using tRNA^®“ and ARPP PO 
(control) primers as indicated. B. c-Myc was induced in MycER fibroblasts by 
addition of 200nM 4-OHT. ChIP assays were performed at the indicated time points 
after MycER activation using antibodies against c-Myc, Gcn5 and TAFi48. The 
samples were normalised by comparing the genomic DNA inputs. The samples were 
then analysed by PCR, alongside input genomic DNA (10% and 1%), using tRNA^™ 
primers as indicated.
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To confirm the presence of Gcn5 on a class III gene in a different system, ChIP assays 
were performed on MycER cells to test for c-Myc-dependent recruitment. ChIP 
assays were performed using anti-c-Myc, anti-gcn5, and anti-TAFi48 antibodies, c- 
Myc is recruited to pol Ill-transcribed genes in response to 4-OHT induction, 
consistent with the results outlined in chapter 4. (Figure 4.3a). The recruitment of the 
HAT Gcn5 coincided with the recruitment of c-myc and TRRAP to a tRNA^™ gene
(figure 5.12b)
■I
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5 .3  Discussion
The data presented in this chapter confirm that, in the model systems used, factors that 
modify cliromatin structure are recruited to the promoters of class III genes and
c-Myc directly interacts with the Snf5 component of the SWI/SNF chromatin
The potential mvolvement of SWI/SNF in the c-Myc-dependent activation of pol III 
transcription is puzzling, due to the fact that components of the complex have been 
demonstrated to be tumour suppressors, for example the c-Myc-interacting protein
199
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implicated in the c-Myc-dependent activation of pol III transcription.
remodelling complex, via an interaction with its C-terminal basic helix-loop-helix
zipper domain, and expression of an inactive catalytic subunit, Brgl, resulted in c- 
myc transactivation being inhibited in a reporter assay (Cheng et al, 1999). Both Snf5 
and the catalytic subunit Brgl are present at the promoters of pol Ill-transcribed genes
in vivo, as confirmed by ChIP assays, indicating that chromatin remodelling enzymes 
may play a role in organising the localised chromatin structure surrounding pol Ill- 
transcribed genes to regulate transcription. In an attempt to explore the possibility
that Snf5 and Brgl were recruited to class III genes in a c-Myc-dependent manner, 
ChIP assays were performed using a c-Myc inducible cell line. However, as 
discussed previously, these assays were unsuccessful, perhaps due to an inability to 
immunoprecipitate these proteins in a rodent cell line. The SWI/SNF complex was 
not detected on the well-characterised c-Myc target gene cyclin D2 in these assays.
further suggesting a problem with the immunoprécipitation, or that SWI/SNF is not 
recruited to this promoter. I
I
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Snf5 (Roberts et al, 2003), To address this further, experiments are required to assay 
whether SWI/SNF is involved in the regulation of pol Ill-transcribed genes including 
experiments to assess pol III activity in cells deficient in SWI/SNF subunits, or to 
target sub-units with RNA interference to selectively knock down their expression.
These techniques could be used to uncover any mvolvement of SWI/SNF on 
expression of class III genes.
The c-myc associated protein, TRRAP, has been shown to be critical for myc 
transforming activity by being necessary for the activation of a subset of c-Myc target 
genes (McMahon et al, 1998; Herceg et al, 2001; Herceg et al, 2003). TRRAP is a 
component of several HAT complexes that are recruited to the promoters of c-myc 
target genes (Bouchard et al, 2001; Frank et al, 2001). The data presented have not 
only demonstrated TRRAP association with pol Ill-transcribed genes, but also that 
enhanced TRRAP binding to the promoter coincides with c-Myc binding, and 
precedes pol III transcriptional activation, as confirmed by ChIP analysis in the 
MycER cell line (Figure 5.6a; Figure 4.3a). Confirming the c-Myc dependent 
TRRAP protein association with Class III genes, TRRAP is enriched on the promoters 
of pol Ill-transcribed genes in c-Myc wildtype, compared to c-Myc deficient cell lines 
(Figure 5.5a).
'i:.
The c-Myc protein is associated with the pol Ill-specific transcription factor TFIIIB, 
and it is this interaction which is thought to be responsible for its association with pol 
Ill-transcribed genes (Gomez-Roman et al, 2003, Felton-Edkins et al, 2003b) Co-
immunoprecipitation assays were performed that demonstrated that TRRAP can 
interact with the Brfl component of TFIIIB (Figure 5.9a). This interaction is
200
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dependent on c-Myc, as the interaction is not observed in c-Myc deficient fibroblasts 
(Figure 5.9b). Although the TRRAP/ TFIÏIB interaction is dependent on the presence 
of c-Myc, there is evidence that low levels of TRRAP are associated with the 
promoters of pol III transcribed genes in a c-Myc independent manner (Figure 5.5).
This may be due to a non-specific background signal obtained from the antibody, or a 
secondary uncharacterised interaction between TRRAP and the pol III transcription
apparatus.
As discussed previously in this chapter the TRRAP protein is a common subunit of
several histone acetyltransferase complexes, and recruitment of TRRAP coincides
with an increase in histone H3 acétylation (figure 5.7a). This may represent a
requirement for a localised increase in histone acétylation surrounding the promoters
of pol Ill-transcribed genes to lead to an increase in pol III transcription. In studies
.performed in vitro on a 5S rRNA gene, increased histone acétylation and disruption of 
higher order chromatin structure leads to a 15-fold increase in the level of 
transcription of this template (Tse et al, 1998). Preliminary data demonstrate that 
treatment of mammalian cells with the HD AC inhibitor TSA leads to an increase in 
localised histone acétylation surrounding the promoters of class III genes and an 
activation of their transcription (Ramsbottom and White, unpublished observations).
The pattern of the histone acétylation is surprising; the majority of work on this area 
has focused on a subset of well-characterised pol Il-transcribed genes, which mainly
Îexhibit localised changes in histone H4 acétylation and some changes in histone H3
(Frank et al, 2001; Fernandez et al, 2003). c-Myc has also been shown to enhance 
.localised histone acétylation surrounding the ribosomal DNA and stimulate
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pol II.
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transcription by Pol I (Grandori et al, 2005; Arabi et al, 2005). The activation by c 
myc in this case has been followed by a recruitment of TRRAP to the pol I- 
transcribed large ribosomal RNA genes. (Arabi et al, 2005). Again, the studies on c 
Myc activation of Pol I transcription reveal an increase in levels of predominantly 
histone H4 acétylation surrounding the promoters of the pol I-transcribed genes 
(Grandori et al, 2005; Arabi et al, 2005). The significance of the preferred acétylation 
of histone H3 is unclear, but it would suggest that the activation of pol Ill-transcribed 
genes by c-Myc involves different TRRAP/HAT complexes at the promoters of pol 
III target genes than it when activating transcription of genes transcribed by pol I and
i
The specific acétylation of histone H3 indicated that it was likely that the HAT 
recruited by c-Myc and TRRAP to the promoters of pol Ill-transcribed genes would :
have substrate specificity for histone H3. The HAT Gcn5 was demonstrated to be 
associated with pol Ill-transcribed genes in a c-Myc-sensitive manner. The Gcn5 
HAT and TRRAP are recruited to pol Ill-transcribed genes at the same time as c-Myc 
in the MycER cell line. Gcn5 complexes have been demonstrated to prefer the
Histone H3 tail as their preferred substrate and this result fits with the observation that
c-Myc induces localised acétylation of histone H3 associated with certain class III 
genes (Sterner and Berger, 2000; Roth et al, 2001). The human form of Gcn5 has
been demonstrated to exist in two distinct HAT complexes with TRRAP, TFTC and 
STAGA; but the nature of the complex associated with class III genes has yet to be 
determined.
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The HAT Gcn5 has been shown to be present on pol Ill-transcribed genes in a c-myc
.sensitive manner. In a cell line where the Gcn5 HAT has been deleted using a gene
targeting technique, the Gcn5 deficient cells have shown to have a reduced growth
rate and deficiencies in progressing through the cell cycle (Kikuchi et al, 2005). As
the rate of protein synthesis correlates with the growth rate of a cell (Zetterberg and
Killander, 1965), the deficiency in the growth rate in Gcn5 null cells may be due to a
.reduced supply of pol Ill-transcribed factors involved in protein synthesis.
The tai'get of the TRRAP/HAT complex may not be solely a histone substrate, as 
there have been many studies published showing that HATs can act on transcription 
factors to increase transcription of target genes (Kouzerides, 2000). c-Myc itself can 
be acetylated by HAT complexes (Vervoorts et al, 2003; Patel et al, 2004). It has
i
been demonstrated that acétylation of c-Myc can lead to c-Myc stabilisation and an 
increase in its half-life (Patel et al, 2004). c-Myc’s affinity for target genes may also 
be increased in response to acétylation, in a mamier analogous to that observed with 
p53 (Gu and Roeder, 1997). The results here show that an increase in c-Myc/TRRAP 
and associated HAT, leads to an increase in histone H3 acétylation at the promoters of 
class III genes, but does not answer the question whether non-histone substrates are 
also targets.
Class III genes do not have any E-box sequences in their promoters, which are 
required for c-Myc/Max bindmg to the DNA, instead c-Myc is thought to be 
associated with promoters via an interaction with TFIIIB (Gomez-Roman et al, 2003). 
Immuno precipitation experiments have shown that TRRAP is also associated with 
the TFIIIB complex (Figure 5.9). This interaction with TFIIIB is dependent on the
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TRRAP null cells could be attributed to repression of pol III transcription.
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presence of c-Myc, as shown by further immunoprécipitations using extracts from c- 
Myc null and c-Myc wild type cell lines (Figure 5.9). These results suggest that the 
recruitment of a TRRAP/Gcn5 HAT complex is through an indirect interaction with 
TFIIIB, through a bridging interaction with c-Myc, or perhaps the TRRAP can bind to 
TFIIIB weakly and c-Myc can act to stabilise it. The timing of the recruitment of 
TFIIIB, c-Myc, TRRAP and Gcn5 and the c-Myc dependent recruitment of these 
factors, may suggest they aie recruited to the promoter as a complex, with c-Myc 
being the limiting factor.
Although do not know if the histones are the only substrates of the c-Myc recruited 
TRRAP/Gcn5 HAT complex, TRRAP is involved in the activation of class III genes. 
Partially knocking-down TRRAP protein levels in a human cell line, by using vectors 
encoding shRNAs against the TRRAP transcript, results in lower levels of pol III 
transcription of the tRNA^^“ and tRNA^^ genes, showing a requirement for the 
TRRAP protein for activation of class III genes (Figure 5.10). TRRAP null cells 
display reduced proliferation and growth rates and have been demonstrated to 
differentially regulate a whole host of genes compared to matched wildtype cells 
(Herceg et al, 2003). The data above strongly suggest that pol Ill-transcribed genes 
are regulated, in part, by the TRRAP protein, and some of the growth defects in
The promoter occupancy of the TRRAP protein and localised acétylation of Histone 
H3 is reduced in response to chemical differentiation of MEL cells (Figure 5.8c). 
This reduction of TRRAP levels associated with the promoter coincides with reduced 
levels of c-Myc and pol III. It is interesting that the levels of promoter-bound TFIIIB
204
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do not change in response to chemically-induced differentiation. This would indicate 
that if TFIIIB, c-Myc, TRRAP and Gcn5 are recruited as a complex, they do not 
dissociate from the promoter as one. The rapid reduction of the levels of histone H3 
acétylation not only agrees with the reduction in c-Myc and TRRAP levels, but may 
also indicate the recruitment of an HD AC complex to class III genes in the absence of 
c-Myc.
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The promoter-bound levels of the c-Myc binding partner Max also remain constant 
after differentiation (Figure 5.8). c-Myc recruitment to pol Ill-transcribed genes is 
thought to be thiough an interaction between TFIIIB and the transactivation domain 
of c-Myc (Gomez-Roman et al, 2003). Differentiating MEL cells have lower levels 
of the c-Myc protein than non-differentiated cells and this is reflected in the promoter 
occupancy of c-Myc on class III genes (Figure 4.10 and 4.12a). The observation that
Max levels do not change on the promoters of class III genes indicates that Max can
bind independently of c-Myc (Figure 5.8). As Max does not contain a homologous 
.transactivation domain, this indicates it binds to class III genes through a novel 
interaction, and may suggest that other members of the Myc/Max/Mad family of 
transcription factors may influence transcription by pol III. The levels of the c-Myc 
antagonist Mad proteins increase in response to MEL cell differentiation, and perhaps 
Mad/Max complexes may replace c-Myc/Max complexes to recruit HD AC complexes 
to class III genes (Rime and Wright, 2003). Tins switch from Myc/Max to Mad/Max 
complexes in response to differentiation has been observed on c-Myc target genes 
transcribed by pol II (Bouchard et al, 2001; Xu et al, 2001). Indeed, preliminary data 
suggests that Mad proteins are associated with class III genes in vivo (Robertson and 
White, unpublished observations).
Chapter 5 Myc co-activator proteins associated with class III genes
The activities of ATP-dependent chi'omatin remodelling enzymes and HATs are not 
exclusive and independent. Synergy between these factors has been demonstrated in 
the activation of a variety of genes. The ATPase subunits of several SWI/SNF ATP- 
dependent chromatin remodelling complexes, including the Brgl ATPase that is 
associated with class III genes in vivo, have been shown to contain bromodomains 
(Sif, 2004). Bromodomains recognise acetylated lysines, and through this motif 
proteins can be recruited to hyper-acetylated histones, representing a mechanism by 
which SWI/SNF chromatin remodellers can be recruited to active genes (Bottomley, 
2004; Horn and Peterson, 2001). The observation that both ATP-dependent chiomatin 
remodelling complexes and HAT complexes are present on class III genes raises the 
possibility that they may work in concert to enable the recruitment of pol Ill-specific 
transcription factors to the promoters of these target genes.
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Cancer is a disease that will affect 1 in 3 of the population of the United Kingdom and 
will eventually lead to the death of 1 in 4 (statistic from the Cancer Research UK web 
site, www.cancerresearchuk.org). Studying the mechanisms through which normal 
cells can become cancerous is critical to understanding tumour formation and the 
development of therapeutic agents. One of the key features of cancer cells is their 
ability to grow and proliferate in an uncontrolled manner (Hanahan and Weinberg,
2000). Analysis of the genetic alterations in cancer cells has revealed a large number 
of proto-oncogenes and tumour suppressor genes that encode proteins that are 
deregulated in tumour cells and can lead to aberrant growth and proliferation. The 
vast majority of work on the products of these tumour suppressor and oncogenes has 
focussed on their ability to control the cell cycle, and comparatively little work has 
been done on their ability to regulate cell growth. S'
Cell growth requires an accumulation of protein, which is dependent on the increase
in the translational capacity of the cell. Translational capacity is determined by the 
. .availability of a number of factors including ribosomal proteins, rRNAs, tRNAs and 
limiting translation factors (outlined in Chapter 1). Products of the genes transcribed 
by pol III are critically involved in the biosynthetic capacity of the cell, and the :
understanding of the mechanisms behind their regulation is essential to understanding 
cell growth (White, 2002). Pol III transcription is elevated in many transformed and 
tumour cell types and its activity regulated by a number of tumoui" suppressors and 
oncogenes (White, 2004).
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The C"Myc proto-oncogene is mutated or deregulated in a high proportion of tumours 
and can lead to the formation of tumours in experimental model systems (Dang, 1999;
Nesbit et al, 1999). In fact, deregulated expression of Myc is found in 1 in 7 of all US 
cancer deaths (Dang, 1999; Nesbit et al, 1999). Initial characterisation of Myc target 
genes revealed many of its functions could be attributed to regulating the cell cycle, ■
leading to the view that regulation of cell division is the principle mechanism for c-
Myc dependent transformation of cells (Grandori and Eisenman, 1997). It is now
becoming cleai’ that c-Myc not only regulates genes involved in the cell cycle, but 
also has a profound influence on cell growth though activation of genes critical in this 
process (Gomez-Roman et al, 2005). c-Myc can potently and directly activate 
transcription by pol III and this accumulation of essential components, critical for 
protein synthesis, may be key to c-Myc-induced growth (Gomez-Roman et al, 2003). I
The work in this thesis examined the mechanisms behind the activation of pol III 
transcription by c-Myc, and identified co-activator proteins involved in this process. 
An understanding of how oncogenes can activate cell growth is critical to our 
understanding of cancer and with c-Myc being proposed as an attractive therapeutic 
target in cancer (Hermeking, 2004; Prochownik, 2004), it is important to fully 
understand its action.
Î
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6.1 Mechanisms behind the c-~Myc-dependent activation of pol 
Hi transcription
6.1.1 c-Myc can bind to TFIIIB and contributes to Its recruitment to 
pol III promoters
The transcription of a class III gene is dependent on the recruitment of the general
transcription factors followed by recruitment of the polymerase (Schramm and 
Hernandez, 2002). For the majority of genes transcribed by pol III, this is determined 
by the binding of TFIIIC and TFIIIB to the promoter regions and subsequent binding
iof the polymerase (Schramm and Hernandez, 2002). I have demonstrated that c-Myc
can facilitate the formation o f this complex by promoting the recruitment of TFIIIB
and pol III to the promoters of 5S rRNA and tRNA genes in vivo, but does not alter
the promoter occupancy of TFIIIC (Figures 4.6 and 4.8). The mechanism by which c-
Myc can do this is unclear, as neither 5S rRNA nor tRNA genes contain E-box
sequences to which c-Myc could bind and recruit the transcription machinery
,(Gomez-Roman et al, 2003). The observation that c-Myc and TFIIIB can bind in the
absence of DNA through co-immunoprecipitation experiments (Figure 3.8; Gomez-
Roman et al, 2003), may suggest that their initial interaction is in the nucleoplasm and
precedes DNA binding; this binding could lead to the activation of the TFIIIB 
.complex that increases its affinity for TFIIIC. I have further characterised the 
interaction between c-Myc and TFIIIB, demonstrating that c-Myc can bind to TBP 
and Brfl in vitro (Figure 3.2). The activation of TFIIIB by c-Myc may be through a 
host of mechanisms, from precluding a TFIIIB/repressor complex interaction, altering 
the conformation of TFIIIB, tlirough binding or post-translational modification of
I
TFIIIB by Myc interaction complexes (Figure 6.1).
I
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Figure 6.1 Activation of TFIIIB by c-Myc
Induction of c-Myc may activate TFIIIB and promote the formation of the TFIIIB- 
TFIIIC complex in several ways; competing for binding sites with repressor (R) 
proteins, inducing a conformational change in TFIIIB and/or post-translational 
modification by one of the many c-Myc-binding complexes (MBCs).
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6.1.2 c-Myc activation of pol III transcription by a sequential
Î
recruitment of general transcription factors
The formation of the transcription complex on class III genes is well studied in vitro 
and the order of binding relatively well defined (Figures 1.2, 1.3, 1.4; Schramm and 
Hernandez, 2002). However, this step-wise ordered recruitment of transcription 
factors onto a pol Ill-transcribed gene may not happen in vivo. In the formation of 
the transcription machinery of pol II, there is considerable evidence that factors may 
be assembled off of the DNA and may therefore be recruited to the promoters as a 
pre-formed complex. Various groups have identified these holoenzyme complexes 
and have proposed that pol II transcription complex formation may bypass some of 
the stages of the sequential recruitment of factors to a gene (Thomson et al, 1993;
Ossipow et al, 1995). TFIIIB, TFIIIC and pol III have also been found to be 
associated in the absence of DNA in Drosophilia and human cell extracts (Burke and 
Soil, 1985; Wingender et al, 1986). The formation of a pol III holoenzyme complex
containing TFIIIB, TFIIIC and pol III has been proposed (Wang et al, 1997).
■ ■■
During the activation of 58 rRNA and tRNA transcription by c-Myc there is no 
.evidence of the recruitment of a preformed holoenzyme complex. ChIP analysis
I
reveals that the promoter occupancy of TFIIIC remains constant, regardless of the 
presence of c-Myc (Figure 4.4 and 4.6). The activation of c-Myc results in a 
recruitment of TFIIIB to 58 rRNA and tRNA genes, that precedes the activation of 
transcription (Figures 4.4 and 4.6). The recruitment of pol III is delayed and occurs 
after TFIIIB recruitment (Figure 4.6). In the experimental conditions, c-Myc does not 
alter the levels of the pol III general transcription factors examined; therefore the
212
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changes in occupancy are dependent on c-Myc dependent recruitment (Figures 4.5 
and 4.6). This evidence would suggest that, at least in response to activation by c- 
Myc, the recruitment of a pol III transcription complex to the promoters of target 
genes involves a step-wise formation of the pre-initiation complex.
6.1.3 c-Myc recruitment leads to Increases in localised histone 
acétylation surrounding pol III transcribed genes
The correlation between histone acétylation and increased transcription has been
known for many years (Allfirey et al, 1964), In recent years it has become apparent
that changes in the localised histone acétylation state surrounding the promoters of
genes can have effects on their transcription (Lee et al, 1993; Mizzen and Allis,
1998). High levels of acétylation are generally associated with active genes, with
areas of the genome that are hypo-acetylated associated with a repressed state of 
. .transcription (Jenuwein and Allis, 2001; Eberharter and Becker, 2002). c-Myc can 
directly interact with several HATs, including CBP and TRRAP-containing HAT 
complexes, and can recruit these complexes to the promoters of target genes 
(Bouchard et al, 2001 ; Frank et al, 2001 ; Vervoorts et al, 2003). The recruitment of c- 
Myc to 5S rRNA and tRNA genes leads to a significant increase in levels of 
acetylated histone H3, but no change in the levels of histone H4 acétylation (Figure 
5.8). This observation is surprising, as the majority of the work performed on c-Myc 
dependent acétylation of the promoters of target genes implicated both histone H3 and 
H4 as being acetylated, with histone H4 being the primary target (Frank et al, 2001; 
Bouchard et al, 2001; Nikiforov et al, 2002; Fernandez et al, 2003; Grandori et al, 
2005; Arabi et al, 2005).
.'g
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and the occupancy of this factor does not change throughout the experiment, it is
enzymes.
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The acétylation of histones surroimding the promoters of genes is postulated to 
activate transcription of genes in two ways. Acétylation of the histone tails can 
weaken the histone-DNA and histone-histone interactions to lead to the opening of the 
chromatin to facilitate the association of transcription complexes with the DNA 
(Strahl and Allis, 2000; Turner, 2000; Fischle et al, 2003). The other mechanism is 
that the acetylated histone tails form interaction domains for the binding of other 
effector molecules that contain bromodomains, which can specifically bind to 
acetylated lysme residues (Ornaghi et al, 1999; Dhalluin et al, 1999; Bottomley, 
2004). As TFIIIC is associated with almost the entire length of a tRNA or 5S gene,
difficult to imagme the need for alleviating chromatin-mediated repression of pol III 
transcribed genes, albeit it may be necessary at the start site of transcription and 
upstream of the gene to allow TFIIIB and pol III binding (Schramm and Hernandez, 
2000; White, 2002). The localised histone acétylation may in fact form binding 
domains on the chiomatin for unidentified bromodomain-containing complexes to act 
as co-activators for pol III transcription (Roth et al, 2001; Bottomley, 2004). This 
additional unidentified step may explain the delay in binding of the polymerase. It is 
interesting to note that the Brgl ATPase, the catalytic subunit of a SWI/SNF complex 
found associated with pol Ill-transcribed genes, contains a bromodomain (Sif, 2004),
and the histone acétylation may recruit ATP-dependent chromatin remodelling
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6.1.4 TRRAP and Gcn6 are recruited to pol Ill-transcribed genes by 
c-Myc and are involved in activation of transcription
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TRRAP was originally identified as a c-Myc co-activator protein that was necessary 
for c-Myc-mediated transformation, and forms the scaffold of a variety of HAT 
complexes with different catalytic subunits (McMahon et al, 1998; Ogryzko et al, 
1998; Ikura et al, 2000). Work in this thesis has demonstrated that TRRAP is present 
on the promoters of pol Ill-transcribed genes in five different cell lines, and its 
occupancy correlates with the presence of c-Myc (Figures 5.3, 5.5, 5.6, 5.7 and 5.9). 
When using a c-Myc-inducible cell line, TRRAP is recruited to 5S rRNA and tRNA 
genes in a c-Myc-dependent manner and this correlates well with the hyperacetylation 
of histone H3 and recruitment of Gcn5, a H3-specific HAT (Figures 5.7, 5.8 and
5.12). When the endogenous TRRAP protein is knocked down by RNAi, this results 
in a specific down-regulation of pol III transcription, indicating that TRRAP is indeed
involved in the activation of class III genes (Figure 5.11). TRRAP can bind to TFIIIB 
through an interaction that is dependent on c-Myc, and this may represent a 
mechanism tluough which TRRAP is bound to the promoters of class III genes 
(Figure 5.9). Another line of evidence suggesting that TRRAP is involved in the 
activation of pol III transcription is the lack of any transcriptional activation from a 
mutant Myc protein that fails to interact with TRRAP. The mutant missing the MBII 
region can efficiently bind to TFIIIB, but cannot activate the transcription of a pol III
..Vreporter gene in cells (Figures 3.8 and data not shown). MBII is critical for the 
binding of c-Myc to TRRAP-containing complexes, and the inability of this mutant to
:::
interact with the HAT complex may explain the lack of transcriptional activation 
(McMahon et al, 1998).
I
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Although its presence is enhanced on pol Ill-tianscribed genes, there is evidence that
The target of the acétylation may not only be histones; there is a variety of evidence 
now that many cellular proteins including transcription factors can be acetylated and 
this acétylation can alter their activities (Kouzarides, 1998). For example, the pol ÏI 
basal transcription factors TFIIB, TFIIEp and TFHF can be acetylated to regulate their 
activities (Choi et al, 2003; Imhof et al, 1997). The c-Myc protein may form a 
complex with TFIIIB, prior to binding to the DNA, and recruit HATs to acetylate 
subunits of this complex to alter TFIIIB activity. This needs to be investigated, but 
would offer a mechanism for the activation of TFIIIB by c-Myc. Also a possibility is 
that c-Myc/TRRAP/Gcn5 recruitment may lead to acétylation of other factors of the 
pol III transcription machinery to activate transcription.
The deletion of the MBI region of c-Myc can also prevent c-Myc-dependent 
activation of pol HI transcription, but not bmding to TFIIIB (Figures 3.8 and data not 
shown). Why deletion of this region prevents activation pol III transcription is 
unclear, but may indicate another protein complex that can bind to c-Myc in a MBI- 
dependent manner and act as a co-activator for pol III transcription.
TRRAP can bind to pol Ill-transcribed genes in the absence of c-Myc (Figure 5.6). 
TRRAP is homologous to the yeast Tral protein, which is an essential protein in yeast
and, like its mammalian equivalent, is also a scaffold for essential HAT complexes 
(Saleh et al, 1998; Grant et al, 1998; Allard et al, 1999; Brown et al, 2001). As there 
is no c-Myc homologue in yeast, it would be interesting to test if Tral disruption 
would have any effect on pol III transcription in these cells. In mammalian cells,
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TRRAP not only binds to c-Myc but has also been demonstrated to interact with the 
E2F-1 transcription factor and to nuclear receptors (McMahon et al, 1998;
Yanagisawa et al, 2002; Fan et al, 2004), so there may be an unidentified interaction 
with other pol III transcription factors that can explain its presence at the promoters of 
5S and tRNA genes in the absence of c-Myc. Further work needs to be done to 
determine if TRRAP can and act on transcription in the absence of c-Myc.
6.1.5 Is TRRAP a regulator of cell growth?
Work in this thesis has demonstrated that the TRRAP protein is involved in the 
activation of pol III transcription. Recent work on c-Myc activation of pol I 
transcription has demonstrated that TRRAP is also recruited to the rDNA repeats in a 
c-Myc dependent manner (Arabi et al, 2005). TRRAP knockout mice die at less than
7.5 embryonic days (<7.5E) and TRRAP blastocysts recovered at 3.5E displayed 
severe growth retardation and the absence of an inner cell mass (Herceg et al, 2001). 
The regulation of pol I and pol III transcription may contribute to tiiis growth 
retardation, as their products are essential for protein biosynthesis. Primary cells with 
TRRAP deleted are not viable, but conditional TRRAP knockout embryonic stem 
cells were developed and global gene expression was analysed using a cDNA 
micro array (Herceg et al, 2003). A number of genes down-regulated by TRRAP were 
involved in protein biosynthesis, including a polymerase subunit shared by pol I, II 
and III (Herceg et al, 2003). Although pol I and pol III transcripts were not looked at 
in this study, it would be interesting to discover if the rates of transcription of their 
respective products are affected by this deletion.
■I:'
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Î6.1.6 Proposed mechanism of c-Myc activation of pol
transcribed genes
The data summarised above have led to the following model of the c-Myc dependent
activation of pol III transcription. Mitogenic stimulation of cells can lead to the
.induction of the c-Myc protein. c-Myc can then interact with the TFIIIB complex to 
promote the formation o f the TFIIIB-TFIIIC interaction. The c-Myc protein can 
recruit TRRAP and Gcn5 to TFIIIB, and they are present on 5S rRNA and tRNA 
genes in vivo. This recruitment of the TRRAP/Gcn5 complex correlates with a 
localised increase in the levels of histone H3 acétylation, followed by the recruitment 
of pol III and the subsequent activation of pol III transcription (Figure 6.2)
%
Chapter 6 Final Discussion
Figure 6.2 Activation of a tRNA gene by c-Myc
A. Inactive tRNA gene with TFIIIC bound. B. c-Myc induction leads to recruitment 
of the of c-Myc, TFIIIB and the TRRAP/ Gcn5 HAT complex. This leads to localised 
acétylation of histone H3. C. The recruitment of the HAT complex is followed by 
recruitment of the polymerase and activation of transcription.
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6.2 c-Myc may activate pol III transcription directly and
Indirectly
Î
.It has been unequivocally demonstrated that c-Myc can bind to pol Ill-transcribed 
genes and directly activate their transcription (Gomez-Roman et al, 2003). In the 
context of a cell, c-Myc may also indirectly contribute to the activation of pol III 
transcription. It has been demonstrated in this thesis that c-Myc fibroblasts have 
lower levels of the Brfl protein than the matched wildtype; this may be a direct effect 
as the Brfl promoter contains good matches for E-box sequences (Figures 4.9 and
4.13). This is an interesting observation, as levels of the Brfl protein can be limiting 
for pol III transcription in certain cell types (Fahley et al, 2003, Felton-Edkms et al, 
2003a). It has been previously demonstrated that c-Myc can directly activate the 
transcription of the pol III subunit BN51 (Figure 6.3; Greasley et al, 2000; Fernandez 
et al, 2003). The BN51 subunit of pol III has been demonstrated to be critical for cell 
cycle progression in both yeast and mammals, with temperature-sensitive mutations 
of BN51 in a hamster cell line and the BN51 homologue in S. cerevisiae causing G1 
arrest at the non-permissive temperature (Ittmann et al, 1987; Ittmann et al, 1993; 
Jackson et al, 1995; Mann et al, 1992). It may be that c-Myc can alter the levels of 
limiting pol Ill-specific transcription factors to stimulate pol III transcription, and 
further work may reveal that Brfl and BN51 are not isolated examples of this. Also it 
is well established that c-Myc can stimulate cell cycle progression through activation 
of CDKs and repression of CDK inhibitors (Figure 6.3; Dang et al, 1999; Eisenman, 
2001; Adhikary and Eilers, 2005). This stimulation of cell cycle progression will 
result in the hyper-phosphorylation and inactivation of RB and the related pocket 
proteins, leading to a derepression of pol III transcription (Figure 6.3; Scott et al,
2001). RB and c-Myc may also compete for binding sites on the TFIIIB complex
221
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(discussed in Chapter 3). Although the interaction domains of c-Myc and RB on Brfl
are clearly distinct, they are both in the same region of the protein, and perhaps due to 
steric interactions RB and c-Myc may not be able to bind to TFIIIB at the same time
(Figures 3.4 and 3.5). It would be interesting to determine if they could complete for 
binding sites on TFIIIB, thus changing its activation state (Figure 6.1). Work still has 
to be done to elucidate any indirect effects of c-Myc and their contribution to the 
activation of pol III transcription.
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Figure 6.3 Indirect and direct activation of pol III transcription
c-Myc may work in several ways to activate pol III transcription. A. Activation of c- 
Myc is directly involved in the induction of cyclins and CDKs, as well as inhibiting 
the expression of CDK inhibitors. These events will lead to phosphorylation of RB 
and the related pocket proteins, and would relieve Rb- and pi 30-dependent repression 
of pol III transcription. B. c-Myc can bind to pol Ill-transcribed genes and directly 
activate transcription. C. c-Myc may promote the expression of limiting factors in 
pol III transcription: it has previously been demonstrated that the pol III subunit BN51 
is a direct target of c-Myc and work in this thesis has suggested that Brfl may also be 
induced by c-Myc.
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6 .3  Are other members of the Myc/Max/Mad family involved in 
the reguiation of poi III transcription during differentiation of 
MEL cel is?
I  
iDuring the terminal differentiation of MEL cells there is a marked reduction in the 
levels of c-Myc and this is accompanied by a reduction in the levels of pol III 
transcription (Figui'cs 4.10 and 4.11). This is reflected on the promoters of these 
genes with the reduced occupancy o f c-Myc and pol III, as confirmed by ChIP 
analysis (Figure 4.12). In the same experiment, the promoter occupancy of Max was 
also tested, and surprisingly the levels associated with the 5S rRNA and tRNA genes 
stayed constant throughout the experiment (Figure 5,9). This would suggest that Max 
can bind to pol Ill-transcribed genes in the absence of c-Myc, and perhaps it is present 
there in complex with other binding partners.
I
I
Also witnessed during the differentiation of the MEL cells is a reduction in the levels ;
of histone H3 acétylation surrounding the 5S rRNA and tRNA genes (Figure 5,9).
This may simply be due to the dissociation of the c-Myc/TRRAP complex, but the 
short time course of this experiment may suggest that the deacetylation is an active 
process and that HDAC complexes are recruited (Figure 5.9), During the 
differentiation of these cells the levels of the Mad proteins have been shown to 
increase as the level of c-Myc decreases (Cultraro et al, 1997; Kime and Wright,
2003). Mad proteins can interact with HDAC complexes via an interaction with 
mSin3, through the SID in Mad (Ayer et al, 1995; Hassig et al, 1997; Sommer et al,
1997), and these complexes can be recruited to the E-boxes of target genes during 
differentiation of HL-60 cells (Bouchard et al, 2001; Xu et al, 2001). It may therefore 
be that HDACs can be recruited to pol III-transcribed genes during MEL cell
225
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This model leaves the intriguing question as to how Max alone or a Mad/Max 
complex can associate with pol Ill-transcribed genes. The TFIIIB complex is still 
present on the promoters in these genes and it could be that Mad family proteins can 
bind to TFIIIB proteins through an unestablished interaction domain with a TFIIIB 
subunit.
In summary the work in this thesis describes novel insights into how c-Myc can 
activate pol III transcription. I have demonstrated that c-Myc can recruit HAT 
complexes to pol Ill-transcribed genes and alter the levels of localised histone 
acétylation, which correlates with an activation of pol III transcription. This work 
further improves our understanding of the regulation of pol III transcription by the c- 
Myc protein in vivo.
226
Chapter 6 Final Discussion
differentiation (Figure 6.4). This switching from c-Myc and associated HATs bound 
to an active hyperacetylated gene to Madl and HD AC binding to repressed 
hypoacetylated genes has been demonstrated on genes transcribed by pol II (Bouchard 
et al, 2001 ; Xu et al, 2001). This may happen on the promoters of pol Ill-transcribed 
genes, but still needs to be investigated.
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Figure 6.4 Model for differentiation of the MEL cell line
During differentiation of the MEL cell line the levels of the c-Myc protein fall sharply 
and this correlates with a reduction in pol III transcription. At the promoter level, 
occupancy of c-Myc and pol III are reduced during differentiation. Histone H3 
acétylation is also lower in the differentiated cells. The levels of the c-Myc binding 
protein Max and TFIIIB stay constant during this process. As Max levels do not 
reduce, it may suggest that the reduction in histone acétylation is perhaps due to the 
recruitment of Mad and an associated HD AC complex.
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